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Abstract 
 
In recent years there has been an increasing interest in using lipid vesicles and related 
membrane structures as (i) artificial cells that mimic biological processes and (ii) bio-
inspired micro-machines that serve functional purposes. To date, vesicles have largely 
been single-compartment structures with homogenous interiors, which has impeded 
the fulfilment of these goals. 
This thesis details the development of technologies to address this. We develop 
droplet-based methods to controllably generate multi-compartment vesicles (MCVs) 
for the first time. The potential of these novel structures as artificial cells capable of 
hosting a range of biological and bio-mimetic processes is explored. Most notably, we 
introduce spatial segregation of function, thus mimicking eukaryotic organelles, and 
incorporate an artificial enzymatic signalling cascade to transmit chemical signals 
between distinct vesicle regions.   
We also construct microfluidic devices to generate related structures known as 
multisomes. Microfluidic technologies enable the size of these constructs to be scaled-
down (approaching characteristic cellular sizes), and the production throughput to be 
scaled-up (hundreds of multisomes produced a minute). We demonstrate their use as 
programmable modular microdroplet ‘factories’ for in situ chemical synthesis in 
physiological environments, with potential relevance for therapeutic applications.  
The above technologies provide a platform for further developments in bottom-up 
synthetic biology and in microreactor technologies, and will pave the way for the 
fulfilment of some of the ambitious goals of these fields.   
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Chapter 1 - Introduction 
  
Parts of the introduction have been published by us as  Yuval Elani et al., Novel 
technologies for the formation of 2-D and 3-D droplet interface bilayer networks, Lab 
on a Chip 12.18 (2012): 3514-3520.[1]  
1.1 CHAPTER OUTLINE 
The broad aim of this thesis is to develop droplet-based technologies to construct 
compartmentalised vesicles, and to demonstrate their use as artificial cells and 
microreactors. The introduction that follows serves to give readers the basic 
background information concerning relevant topics, and to put this thesis into the 
context of current scientific literature. It is split up into four sections. The first 
provides an overview of cell membranes, describing their structure and function, as 
well as some of their biophysical properties. The second introduces the discipline of 
microfluidics, with particular emphasis on how it has been used to construct model 
membranes and artificial cells. In the third section, a brief review of artificial cells and 
bottom-up synthetic biology will the given. Finally, the thesis aims will be presented. 
This introduction is not intended to be an exhaustive review of the literature, but 
presents only the most necessary and relevant topics. Many excellent recent reviews 
have been published in these and related fields and we refer the reader to them as they 
are discussed.  
1.2  LIPIDS AND MEMBRANES  
1.2.1 Membranes in Biology 
1.2.1.1 Cellular Compartmentalisation  
Biological membranes act as semi-permeable barriers between various biological 
bodies: they define the outer parameters of cells, and compartmentalise intra-cellar 
structures (organelles) such as the nucleus, lysosomes, mitochondria, endoplasmic 
reticulum, and golgi apparatus.[2] Membranes protect the integrity of cellular interiors 
by selectively allowing certain substances in whilst keeping others out. They are 
principally composed of lipid bilayers, and are approximately 5 nm thick (although this 
depends on the length of the fatty acid tails of the constituent lipids).[2] The intra- and 
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inter-cellular compartmentalisation created by membranes is essential for 
concentration gradients to be built up, thus enabling chemical and biological processes 
to occur.[3]  
1.2.1.2    Membrane Lipids 
Lipids, the primary components of membranes, are amphiphilic molecules: they are 
composed of a hydrophilic headgroup and a hydrophobic fatty acid tail region. In 
membranes, they arrange themselves as bilayers with hydrophobic tail regions facing 
each other, thus preventing unfavourable interactions between their hydrophobic 
components and the surrounding aqueous solution.  
There exists a tremendous degree of heterogeneity in lipid composition of membranes 
— a feature which exists across all life classes — with thousands of different lipid 
types present in a typical membrane.[2] These differ from one another in the 
headgroup chemical structure, and in the number, length and saturation of their fatty 
acid tails.   
Lipids are usually classed together according to their headgroup, which leads to three 
main broad lipid categories:   glycerophospholipids, sphingolipids (together classed as 
phospholipids) and glycolipids. The sterols (e.g. cholesterol) are another type of lipid 
with a distinct structural motif; they  have a bulky structure that influences membrane 
rigidity and fluidity.[4] The chemical structure of the various lipid types are shown in 
Fig. 1.1. For a review of membrane lipid composition, refer to the review publication 
by van Meer et al.[2]  
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Fig. 1.1 – Lipid chemical structures. An illustration of the different types of common lipids 
found in cell membranes, grouped according to headgroup motif. Notice that lipids can vary in 
terms of their headgroups, fatty acid chain length and degrees of saturation. Image modified 
from Wikimedia Commons. 
Different lipid families are found in different proportions in the various membranes 
within the same cells. For example in plant cells, phosphatidylserine (PS) lipids are 
found in larger quantities in the plasma membrane, compared to the mitochondrion 
membrane.[5] In addition, the presence of different lipid classes differ across the life 
classes. For example, phosphatidylinositols (PI) lipids are found in significantly greater 
numbers in fungi compared to plant cells.[2] Fig. 1.2 depicts the variation present in 
various eukaryotic membranes.  
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Fig. 1.2 – Lipid heterogeneity in eukaryotic cell membranes. The bar charts show the 
relative lipid compositions in various membranes in plant cells (dark blue) and yeast cells (light 
blue). Image modified from referenced publication.[2] 
1.2.1.3    Gross Membrane Structure  
In 1972, Signer and Nicolson proposed the fluid mosaic model to describe the 
membrane’s gross structural features, portraying the membrane as a sea of lipids in 
which proteins are embedded.[6]  The membrane can thus be considered a two 
dimensional viscous fluid, where lipids are able to traverse in the plane of the 
membrane. A typical membrane is composed of lipids, cholesterol and proteins (all of 
which may be glycosylated), as well as cytoskeletal filaments. A schematic of this is 
shown in Fig. 1.3. 
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Fig. 1.3 - Typical gross membrane structure and composition. Membranes consist of 
integral and peripheral proteins, which may or may not be glycosylated, embedded in a fluid 
lipid bilayer. Specific groupings of lipids and proteins aggregate to form microdomains of high 
order and rigidity called lipid rafts. Image adapted from referenced publication.[7] 
Membranes possess several well-established localised properties, including electrical 
membrane potentials and dipole potentials.[8] One more widely disputed feature is that 
of lipid rafts: these are thought to be microdomains of high rigidity that exist within 
the plasma membrane.[9] They are believed to be more ordered and more tightly 
packed than the surrounding membrane, yet able to float freely within it. It has been 
argued that rafts are enriched in sphingomyelin, glycolipids, and cholesterol – species 
that are responsible for their high order and rigidity. [10] Some studies suggest that they 
serve functions in protein recruitment (they show higher affinities for certain proteins 
and lower affinities for others), while others suggest that they influence protein 
trafficking.[10] However, their precise function and even existence is still hotly debated, 
with several researchers arguing they are simply experimental artefacts.[11]  
1.2.1.4    Membrane Proteins  
In addition to providing a chemical barrier to the cellular interior, membranes also act 
as hosts in which proteins reside. Membrane proteins can be either fully embedded 
(integral proteins) or partially embedded (peripheral proteins) within the membrane 
(see Fig. 1.3). A survey of the proteome revealed that ca. 30% of all proteins within a 
typical cell are membrane-associated, with a further ca. 20% interacting with the 
membrane in some way.[12]   Amongst other functions, membrane proteins can act as 
pores or pumps, facilitating molecular transfer with varying degrees of selectivity, or as 
receptors which transmit external chemical signals to cellular interiors.[3] Membrane 
proteins differ from non-membrane proteins: the regions that reside in the bilayer 
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(known as the transmembrane domains) are hydrophobic, and the regions exposed the 
aqueous environment are hydrophilic. This feature means that membrane-associated 
proteins do not typically adopt their native fold in aqueous solution. Membranes 
however do not simply provide a passive matrix in which proteins reside: they also 
exert an active influence on protein structure and function via collective properties, as 
discussed later.  
1.2.1.5    Membrane Asymmetry 
Biological membranes are almost universally asymmetric: there is a compositional 
difference in the lipid compositions of the inner and outer leaflets of the bilayer. This 
feature is found across various life classes (in plants, fungi, and metazoa), and amongst 
membranes of several types (plasma membranes, golgi apparatus, and endosomal 
membranes).[2] 
Different membranous structures possess varying degrees of asymmetry, with plasma 
membranes generally possessing greater asymmetry compared to intra-cellular 
membranes. The extent of asymmetry also differs between the lipid families (Fig. 1.4). 
For instance, in mammalian plasma membranes, choline-containing phospholipids are 
more predominant in the outer leaflet, while amino-phospholipids are present to a 
greater degree in the inner leaflet. Serine-phospholipids are almost exclusively 
contained to the inner leaflet.[2]  
 
Fig. 1.4 – Asymmetric membranes. The bars show the relative proportions of each lipid 
class in the inner and outer leaflet of a mammalian erythrocyte membrane, showing an 
asymmetric lipid distribution. It also shows that certain lipid families exhibit a greater 
asymmetry than others. Image taken from referenced publication.[13]  
1.2.1.6    Lipid Flip-flop  
In contrast to movement within the bilayer plane, the movement of lipids through the 
bilayer (referred to as flip-flop) is generally much slower, as hydrophilic headgroups 
Introduction  
  20   
 
must pass through the hydrophobic bilayer interior — an energetically unfavourable 
process. Flip-flop kinetics depend on the size and charge of the headgroup as well as 
the length and saturation of the lipid tails.[14]  For example, DOPC flip-flop is several 
orders of magnitude slower that than uncharged fatty acids, which have half-lives of 
milliseconds.[15] However, it is important to note that precise flip-flop rates are still 
under scrutiny. Several studies which used sum-frequency vibrational spectroscopy 
(SFVS) for flop-flop measurements indicate that spontaneous flip-flop is actually 
significantly faster than previously reported.[16-18]  
Membrane asymmetry exists in cells despite the stochastic flipping of lipids between 
the leaflets which would normally lead to an equilibrated symmetric bilayer.[15] This is 
achieved by specialised enzymes which move lipids from the outer to the inner leaflet 
(flipases), as well as in the opposite direction (flopases).[5] These processes are 
adenosine triphosphate (ATP) dependent, with the cell devoting significant resources 
in order to maintain asymmetry  — a strong indication that asymmetry plays 
important roles in cellular events.[19]  A third enzyme type, scramblases, facilitate 
translocation in both directions (thus ‘scrambling’ lipid asymmetry) and are dependent 
on the presence of calcium.[19] The functions these three enzymes are summarised in 
Fig 1.5. 
 
Fig. 1.5 – Enzymes involved in lipid flip-flop. This schematic summarises the three types of 
enzymes which are involved in the maintenance (and indeed the disruption) of asymmetry, and 
their dependence on ATP or Ca2+. Flipases move lipids from the outer to the inner leaflet, 
flopases do the reverse, and scramblases facilitate movement in both directions. 
 
1.2.1.7    Biological Role of Asymmetry  
Processes thought to be associated with membrane asymmetry include: endocytosis,[20] 
vesicle budding and trafficking,[19] signal transduction,[21-22], membrane curvature,[23] 
modulation of protein channel opening,[24] and the regulation of membrane associated 
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enzyme activity[25] (refer to publications by van Meer et al. and Boon et al.  for 
excellent reviews).[2, 22] 
One of the more well established phenomena is the role that loss of asymmetry plays 
in the apoptotic process: when cells apoptose, scrablases are activated, resulting in the 
exposure of PS on the outer leaflet of the bilayer.[26] This serves as a signal for 
macrophages to phagocytose these apoptotic cells. Surface-exposed PS has also been 
shown to be involved in the coagulation cascade in blood platelets. Dysfunction of 
asymmetry maintaining enzymes has been implicated in several pathologies, including 
Scott Syndrome, which is thought occur due to defective scrambling of membrane 
phospholipids.[27] 
Although asymmetry appears to be important in influencing cellular processes, its 
exact consequences and the mechanism by which it does this are considered to be 
relatively poorly explored and understood. One reason for this is the lack of 
appropriate methods to generate asymmetric model membranes. The recent 
development of phase transfer methodologies for vesicle generation allows this state 
of affairs to change. In this thesis, we explore the possibility of asymmetry influencing 
cellular processes by affecting membrane mechanics.  
1.2.1.8    Lipid Function 
Apart from forming a chemical barrier between the cellular interior and exterior and 
acting as hosts for membrane proteins, lipids have a variety of other functions. They 
act as cellular energy stores (particularly triglycerides) and influence protein behaviour 
via direct protein-lipid interactions.[28] They also play a key role in influencing 
membrane fluidity. Membrane composition is controlled by cells to maintain constant  
fluidity in response to environmental pressure and temperature changes (for example, 
sea organisms traversing through varying ocean depths, and varying pressures).[29]  
In addition, lipids are used as secondary messengers (signalling molecules), relaying 
messages received at the receptor, through the cell membranes, into the cellular 
interior.[3] One such example, the phosphoinositides, are a lipid group found on the 
cytoplasmic side of the membrane. These have been extensively studied due to their 
involvement in, and relevance to, cancer signalling pathways.[30]  
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Furthermore, lipid composition can direct local membrane shape away from the flat 
bilayer geometry. For example, it has been suggested that cells induce the formation of 
highly curved structures during membrane fusion and exocytosis by adjusting local 
lipid composition to include non-bilayer forming lipids.[31-32]  
Lipids also play an indirect role in cellular processes by influencing a membrane’s 
global biophysical features. These are being increasingly understood to have biological 
implications, for example by influencing tertiary protein structures, protein folding 
pathways, and gating of pores (particularly mechanosensitive channels)[2] as well as 
determining drug-membrane interactions.[33] Some of the relevant concept in 
membrane biophysics will now be discussed.  
1.2.2  Membrane Biophysics 
1.2.2.1    Lipid Phases  
In aqueous solutions, lipids self-assemble to yield a variety of supramolecular 
assemblies, known as lipid phases. The thermodynamic driving force behind this is the 
hydrophobic effect,[34] with lipids arranging themselves to minimise their hydrophobic 
component’s contact with water, whilst still keeping their polar headgroups hydrated. 
The precise phase that lipids adopt depends on their chemical structure (which 
influences their intrinsic curvature, discussed below), concentration, hydration levels, 
and surrounding temperature and pressure.  
In cells, the most common phase is the lamellar or bilayer phase. However, both in 
cells and in artificial lipid systems, other phases may also assemble, which differ from 
one another by the extent and direction of monolayer curvature. These include the 
micellar, hexagonal, and cubic phases (Fig. 1.6), and their inverse counterparts. In 
addition, within these generic phases, lipids can exhibit differing degrees of order. For 
example in the lamellar liquid phase, Lα lipids have high translational mobility, and 
high diffusion rates across the plane of the bilayer. This is in contrast to the gel phase, 
Lβ, where lipids are more ordered and the bilayer more viscous. For a review of 
polymorphic lipid phase behaviour, refer to the review publication by Seddon et al.[35]   
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Fig. 1.6 – Lipid phases. (A) Liquid lamellar phase, Lα. (B) Gel lamellar phase, Lβ. (C) Micelle 
phase. (D) Hexagonal phase. (E) Inverse cubic phase. Images adapted from various review 
publications.[31, 36-37] 
1.2.2.2    Phospholipid Type Based on Geometric Profile 
Lipids can be broadly split into three types according to their geometrical profile, 
which is based on the relative cross-sectional areas of the headgroups and tail 
regions.[38] As such the degree of saturation, number of fatty acid tails, and the 
chemical substituents present all contribute to the geometrical profile of the lipid in 
question. These three classes exhibit a different preferred monolayer curvature and 
therefore tend to form different phases (Fig.1.7).  
Type 0 lipids (for example, DOPC) have a cylindrical geometric profile due to the 
similar cross sections of the tail and headgroup regions. Such cylinders can pack 
adjacent to one another with no resulting desire for curvature. Their presence 
therefore favours the adoption of the lamellar phase. Type I lipids have larger 
headgroup cross-sectional areas compared to the tail regions. They therefore have a 
cone like profile, and when arranged adjacent to one another have a desire to curve 
away from the water interface. They therefore favour the adoption of micellar phases. 
Lipids that have a single fatty acid chain (lysophospholipids) have a small associated 
tail cross sectional area belong to this class. Type II lipids have a larger tail cross 
sectional area compared to the headgroup region, and thus possess an inverse cone 
profile. Type II lipids include those with small headgroup substituents (such as PE). 
When packed adjacent to one another they have a desire to curve towards the water 
interface, favouring the formation of inverse phases.  
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Fig. 1.7 – Lipid types based on their geometrical profile. (A) Lipid types are defined by 
the relative cross sectional areas of the headgroup and tail regions. (B) This causes lipid 
monolayers to possess different intrinsic curvatures. (C) Different monolayer curvatures tend 
to result in lipids adopting different phases.  
1.2.2.3    Membrane Curvature and Bending Elasticity  
In order to mathematically describe membranes as two-dimensional surfaces existing 
in three-dimensional space, it is necessary to determine the two curvatures that 
characterise their geometrical shape. These are known as the principle curvatures, 
denoted as c1 and c2, which are equal to the inverse of the principle radii of curvature 
R1 and R2 respectively (Equation 1.1), as shown in Fig. 1.8. 
ܿଵ ൌ 1ܴଵ 																		ܿଶ ൌ
1
ܴଶ 																				ሺ1.1ሻ 
 
Fig. 1.8 – Membrane Curvature. (A) Image showing the principle radii of curvature, R1 and 
R2, for a given surface. The corresponding principle curvature, c1 and c2, can be found by 
taking an inverse of these. (B) Images of various geometrical shapes and the principle 
curvatures they possess. Images modified from referenced publication.[33]  
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In biological systems, one driving force for membrane curvature is the spontaneous 
curvature that the constituent lipids possess. Another factor is the presence of 
membrane-associated proteins, for example the rigid, banana-shaped BAR domain, 
which exist in a large family of protein that which induces curvature upon binding.[39]  
The mean curvatures (H) and Gaussian curvatures (K) are defined in Equations 1.2 
and 1.3 respectively:  
																						ܪ ൌ 12 ሺܿଵ ൅ ܿଶሻ																												ሺ1.2ሻ 
																					ܭ ൌ ܿଵ 		ൈ 	ܿଶ																																	ሺ1.3ሻ 
There is an energetic cost associated with deforming a membrane away from its 
preferred curvature, known as the curvature elasticity per unit area. To model this 
cost, the bilayer is first approximated to a single sheet of infinitesimal thickness. The 
bending energy is dependent on the bending modulus, κ, and the Gaussian modulus, 
κG, which are terms associated with the energy cost per unit area of changing the mean 
and Gaussian curvatures respectively. These relate to the bending energy per unit area, 
gc according to Equation 1.4, where H0 describes the spontaneous mean curvature 
when the surface is relaxed:[40] 
݃௖ ൌ 2ߢ	ሺܪ െ ܪ଴ሻଶ ൅	ߢீ		 ൈ 	ܭ																						ሺ1.4ሻ 
Importantly, the above properties can be experimentally determined using model 
membranes. However, as we shall see, the lack of appropriate methods to construct 
asymmetric membranes has prevented the mechanical measurements of asymmetric 
membranes from being studied. This is one of the issues addressed in this thesis.  
1.2.2.4    Lateral Stress Profile 
An important biophysical concept associated with lipids in membrane is their lateral 
stress profile.[41] This describes the stress exerted along the length of the lipid in the 
plane of the bilayer by various forces (e.g. ionic attraction/repulsion, hydrogen 
bonding, steric interactions, hydrophobic effects etc.), and it allows a fuller 
understanding of the desire for certain lipids to induce curvature. The typical 
components and contributing factors to the lateral stress profile is shown in Fig. 1.9. 
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Fig. 1.9 – Lateral stress profile. (A) Image showing the origins of the various stresses 
involved along the lateral profile of the membrane. The headgroup region has a positive 
‘outward’ pressure resulting from steric clash and charge repulsion. The tail regions also exert a 
pressure in this direction due to chain rotation and collision. The polar/apolar interface has a 
negative ‘inward’ pressure due to hydrophobic chains crowding together to reduce contact with 
water. (B) A representation of the lateral stress profile of lipids in a bilayer. Picture taken from 
paper by Ces et al.[38] 
The lateral stress profile will vary with the type of lipid present. It is dependent on 
factors such as headgroup charge and chemical substituents, as well as fatty acid 
length and degree of saturation. A non-uniform distribution of lateral stress associated 
with the lipid result in a non-zero spontaneous mean curvature.[42]  This is the physical 
origin of the different lipid ‘types’ discussed earlier, and gives a more comprehensive 
account of lipid curvature properties.  
When in a monolayer the sum of lateral pressures at equilibrium will be zero. This is 
known as the net lateral pressure and is represented in the Equation 1.5: 
													׬ t	ሺzሻdzൌ0																								ሺ1.5ሻ																									
The torque of the monolayer (τ) is generally given by the first moment of the stress 
profile, given by the Equation 1.6, where κ is the mean curvature modulus and C0 is 
the spontaneous curvature of the monolayer: 
߬ ൌ ׬ ݖ. ݐሺݖሻ݀ݖ ൌ 	െߢܿ଴ 														ሺ1.6ሻ						
In type I and II lipids the torque value is non-zero, and monolayers will therefore have 
a desire to curve away/towards water respectively. Ultimately, this is due to the 
imbalance of forces resulting from their lateral stress profiles.  
1.2.2.5     Stored Curvature Elastic Stress  
Another important biophysical property is the stored curvature elastic stress. This 
refers to the stress arising from the presence of non-bilayer forming lipids in a bilayer. 
These lipids have a desire to adopt non-flat curvatures, but are forced to do so in 
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order not to disrupt the back-to-back lipid arrangement (Fig. 1.10). The more non-
bilayer forming lipids are present, the higher the stored curvature elastic stress will be. 
However, one must note that this will not increase indefinitely: eventually, non-bilayer 
phases will result. It has been postulated that this stress is used by cells to modulate 
protein pore gating as well as protein activity, for instance, by favouring processes that 
release it.[25] For a review examining the regulation of protein behaviour via such 
processes refer to the publication by Ces and Mulet.[38] 
 
Fig. 1.10 - Stored curvature elastic stress. Illustration showing the desire for monolayer 
curvature towards water, and the stress resulting from the inability to do so due to the creation 
of unfavourable voids in the bilayer. Picture taken from referenced publication.[38] 
1.2.2.6     Partition and Distribution Coefficients  
The ability for molecules to passively diffuse through cell membranes is important in a 
medicinal setting, as without specialised protein pumps, this is the mechanism by 
which drugs reach cellular interiors and their target site. In simple terms, the ability of 
a molecule to diffuse through cell membranes is thought to be governed by Overton’s 
rule: the more soluble in lipids the molecule is, the greater its permeability.[43] The 
partition coefficient (LogP) between octanol and water can therefore give an 
indication of a molecule’s membrane permeability. LogP is defined as the ratio of 
concentrations of un-ionized compound between the two solutions (Equation 1.7): 
݈݋݃ܲ ௢௖௧
௪௔௧௘௥
ൌ ݈݋݃ ቆ ሾݏ݋݈ݑݐ݁ሿ௢௖௧௔௡௢௟ሾݏ݋݈ݑݐ݁ሿ௪௔௧௘௥௨௡ି௜௢௡௜௦௘ௗ
ቇ																							ሺ1.7ሻ 
However, there exist many exceptions to this rule, and although useful as a 
generalisation, it does not paint the whole picture. For example, recent experiments by 
Grime et al.[44] found evidence that compounds with greater lipophilicities actually 
demonstrate decreasing membrane permeability — this demonstrates the deficiencies 
of using partition coefficients as the sole predictor of diffusion rates.  
Log P is also a deficient model as it only considers un-ionised forms of the molecule. 
A more useful concept is the distribution coefficient, which is the ratio of the 
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concentrations of all forms of the compound (ionized plus un-ionized) in each of the 
two phases (Equation 1.8): 
݈݋݃ܦ ௢௖௧
௪௔௧௘௥
ൌ ݈݋݃ ቆ ሾݏ݋݈ݑݐ݁ሿ௢௖௧௔௡௢௟ሾݏ݋݈ݑݐ݁ሿ௪௔௧௘௥௜௢௡௜௦௘ௗ ൅ ሾݏ݋݈ݑݐ݁ሿ௪௔௧௘௥௟௡௘௨௧௥௔௟		
ቇ												ሺ1.8ሻ											 
 
1.2.2.7      Passive Diffusion and Active Transport 
In addition to the chemical nature of the compound, the rates at which molecules 
traverse membranes are also dependent on various other factors. Specifically, the rate 
of diffusion of a molecule between two compartments separated by a homogenous 
lipid bilayer depends on the following parameters: diffusion coefficient (D), 
membrane surface area (A), partition coefficient (Kp), membrane thickness (d), and 
the concentrations of species either side of the membrane (C1 and C2). The 
relationship between these is given by Fick’s law, Equation 1.9[45]: 
 
																								݀ܳ݀ݐ ൌ ൬
ܦ. ܣ. ܭ௉
݀ ൰ ሺܥଵ െ ܥଶሻ																											ሺ1.9ሻ 
       
Polar molecules such as water diffuse through the bilayer at a slower rate than 
hydrophobic molecules such as oxygen and carbon-dioxide, which readily diffuse 
through the membrane.[46] Charged molecules, including many drugs, have an even 
slower rate of diffusion through membranes, due to the difficulty traversing through 
the packed bilayer core.[33]  
 
Passive diffusion can also be facilitated by proteins which are fully embedded in the 
membrane, and which allow substances to pass through (known as facilitated passive 
diffusion). These can either be membrane channels or carrier-mediated 
transporters.[46] The diffusion is still passive however, and must still occur down a 
concentration gradient. A key point to stress is that both passive and facilitated 
diffusion are not dependent on the expenditure of cellular energy.  
 
Active transport refers to processes where cellular energy is expended by the cell via 
the hydrolysis of ATP. Using such processes, molecules can therefore move up 
concentration gradients towards more concentrated regions.[46] For instance, efflux 
pumps serve to expel foreign molecules (such as drugs) from the blood brain barrier 
into the systemic circulation.[47]  
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1.2.3 Model Membranes  
As we have seen, biological membranes are complex structures that are composed of a 
large array of lipids, and integral and peripheral membrane proteins. This complexity, 
coupled with difficulty to systematically vary individual parameters of interest, hinders 
the study of biomembrane behaviour and function. To combat this, model (or 
artificial) membranes have been employed, which (ideally) retain key features of 
biomembranes, and allow investigation away from the complex cellular environment, 
giving researchers more scope for rigorous studies. As such, they have proved to be 
an important tool in the study of the mechanical and physical properties of 
membranes, as well as for studying properties of membrane proteins.[48] Furthermore, 
in recent years model membranes have been put to functional use, where they have 
been used as bio-inspired devices. Recent years have seen major developments in their 
use as carriers of ion channels for applications in bio-sensing,[49] DNA sequencing,[50] 
and single molecule mass spectrometry.[51] 
Common model membrane systems include black lipid membranes (where bilayers are 
formed across a hydrophobic aperture) and supported lipid bilayers (which consist of 
a continuous bilayer sitting on a solid support), shown in Fig. 1.11. Other widely used 
model membranes are vesicles and droplet interface bilayers (DIBs). Both vesicles and 
DIBs are heavily employed and developed in this thesis, and will now be outlined. For 
a detailed review of alternative model membranes systems, refer to Chan et al.[48] 
 
Fig. 1.11 - Model membranes. (A) Schematic of supported lipid bilayers formed by fusing 
vesicles on a solid substrate (PDMS, Mica, Silicon, etc.). (B) Schematic of black lipid 
membranes (otherwise known as planar lipid membranes). These consist of a bilayer between 
two hydrophobic posts separating two aqueous reservoirs. Method to form these include the 
Montal-Mueller method, and the ‘paining’ method of bilayer deposition.  
1.2.3.1     Vesicles 
Vesicles (or liposomes) are fully enclosed spherical shells of bilayers that have an 
aqueous interior and exterior. Vesicles can fall into several categories  classed both 
according to their size and lamellarity:[52] multilamellar vesicles (MLVs), multi-vesicular 
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vesicles (MVVs), small unilamellar vesicles (SUVs) large unilamellar vesicles (LUVs) 
and giant unilamellar vesicles (GUVs). These vesicles, formed using different 
methods, are schematically depicted in Fig. 1.12. 
 
Fig. 1.12 – Different lipid vesicle families. An illustration showing the difference in the 
number of layers (lamellarities) and relative sizes of various types of lipid vesicles. Image 
modified from Stano et al. (not to scale).[53]  
Vesicles have the advantageous property of being stable with a range of lipid 
compositions. In addition, they are simple to form and allow facile reconstitution of 
membrane proteins within them. The small aqueous volumes contained within their 
interiors also makes them particularly useful for biological assays involving the activity 
of pore-forming proteins, as dye released from the internal compartments can be 
measured. This makes vesicles the platform of choice for a number of wide-ranging 
studies for both drug/membrane and protein/membrane interactions.[33, 48] They have 
also been used as analytes in immunoassays, and for lipid phase transition studies.[54]  
Vesicles also have commercial pharmaceutical use, where they are used as vehicles for 
drug delivery.[55] They can be used to deliver drugs of varying lipophilicities: 
hydrophobic drugs are carried in the bilayer itself, while hydrophilic compounds are 
carried in the internal aqueous volumes. To date, 12 drugs with liposomal delivery 
systems have been approved for clinical applications.  
Vesicles are the starting point for other model membranes including supported lipid 
bilayers, black lipid membranes and DIBs (to be discussed later). They are simple to 
form: the addition of water to dry lipid results in large-multilamellar vesicles. 
Extrusion and sonication processes downsize these to small unilamellar vesicles of a 
set diameter.  
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This thesis mainly concerns GUVs due to their cell-like size, and ease of visualisation 
and manipulation using microfluidic and other techniques. GUVs can be generated 
using a host of methods, including spontaneous swelling, the ‘ethanol-injection’ 
method, fusion of SUVs, electroformation, and phase transfer (see Walde et al. for a 
review).[56] Only the latter two techniques are relevant to this thesis and will be 
discussed in further detail. 
1.2.3.2     Electroformation  
The most widely used method for GUV generation is electroformation,  where an 
alternating electric current is applied across a hydrated film of lipid deposited between 
two indium tin oxide (ITO) plates. This produces unilamellar vesicles at size ranges of 
between 1 and 100 µm diameter. The mechanism by which this happens is poorly 
understood. It has been proposed that the current causes a periodic electroosmotic 
movement of water between the individual bilayer lamellae in the film (Fig. 1.13).[56] 
These vibrations, perpendicular to the electrode surface, pull the bilayers off surface 
to form a mushroom-like structure. The vesicles continue to grow until the 
mushroom neck closes, and the vesicle detaches from the surface.  
 
Fig. 1.13 – Proposed mechanism for electroformation. An electric field (direction of 
arrows) creates electroosmotic movement of water between the layers of the deposited lipid 
film. This leads to vesicles gradually budding off the surface. They are first connected to the 
underlying film by a tether, before becoming completely detached, resulting in GUVs.  
Limitations of the electroformation method include the inability generate asymmetric 
vesicles, the wide size distribution of vesicles generated, and the restriction on the 
types of buffer used (the method only works with low ionic strength buffers). 
Arguably the most important drawback is that inefficient encapsulation of large, 
charged molecules. This is because in order to be encapsulated, compounds must 
move through the external layer of the lipid film. Depending on molecular size and 
charge, such inter-leaflet movement is extremely slow, and almost impossible for large 
biomolecules such as DNA and proteins. This limitation can be circumvented by 
microinjection into individual vesicles interiors after they are formed.  
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1.2.3.3     Phase Transfer 
The preceding decade has seen the development of the phase transfer technique for 
GUV generation. In this method, GUVs are formed by transferring a monolayer-
coated water-in-oil (w/o) droplet from an oil phase into an aqueous phase, through an 
interfacial monolayer.[57-58] As the droplet is transferred, the interfacial monolayer 
envelops the droplet, leading to the formation of a vesicle (Fig. 1.14). To drive phase 
transfer gravitational methods are primarily used. By loading droplets with a dense 
internal solution (e.g. with glucose or sucrose) they sink through the column due to 
their higher densities compared to the surrounding oil and aqueous phase. This 
process can be supplemented by centrifugation.[59] Alternative methods involve 
physically driving droplets through the interface using a micromanipulator.[60] 
 
Fig. 1.14 – Phase transfer method of GUV generation. (A) Water-oil emulsions are first 
prepared in a lipid-in-oil solution. Monolayers spontaneously form around each droplet. (B) A 
water-oil column with lipid dissolved in the oil is prepared, and left to stabilise for a period of 
two hours. During this time a well-packed monolayer self-assembles at the water-oil interface. 
The emulsion is then added to the column. (C) Droplets descend, and are transferred into the 
aqueous phase due to gravity (if droplets are loaded with sucrose) or using a micromanipulator. 
Lipid dissolved in the emulsion oil (blue) form the inner leaflet, and those present in the 
column (red) form the outer leaflet. 
Advantages of the phase transfer methodology include control over size distribution 
(as this is defined by emulsion distribution), amenability to be translated into 
microfluidic formats (due to the water/oil starting points), and a 100% encapsulation 
efficiency (content of droplet = content of vesicles). The latter feature in particular is 
primarily responsible for the heavy use of phase transfer for vesicle-based artificial 
cells, as these require the encapsulation of large, charged biological macromolecules, 
which is more difficult to achieve using alternative methods.  
A further crucial advantage is that this method uniquely allows asymmetric GUVs to 
be constructed.[59, 61] This is achieved by incubating droplets in a lipid/oil solution 
containing lipid A (which forms the inner leaflet), and then adding them to a water-oil 
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column containing lipid B (which forms the outer leaflet). The presence of asymmetry 
has been validated using fluorescence quenching assays, and by selective protein 
binding experiments.[59, 62] It must be noted that beyond proof-of-asymmetry 
experiments, further investigations into the effects of asymmetry on GUV properties 
have not been carried out – this is addressed in this thesis. 
Disadvantages of this method mostly relate to its relatively recent emergence, and 
subsequent lack of characterisation: lamellarity, integrity, the mechanical properties of 
such vesicles have not been established, with some researchers hypothesising that 
significant levels of oil remain trapped. This thesis attempts to resolve some of these 
issues.    
1.2.3.4     Droplet Interface Bilayers (DIBs) 
DIBs are membranes that form when lipid monolayer-encased water-in-oil droplets 
are brought into contact with one another: oil is excluded from the interface and a 
bilayer results (Fig. 1.15). This concept was first reported in 1966 by Tsofina et al.,[63] 
but further investigations did not  occur until 2006[64-65] — the platform is therefore 
still in its relative infancy.  
Some of key advantages of DIBs include: large temporal stability (weeks); ease of 
electrical measurements (by inserting electrodes into droplets); physical and electrical 
robustness (can withstand potentials of up to 150 mV); ability to form asymmetric 
bilayers;[66] control over bilayer area; ability for translation into microfluidic formats, 
allowing for automation and high-throughput generation;[1, 67-68] ability to form bilayer 
networks.[64, 69] Some of these properties are discussed below in further detail.  
1.2.3.5     DIB Methods of Formation 
There are two approaches to DIB formation, which differ in how monolayers are 
assembled around the aqueous droplets (Fig. 1.15). In the ‘lipid-out’ approach, lipids 
are dissolved in the organic phase and spontaneously form a monolayer at the 
interface with the aqueous phase. In the ‘lipid-in’ approach, liposomes are present 
within aqueous droplets, and rupture at the oil interface forming a monolayer around 
the droplet. In both these cases, monolayer formation is driven by the amphiphilic 
nature of lipids:  hydrophobic tails face the oil while the hydrophilic headgroups face 
the aqueous phase. The key difference between the two is that asymmetric bilayers can 
be formed using the ‘lipid-in’ method, as different lipid compositions can be present 
in the constituent droplets.  
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Figure 1.15 – Droplet Interface Bilayer schematic. (A) In the ‘lipid out’ approach, lipids are 
dissolved in the oil phase, and self-assemble as a monolayer around each droplet. A bilayer 
(black box) is formed when droplets are brought into contact. (B) In the ‘lipid-in’ approach 
vesicles are present inside the aqueous droplets. This approach allows the formation of 
asymmetric bilayers if each droplet contains different lipids within them. (C) An illustration of 
vesicles rupturing at the oil/aqueous interface to form a monolayer around the droplet for the 
lipid-in approach.  
The most extensively used method to generate DIBs  is by pipetting or microinjecting 
aqueous droplets into an organic phase, followed by manually bringing these droplets 
together, either using a needle or with micromanipulators.[64, 69] However, in recent 
years, more controlled and automated microfluidic methods have been developed, 
discussed in detail in Section 1.3.5. 
1.2.3.6     DIB Applications   
DIBs have been used for the electrical characterisation of membrane proteins, mostly  
α-hemolysin (α-HL) but also gramicidin A, bacteriorhodopsin (BR), outer membrane 
protein G (OmpG),  and Kcv (a viral potassium channel).[64] DIBs have shown 
promise as a tool to investigate the effect of membrane asymmetry of protein gating. 
In an elegant study,  Bayley et al. showed that a mutated version of OmpG had 
different gating behaviour depending on its orientation within an asymmetric 
bilayer.[70] DIBs have also been used to study mechanosensitive proteins,[71] for high-
throughput membrane-protein screening,[72] for triggered release of molecules,[73] to 
control 2D membrane protein concentration,[74] for rapid screening ion-channel 
blockers,[75] amongst other studies. For a full review of recent DIB applications, refer 
to review publication by Bayley et al.[64] 
1.2.3.7     DIB Networks  
One of the most useful features of DIBs is their ability to form interconnected bilayer 
networks, which are made by linking together more than two droplets (Fig. 1.16).[76]  
This unique feature has enabled droplet devices to be made, including half-wave and 
full-wave rectifiers. This was achieved by inserting mutated α-HL proteins (which 
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acted as diodes) in different orientations within a three-droplet network.[70] In another 
example, Hwang et al constructed a light sensing and harvesting device, which 
consisted of a network of satellite droplets containing BR proteins which surrounded 
a central droplet. Upon irradiation, a proton current was induced which was 
channelled into a central droplet.[77] Similarly, others have designed and constructed a 
DIB “bio-battery” based on an electrochemical gradient between three networked 
droplets.[76] Finally, electrical behaviours of DIB networks have been modelled and 
analysed,[77] strengthening the theoretical understanding  behind them, and allowing 
more intricate devices to be built in future. The above examples are by no means 
exhaustive, but are simply some of the most impressive achievements of DIB 
networks.  
 
Fig. 1.16 – DIB networks. (A) These are formed when more than two droplets are brought 
into contact. (B) Schematic of a DIB light harvesting network. BR (white pores) pumps 
protons from the white droplet to the central blue droplet upon exposure to light. Protons 
then flow to the green droplet, through α-HL (red-pore). By harvesting light from the multiple 
satellite droplets, a current is generated. (C) Schematic and current traces of DIB-based electric 
devices. (i) A current rectifier is formed with no protein present. (ii) A full wave rectifier is 
formed when two α-HL ‘diodes’ face one another. (iii) A half-wave rectifier is formed the two 
diodes face the same direction. Image modified from paper by Maglia et al.[70] 
1.2.3.8    Multisomes  
The DIB systems described above all exist in a bulk oil environment. Villar et al. 
created droplet networks which function in aqueous environments by microinjecting 
water droplets into a larger oil/water droplets.[78] Bilayers formed between the inner 
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droplets, but also crucially, bilayers connected the inner droplet networks to the 
external environment (Fig. 1.17). In the same study, they demonstrated temperature 
and pH-triggered release of internal droplet content by taking advantage of lipid phase 
behaviour. These structures, termed multisomes, were envisaged to act as devices 
operating in physiological environments, for applications including smart drug delivery 
and for in vivo biosensing. However, these constructs were made one-by-one, by 
sequential pipetting. For multisomes to realise their proposed impact, high throughput 
methods for their formation need to be developed, which is an issue that this thesis 
aims to address.  
 
Fig. 1.17 – Multisomes - DIB networks that function in aqueous environments. (A) 
Multisomes are formed when several water droplets are encapsulated in a larger oil-in-water 
droplet. Monolayers exist at droplet interfaces, leading to bilayers between at all droplet-droplet 
interfaces. (B) An illustration of the potential vision for multisomes acting as droplet devices. 
Image adapted by paper by Villar et al.[78] 
 
1.3  MICROFLUIDICS 
Recent decades have seen the emergence of the field of microfluidics as a tool for 
studies that span across the sciences. In essence, microfluidics involves the control, 
manipulation, and examination of fluids contained in micron-scale channels (i.e. 1- 
500 µm dimensions). Such technologies are integral to many ‘lab-on-chip’ devices, 
where laboratory functions are integrated on portable, often disposable devices.[79]  
For detailed overview of microfluidic and microdroplet technologies and their 
applications the reader is referred of one the many comprehensive reviews that have 
recently been published.[80-83]   
1.3.1     Advantages of Microfluidics 
Microfluidics enables miniaturisation and scaling down of chemical and in vitro 
biological processes, which is attractive for a host of reasons. Physical processes can 
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be more precisely controlled when dimensions are reduced to the micron scale. It 
allows small sample sizes to be used, which is particularly important when dealing with 
expensive or low-quantity materials. Microfluidic systems also possess low 
instrumental footprint, are often portable, have low cost, and increasingly are even 
disposable. Indeed for this reason, they are emerging as a technological pillar for a 
new generation of point-of-care diagnostic devices. Furthermore, the small volumes 
and compactness allow for parallelisation of analytical processes. Microfluidic systems 
therefore lend themselves towards studies of a high-throughput nature, which is 
especially relevant for droplet-based systems. 
In a chemistry setting, microfluidic devices are increasingly being used for used for 
synthesis, where they are commonly referred to as microreactors.[80-81, 84] In 
comparison to traditional bulk chemical reactors, these possess greater reaction 
efficiencies, faster reaction and analysis times, better energy dissipation, and enable 
on-site and on-demand chemical synthesis. In addition, as microreactors operate 
continuously, the delays associated with batch processing are typically avoided. 
Further, as volumetric flow rates of individual fluids can be precisely user-defined, fine 
process control can be achieved.   
The dimensions involved in microfluidics are similar to those of cellular systems, 
which make them highly desirable for biological studies into processes that occur in 
this scale, such as O2 and CO2 diffusion rates between cells.[83] Miniaturisation also 
renders microfluidic platforms attractive for bottom up synthetic biology, where 
biomimetic cell-sized  protocellular models are generated with a fine degree of control 
(see Section 1.3.5).[85]   Additionally, the increased confinement of analytes paves the 
way for single-molecule detection and analysis: single cells can be investigated 
separately in isolation from the bulk population.[86] 
1.3.2  Reynolds Numbers  
Liquid flow at the size regimes associated with microfluidic systems often behave 
differently from those on the macro scale. In the former, laminar flow dominates: two 
streams flowing side by side will flow parallel to one another, and mixing between 
them will occur through diffusion. In the latter, turbulent flow dominates: flow is 
characterised by chaotic property changes. Fig. 1.18 depicts these different regimes. 
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Fig. 1.18 – Schematic of different flow regimes. (A) Schematic depiction of laminar flow.  
(B) In laminar flow, two streams flowing parallel to each other with only mix via diffusion 
(dotted arrows). (C) Schematic depiction of turbulent flow. 
Whether laminar or turbulent flow occurs is determined by the system’s Reynolds 
number, which defines the ratio of inertial to viscous forces. This is dependent upon 
fluid density (ρ), flow rate (v), hydraulic diameter (Dh) and viscosity (µ). The 
relationship between these parameters and the Reynolds number (Re) is given by 
Equation 1.10. 
ܴ௘ ൌ ߩݒܦ௛ߤ 																							ሺ1.10ሻ 
Typically, when Re > 4000 inertial forces dominate, leading to turbulent flow, and 
when Re < 2300  viscous forces dominate, leading to laminar flow. In intermediate 
Reynolds numbers, both types of flow occur. The presence of laminar flow in 
microfluidic devices has been exploited for applications such as reagent separation, 
rapid mixing, and for the creation of concentration gradients.[80] However, in other 
cases it can be detrimental due to the presence of only slow, diffusion-based mixing. 
This can be countered by the introduction of meandering channel geometries to 
induce chaotic advection.[82]  
1.3.3  Continuous vs. Segmented Flow  
Microfluidic systems can broadly be split into two categories:  continuous flow or 
segmented flow. Continuous flow systems consist of a single phase flowing through 
different regions of a microfluidic device. This raises problems of cross 
contamination, Taylor dispersion, solute surface interactions, and the (relatively) large 
reagent volumes that are required (Fig. 1.19).[87] Segmented flow systems involve 
discrete isolated pico to nanolitre-sized droplets. The droplets (or dispersed phase) 
exist in a surrounding external (or continuous) phase. For most applications, the two 
phases consist of water and oil. Microfluidic systems developed in this thesis concerns 
droplet-based microfluidics.  
Introduction  
  39   
 
 
Fig. 1.19 – Comparison beteween continuous and segmented flow. A and B show two 
separate portions of the same phase. C shows a mixture of the two components (in purple). 
Continuous flow leads to Taylor dispersion due to parabolic flow. The dotted box indicated 
this expansion effect, which leads to mixing and cross contamination. Absorption of reagent 
onto channel walls may also lead to cross-contamination and reagent loss. Picture modified 
from referenced publication.[82] 
In segmented flow microfluidics, droplets are generated with fine size control, and 
each microdroplet can act as a discrete experimental unit that can be analysed 
separately. Coupled with the fact that droplet formation rates can be as rapid as 2 
kHz, this paves the way for parallel and high throughput quantitative analysis.[83] It is 
possible to include single cells within a microdroplet, which is an exciting 
development in the field of single-cell proteomics.[88]   Other applications include 
DNA analysis, drug screening, environmental monitoring, chemical synthesis and 
synthetic biology.[89-90] Finally, microdroplets have been used for a range of chemical 
syntheses, including nanoparticles,[91-94]  microgels,[95] mesoporous particles,[96] 
polymers,[97] as well as for organic functional group transformations.[98-100]. Once 
droplets are created they can be manipulated using a variety of microstructures on 
chip: droplets can be split, mixed, merged, and sorted.[101-103]  
1.3.4      Methods of Droplet Generation  
There are three principle methods by which microdroplets can be generated, shown in 
Fig. 1.20. The first is by embedding a small capillary within a larger one, each carrying 
a different phase.[104]  The second is using commercial droplet-sampling robots, which 
sample droplets of a set-composition one-by-one.[105] The third is via specially 
designed microfabricated channel geometries.[82] This method, which is employed in 
this thesis, is particularly attractive as different channel geometries can easily be 
fabricated using soft lithography, and integrated with other modules in a single device 
without the need for connections.  
Using soft-lithography devices, microdroplets can be generated using either ‘T-
junction’ or ‘flow-focussing’ channel geometries, shown in Fig. 1.20. In both these 
cases, droplet formation is a result of shear forces and interfacial tension at the liquid-
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liquid interface (full theoretical descriptions can be found elsewhere).[106] T-junction 
methods involve oil and water streams contacting each other in a perpendicular 
orientation. Flow focussing techniques involve three channels that meet at central 
point, with two oil-containing channels focussing the aqueous stream. Depending on 
the relative flow rates of the various streams, discrete droplets of set sizes break off, 
resulting in the controlled formation of microdroplets.  
 
Fig. 1.20 – Different methods of microdroplet generation. (A) In the capillary method, 
one capillary is embedded in another, with each one carrying a different phase. (B) Droplet-
sampling approaches rely on custom-built apparatus to sample droplets one-by-one from 
different wells. (C) Microdroplets generated using microfabricated channel geometries. (i) T-
junction geometry (ii) Flow focusing junction. Arrows indicate direction of flow.  
1.3.5      Microfluidic Model Membranes 
There have been significant efforts to generate model-membranes using microfluidic 
methods, driven by the advantages described in the preceding sections. In a 
membrane context, particularly important advantages are the ability to generate 
uniform and defined membranes sizes, automation, and most importantly, high-
throughput generation. A general review of microfluidic methods of membrane 
formation has been published elsewhere.[107] Here, only the most important and 
relevant examples of vesicle and DIB formation are outlined.  
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 1.3.5.1      Microfluidic Vesicles 
Most microfluidic technologies for vesicle generation have employed a variation of the 
phase-transfer method. Malsmstadt et al. used a microfluidic device to generate 
uniform w/o droplets, which were then fed through a phase transfer column to yield 
vesicles with a fine size distribution.[59] Matosovic et al. developed a microfluidic 
assembly line for vesicles: first w/o droplets were formed, which were later directed 
into a water phase with aid of a microfabricated post (Fig. 1.21A).[108] The efficiency of 
this process was extremely low however, with only ~1-5 % of droplets surviving the 
phase transfer. Others used an approach where individual monolayers were deposited 
on droplet templates (Fig. 1.21B). Impressively, this enabled asymmetric membranes 
to be generated, as well as vesicles of defined lamellarity depending on how many 
monolayers were sequentially deposited.[109] Other efforts have focussed on generating 
vesicles using planar membranes as starting points, and then employing a fluidic-
jetting technique to pinch off vesicles.[110]  This technique however lacked the control 
and versatility of w/o methods, and vesicles were only made limited throughput (tens 
a minute).   
 
Fig. 1.21 – Microfluidic methods for vesicle generation. (A) A vesicle assembly line, where 
droplets were transferred from an oil to an aqueous phase with the aid of a microfabricated 
post. (B) Asymmetric vesicles formed by sequential deposition of individual monolayers. 
Droplets were first incubated in an oil solution containing L1 lipid (red), which formed the 
inner leaflet. This oil was then replaced with one containing L2 lipid (green). When an aqueous 
solution was passed through the chip, L2 deposited to form the outer leaflet. Vesicles with 
multiple lamellae were formed by repetition of the above process. Images modified from the 
indicated references.[108-109] 
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1.3.5.2       Microfluidic DIBs  
There have been several attempts to make and manipulate DIBs using microfluidic 
methods. Individual two-droplet microfluidic DIBs were first made by Funakoshi et 
al.,  which used a ‘cross-channel’ devices, where water/oil phases were facing one 
another in a perpendicular orientation (Fig. 1.22A).[65] Aqueous droplets were then 
brought in contact, using flow, to form a DIB. Malmstadt et al. developed an 
automated variation of this method. Instead of using flow, they utilised  the unique 
property of PDMS to absorb organic solvent into the pores that are present in the 
polymer network (Fig. 1.22B).[68] This extraction process brought two monolayers 
together, resulting in a DIB. There have also been methods to produce and control 
DIBs via electrical methods, employing both dielectrophoresis, as well as 
electrowetting on dielectric techniques to manipulate droplets (Fig. 1.22C).[111-112] The 
low sample volumes involved with these methods, as well as the fact that they don’t 
rely on manual movement of the droplets make them more suitable for lab-on-chip 
applications.  
 
Fig. 1.22 – Microfluidic methods for DIB formation. (A) Using a cross-junction chip, 
aqueous droplets were brought together using flow from a syringe pump. Arrows represent 
flow direction. (B) An automated version of this process relied on PDMS to gradually remove 
the oil phase through hydrophobic pores present in the polymer network, bringing aqueous 
droplets together to form a DIB. (C) Using an electrowetting on dielectric approach, droplets 
were brought into contact by activation of an underlying ITO substrate. Image adapted from 
referenced publication.[111] 
The above methods have several limitations. Bilayer area (determined by droplet size) 
cannot be varied without reconfiguration of the equipment. More importantly, a 
maximum of only two bilayers can be produced in sequence, thus prohibiting DIB 
network formation. To combat this, we and other research have developed 
microdroplet methods extensive DIB network generation in high-throughput.  
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1.3.5.3     Microfluidic DIB Networks  
Stanley et al. were the first to demonstrate 3D DIB generation by packing a glass 
capillary with w/o droplets in an undefined manner.[67]  Following from this, Elani et 
al. used flow rates and droplet sizes to influence packing geometries in order to create 
3D network arrays of defined architectures and compositions, including asymmetric 
DIB networks (Fig. 1.23).[1] This allowed extensive networks of thousands of droplets 
to be made. Furthermore, they showed for the first time the ability to make user-
defined 2D DIB networks, with droplet arrangement determined by the contours of a 
microfluidic chip. Uniquely, these approaches were automated, eliminating the need 
for manual management of individual droplets, and were robust enough to form DIBs 
with the more biologically relevant —but less stable —DOPC lipid.  
 
Fig. 1.23 – Microdroplet technologies for high-throughput DIB network generation. (A) 
Defined 2D DIB networks were constructed according the contours of a microfluidic device, 
with droplet position controlled by syringe pumps at the inlets and outlets. (B) An image of a 
2D network, with a pink central droplet connecting the three branches of a ‘Y’ shaped 
network. (C) 3D DIB networks were formed by packing microdroplets into a linear PDMS 
channel. (D) Image of various 3D network architectures. These were user-defined by altering 
droplet size and flow rates. Images modified from publication by Elani et al.[1] 
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Finally, Villar et al. developed a 3D droplet printer to print networks of precise 
geometries in an oil solution (Fig. 1.24).[113]  The collective properties these droplet 
collections showed let to its characterisation as a ‘tissue-like’ material (to be discussed 
later). 
 
Fig. 1.24 - Constructing DIB networks using a 3D droplet printer. (A) Two nozzles 
containing aqueous solutions with different dyes were used to eject droplets onto a glass 
substrate. By moving the substrate using a micromanipulator, defined 3D networks were 
printed. (B) By printing into a w/o droplet, multisome-like structures existing in bulk-oil were 
constructed. (C) Images of the networks that were printed. (D) A 3D design could be 
constructed, with three distinct orthogonal views. Images modified from referenced 
publication.[113]  
 
1.4  SYNTHETIC BIOLOGY 
The past two decades has seen the emergence of the field of synthetic biology. This is 
a rapidly growing discipline that concerns the design and construction of new 
biological parts, devices and systems and the re-design of existing, natural biological 
systems for functional purposes. The distinction between living and non-living thus 
becomes blurred: the resultant organisms can be thought of as engineered machines 
composed of biological components. Due to the increasing interest in this field and its 
predicted impact in to economies worldwide, many reviews and books have recently 
been published.[114-116] [117-118]  This section gives a brief overview synthetic biology and 
highlights the most significant advances relating to the relevant topics of this thesis.  
1.4.1      Engineering Principles  
The use of engineering principles and concepts for the design of biological systems is 
one of the core tenants of synthetic biology. These include standardisation of 
components, and the use of computation and simulation for prediction and 
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characterisation purposes. Furthermore, a strong emphasis is placed on modularity, 
where each component is separately designed, tested, and characterised. Several 
modular components can be added together to yield complex functioning multi-part 
devices.  
Whereas the above principles have usually been applied to genetic components 
(biobricks), this thesis translates these themes to a vesicle context. Importantly, we 
aim to engineer vesicles with multiple compartments, where each compartment 
performs distinct functions and is modular by nature.   
1.4.2   Potential Applications 
It has been suggested that synthetic biology will be the defining technology of the 21st 
century, and will have as great an impact as the computer industry did in previous 
decade.[119] In the next 10-20 years it has been predicted that synthetic biology may 
provide solutions to pressing problems in developed and developing societies 
including:[120] 
 Fuel production – Research efforts are being undertaken to design organisms that 
can generate hydrogen from water using sunlight. This would provide a  
renewable source of clean and cheap fuel;[121-122] 
 Therapeutics – Designed ‘smart’ microorganisms could be used for targeted drug 
delivery to specific tissues by sensing their surroundings and responding 
accordingly; 
 Biosensors – Organisms that produce a visual output in response to chemical or 
biological signals. These could be used to detect diseases before symptoms 
become apparent, as sensitive detectors for pollutants and contaminants in 
commercial products, and for point-of-care tests.[123] 
 Waste disposal – Organic and non-organic waste could be broken down into 
useful by-products by engineered organisms; 
 Bio-factories – The greater efficiency of biological organisms makes the 
biosynthesis of products such as pharmaceuticals and agrochemicals an attractive 
prospect. The production of chemical precursors for the anti-malarial drug 
artemisinin using engineered yeast cells as bio-factories has already been 
demonstrated.[124] Drugs made via this method are expected to enter the 
marketplace in the coming years. 
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1.4.3      Top  Down and Bottom Up Approaches  
There are two generic approaches used by researchers in this field. The first is the top-
down approach, whereby existing cellular genomes are altered (or ‘reprogrammed’) to 
yield the desired functionality. The second is the bottom-up approach, where artificial 
biomimetic systems are constructed out of chemical building blocks, resulting in cell-
like features (they are able to sense and respond, move, replicate etc.). Cell-like 
structures formed using the bottom-up approach are sometimes referred to as artificial 
cells or protocells.  
To date, most efforts have focused on the top-down approach — genetic engineering 
technologies are well established, and the cost of DNA synthesis and analysis is 
rapidly decreasing. Whereas the area of top-down synthetic biology has received much 
attention in the scientific literature, the field of bottom-up synthetic biology is 
somewhat less well explored. However, the status quo has recently started to change 
due to simultaneous advances in technologies such as microfluidics, membrane-
science, and in-vitro cell-free expression allowing inroads into the bottom-up 
approach to be made. 
One of the advantages of the bottom-up approach is that researchers are not 
restricted to the starting point of biological cells, and wholly new and novel systems 
unlike those seen in nature can be designed. In addition, bottom-up artificial cells are 
less complex, and can be designed to only perform a handful of specified functions. 
These approaches are particularly useful to the origin of life-communities, who are 
interested in how living systems emerge from chemical building blocks.  
1.4.4      Vesicles as Artificial Cells 
Several chassis have been used to define the boundary of artificial cells, including 
polymersomes[125] and coacervates.[126] However, by far the most common are lipid 
vesicles, as they are composed of biological materials (lipids) and are therefore 
compatible with other biological components (e.g. embedded proteins and DNA). As 
this thesis concerns lipid vesicles only, alternative chassis are not discussed in further 
detail. 
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Some of the most impressive biological features introduced into vesicles to date 
include: 
DNA replication. By encapsulating DNA templates, primers, and polymerases into 
vesicles, polymerase-chain reaction (PCR) was contained inside vesicles.  These were 
later used for the ultrasensitive detection of biological toxins.[127]  
Protein synthesis. By encapsulating all the biological machinery for transcription and 
translation, protein synthesis of defined sequence occurred within vesicles, according a 
plasmid sequence.[53, 128] Furthermore, by incorporating transmembrane protein pores, 
uptake of the necessary biochemical building blocks from the environment was 
achieved, leading to continual synthesis over many hours.[129] 
Movement. By attaching flagellated bacteria to vesicles using cross-linked antibodies, 
vesicles were propelled at a defined velocity (Fig. 1.25).[130] 
 
Figure 1.25 – Schematic showing vesicle propulsion by attachment of flagellated 
bacteria. 
Vesicle-cell communication. A protometabolism was encapsulated within a vesicle. This 
synthesised complex carbohydrates from simple organic building blocks. The resultant 
products then engaged in the natural quorum-sensing mechanism of bacteria, leading 
to an optically detected response (Fig. 1.26).[131] 
 
Fig. 1.26 – Schematic showing vesicle communication with bacteria via a quorum-
sensing signalling pathway. Image on right, adapted from the referenced publication, shows 
the bio-luminescent bacterial response.[131] 
Introduction  
  48   
 
Artificial membrane protein-protein communication networks. These were generated by 
reconstituting a Mechanosensitive Channels of Large Conductance (MscL) into vesicle 
membranes, together with Phospholipase A2 enzyme (PLA2). The latter protein 
triggered the opening of the former using membrane mechanics as an intermediary 
(Fig. 1.27). 
 
Fig. 1.27 – An engineered protein-protein communication network embedded in 
vesicles. PLA2 hydrolysed lipids, resulting in a change in membrane mechanics. This caused 
mechanosensitive proteins, MscL, to open, leading to release of an encapsulated dye.  Image 
modified from referenced publication.[21] 
Vesicle replication. By incorporating membrane precursors together with appropriate 
catalysts inside vesicles, lipids were synthesised in vesicle interiors. In addition, vesicles 
also contained DNA and DNA polymerase, resulting in amplification. As lipid 
accumulated, daughter vesicles budded off the parent vesicles, and carried with them 
DNA which was produced on-site (Fig. 1.28).[132] 
 
Figure 1.28 – Vesicle and DNA replication. Schematic showing both DNA amplification 
via PCR as well as vesicle replication, in a single vesicle system. For vesicle replication, lipids 
were synthesised using embedded lipid precursors and appropriate catalysts. Image modified 
from referenced publication. [132] 
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Vesicle-vesicle interactions. Two vesicles populations consisting of lipids with opposite 
charge were observed to form discrete ‘colonies’. It has been suggested that these can 
be considered primitive protocell communities.[133]  Other approaches include 
patterning vesicles with short complimentary DNA strands, resulting in vesicle 
networks.[134] 
Tissues-like materials. By 3D printing thousands of lipid-coated droplets in an oil 
droplet, vesicle-like collections were constructed (Fig. 1.29).[113] The resultant ‘proto-
tissues’ exhibited collective behaviours. These include folding (induced by droplet 
osmotic differences), and selective conducting pathways (analogous to neural 
networks). In addition, the material exhibited an elastic modulus comparable to those 
of brain, fat, and other soft tissues.  
 
Fig. 1.9 – An artificial tissue-like material. (A) An illustration of an extended bilayer 
network capable of self-folding and transmitting electrical signals across set paths. (B) 
Illustration of a flat ‘flower-shaped’ network folding due to osmotic differences in droplets, 
which leads to flow between droplets and to a change in droplet size. (C) Computer simulation 
of this process. (D) An electrically conductive pathway. Only green networks contain protein 
pores which make bilayers conductive. Therefore only when both electrodes are connected to 
the green network can an electric current flow. Images adapted from referenced paper.[113]  
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1.4.5      Lack of Spatial Organisation in Artificial Cells  
To date, vesicle-based artificial cells have been simple, uni-compartment structures. 
Importantly, they have a distinct lack of spatial organisation present. This is in 
contrast to biological cells, whose contents are precisely segregated in space. In order 
to effectively mimic biological cells, and for artificial cells to reach to complexity of 
their biological counterparts, this feature needs to be introduced. We propose to 
achieve this using membrane barriers to delineate compartments in an analogous 
manner to eukaryotic organelles.  
1.5      THESIS AIMS AND OVERVIEW 
The broad aims of this thesis are to develop technologies for the generation of 
vesicles with defined number of compartments, and demonstrate their application as a 
new class of modular artificial cells. We aim to construct such structures by combining 
phase transfer and microfluidic methodologies, which will ensure miniaturisation and 
high throughput generation, and will allow content and structure to be user-defined. 
We will also use biological components (membrane proteins, enzymes, protein 
synthesis machinery) to functionalise them. More specifically, this thesis has six aims: 
(i) Develop methodologies to generate multi-compartment vesicles, with full 
control over compartment number, size and content.  
(ii) Introduce biological functionalities (namely in vitro transcription and 
translation) into these vesicles, transforming them into artificial cells. Use this 
to demonstrate segregation of function through separation of content.  
(iii) Introduce an artificial enzymatic signalling cascade into the multi-
compartment vesicles. This will be used to demonstrate signal propagation 
from the external environment through the different vesicle compartments, 
leading to a chemical response.  
(iv) Develop microfluidic devices to generate similar multi-compartment 
structures in high-throughput. 
(v) Demonstrate potential functional applications for these structures, namely for 
in-situ drug synthesis. 
(vi) Characterise the process of GUV generation via phase transfer. Measure 
vesicle mechanics for an indication of phase transfer GUV quality and 
integrity compared to traditional vesicle generation techniques.  
 
Each one of these aims are sequentially addressed within the following chapters. 
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Chapter 2 – General 
Materials and Methods  
 
This chapter outlines the general methods and procedures used repeatedly throughout 
this thesis. Other more specific methods relating to individual experiments are detailed 
in the relevant chapters.   
2.1 LIPIDS 
Several different lipid types are used throughout this thesis. These, together with their 
abbreviations are given below, and their chemical structures shown in Fig. 2.1. 
 
Fig. 2.1 – Chemical structures of the various lipids used in this thesis 
 
DPhPC:  1,2‐diphytanoyl‐sn‐glycero‐3‐phosphocholine 
DOPC:   1,2‐dioleoyl‐sn‐glycero‐3‐phosphocholine 
POPC:  1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
Rh-PE:  1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N- (lissamine-
rhodamine-B-sulfonyl (ammonium salt) 
NBD-PE:  1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-
benzoxadiazol-4-yl) (ammonium salt) 
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Marina Blue DHPE:  Marina Blue® 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine 
 
Marina Blue DHPE was purchased from Life Technologies. All other lipids were 
purchased from Avanti Polar Lipids. 
2.2 PREPARATION OF LIPID IN OIL 
In all experiments, lipids (delivered as powder from the supplier), were first converted 
to lipid films prior to further treatment. Lipid powders were first weighed in a glass 
vial and then dissolved in chloroform to give a 1 mg ml-1 solution. To prepare 
mixtures composed of multiple lipid types, appropriate volumes of different 
lipid/chloroform solutions were gently stirred to ensure a homogenous mixture. 
Chloroform was then removed under a gentle nitrogen stream, leaving behind a lipid 
film on the vial walls. The vial was then placed in a lyophilser for a minimum of two 
hours to remove any trapped solvent.   
Then, lipids were dissolved in oil using a bath sonicator operating at 37 kHz set at 
maximum power at 50° C for 60 minutes to ensure full dissolution. Depending on the 
experiments, either hexadecane or mineral oils were used (Sigma Aldrich).  
2.3 PREPARATION OF SMALL UNILAMELLAR VESICLES 
For experiments where lipids were dissolved in an aqueous solution, they were present 
in the form of 100 nm small unilamellar vesicles (SUVs). These were made by 
preparing a lipid film as before, followed by hydration with the relevant buffer. The 
solution was then vortexed until no solid particulates were seen. At this point the 
vesicles were present as multi-lamellar aggregates, and the solution appeared cloudy. 
These aggregates were then transformed into 100 nm SUVs by extruding 11 times 
through a polycarbonate membrane of 100 nm pore size (Avanti Polar Lipids). Fig. 
2.2 illustrates the steps involved. 
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Fig. 2.2 – Preparation of SUVs. (i) Lipid sample was placed in lyophiliser overnight to 
remove any residual trapped solvent. (ii) Sample was rehydrated with the addition of buffer (iii) 
Agitation using a vortexer created LUVs. (iv) freeze thawing, then extrusion created SUVs of 
100 nm diameter. Image modified from indicated reference.[135] 
2.4 PDMS PREPARATION  
PDMS was used to construct wells in which DIBs were formed, as well as forming the 
basis of the microfluidic devices. PDMS was prepared using the Sylguard 184 
Elastomer Kit (Dow Corning), which was composed of a bulk elastomer and a curing 
agent. These two components were first mixed in a 10:1 mass ratio, and were then 
stirred thoroughly using a glass pipette to produce a homogenous mixture. The 
mixture was then degassed under vacuum to remove any air bubbles, and carefully 
poured onto a plastic petri-dish (to make a PDMS sheet) or onto a silicon master (to 
make a microfluidic device), and left to cure at 50° C for a minimum of three hours.  
2.5 WELL FABRICATION  
PDMS wells were constructed using a ca. 10 mm deep PDMS sheet that had 10 mm 
diameter holes drilled into it using metallic hole punchers. These were then 
irreversibly bonded to a glass microscopy slide (VWR) by exposing the surfaces in a 
plasma oven (Harrick Plasma, Ithaca, NY, USA) for 30 seconds, before gently 
pressing the surfaces together. This procedure is demonstrated in Fig. 2.3.  
General Materials and Methods  
  54   
 
 
Fig. 2.3 – Well fabrication. (A) A 10 mm deep PDMS sheet is first made. (B) Several 10 mm 
diameter holes are then drilled through the sheet. (C) PDMS is irreversibly bonded to a glass 
slide by exposure to plasma.   
 
2.6 DROPLET INTERFACE BILAYERS (DIBS) 
Both the lipid-in and the lipid-out methods were used to generate DIBs. In the lipid-in 
experiments lipids were present as 10 mg ml-1 SUVs in an aqueous solution. In the 
lipid-out experiments, they were present at 25 mg ml-1 in oil. To form DIBs, 0.1 µl 
aqueous droplets were pipetted into 0.5 ml oil solution in the well. The droplets were 
then left to stabilise for one minute in the lipid-in method, and for ten minutes for the 
lipid-out method. This ensured the assembly of a well-packed monolayer at the 
water/oil interface. Droplets were then pushed together using a syringe needle. When 
droplets of different compositions were used, different needles were used to 
manipulate the droplets in order to avoid contamination.  
The successful formation of a DIB was inferred by visual means, as illustrated in Fig. 
2.4. When monolayer-encased droplets came together, an initiation point was formed, 
around which the monolayers ‘zipped-up’ to form a bilayer. The droplets adhered to 
one another, and a deformation of the spherical droplets was observed. In addition, 
characteristic optical ‘shadowing’ patterns appeared between the two droplets.[65] 
Throughout this thesis whenever this optical pattern was seen the presence of a DIB 
was assumed. This relationship has been validated by others using capacitance 
recordings across the bilayer.[64]  
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Fig. 2.4 – Droplet Interface Bilayers. (A) Images before and after a DIB is formed. Notice 
appearance of an optical ‘shadowing’ effect as oil is excluded from the interface and a bilayer is 
formed. (B) A close-up of image of a DIB, clearly demonstrating this optical feature (show in 
red box). 
2.7 FLUORIMETER EXPERIMENTS  
Fluorescence experiments performed on fluorimeter were conducted at room 
temperature on a Cary Eclipse Fluorescence Spectrophotometer (Agilent, Santa Clara, 
USA) in black, low volume (40 µl) 384 well-plates (Dow Corning, Midland, USA). 
Care was taken in pipetting the sample to ensure no air bubbles were present. Scan 
rates, averaging times, detector voltages and band slits were tested for optimal 
intensities and noise levels, and unless otherwise mentioned were set to a scan rate of 
120 nm min-1 , 1 s averaging time, 1.5 nm data interval, 600 V detector voltage and the 
excitation/emission band slits of 5/5 nm.  
2.8 MICROSCOPY EXPERIMENTS  
Brightfield and fluorescence imaging were conducted on a Nikon Eclipse TE 2000E 
microscope. This was connected to either a high-speed camera (Infinity-1, Luminara, 
Ottawa, Canada) for fluctuation experiments, or to a QICAM camera (QImaging, 
Surrey, Canada) for all other experiments. For fluorescent microscopy experiments an 
illuminating mercury arc lamp was used.  
The principles behind fluorescence microscopy are shown in Fig. 2.5. In brief, the 
excitation filter filters out specific wavelengths from the light source. Light then gets 
reflected by the dichroic mirror, and is focused onto the specimen through the 
objective lens. The fluorophore is then exited, emitting light which is shifted towards 
longer wavelengths. This then passes through the dichroic mirror, and finally through 
an emission filter, which separates the illumination light from the much weaker 
emitted fluorescence. The spectral characteristics of the individual fluorophores 
determine which filters and dichroic mirrors are used.  
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Fig. 2.5 - Fluorescence microscopy. Schematic of the principles behind a typical 
fluorescence microscopy setup.  
The filters used throughout this thesis are shown in Table 1.1, together with the 
fluorophores they were used to image. The excitation and emission spectra of the 
individual dyes are given in the relevant chapters.  
Table 1.1 - Fluorescent Microscope Filters 
Filter 
Name 
Ex 
(nm)  
Ex band 
(nm) 
Em 
(nm) 
Em 
band 
(nm) 
Dichroic 
(nm) 
Fluorophore 
FITC 480 30 535 40 505 Fluo-4;  GFP; NBD 
TRITC  535 50 590 long 575 Amplex Red;  RFP; 
Rh; Chromeo P 540; 
Nile Red 
DAPI 355 50 420 long 400 Marina Blue 
Custom 
Filter 
395 11 483 32 458 3-Azido-7-
hydroxycoumarin  
 
2.9 FLUORESCENCE ANALYSIS  
To quantify fluorescence levels in the in the droplet and vesicle microscopy images, 
the “measure mean grey value” functionality on the Image J software package 
(freeware, National Institute of Health, USA) was used. Fluorescence levels were 
often different between various regions of the same image, (e.g., where droplets 
contacted glass, fluorescence was usually higher). Due to this, the size and location of 
the region of interest (ROI) were kept consistent in the time-course experiments. A 
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screenshot of a typical ROI is shown in Fig. 2.6A. In non-time-course experiments, 
where individual droplets/vesicles were compared to one another, the average 
fluorescence values at five random points were taken (Fig. 2.6B).  Regions of high 
intensity where droplets/vesicles touched the glass substrate were ignored. 
In all cases where visual comparisons between two or more images were made, 
brightness and contrast were enhanced equally for all images. Fluorescent images were 
false coloured post-capture according to the fluorophore emission spectra.  
 
Fig. 2.6 – Fluorescence image quantification. Modified screenshots the from image 
analysis software, Image J, of a typical fluorescent sample. Yellow circles = regions of interest 
(ROI). (A) In time-course experiments the mean grey value of ROIs of the same size and 
location were compared to one another. (B) When comparing the values between different 
samples, the intensities of 5 ROIs, dispersed throughout the fluorescent part of image were 
averaged. Note the significantly different fluorescence intensities where droplets touched the 
glass surface (centre of droplets). ROIs were not set at these points.  
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Chapter 3 – Multi-
Compartment Vesicles 
(MCVs) 
 
The results described in this chapter have been published as: Yuval Elani et al., 
Engineering multi-compartment vesicle networks, Chemical Science,  4.8 (2013): 
3332-3338.[136]  
3.1 INTRODUCTION 
Phase-transfer methodologies to transform water-in-oil droplets into giant unilamllar 
vesicles (GUVs) have been established in the literature (Section 1.2.3.3), and further 
developed in Chapter Eight. This chapter is concerned with modifying this procedure 
to controllably generate multi-compartment vesicles (MCVs) with user-defined 
architectures and compartment content for the first time. This will enable vesicles to 
be split into distinct regions, each separated from one another by a partitioning lipid 
bilayer. To form MCVs it was decided to employ a strategy of transferring multiple 
droplets across the monolayer interface together.  
The general principle which we will use to generate MCVs is as follows. First, we form 
the internal bilayers of the final vesicle (which separate compartments from one 
another), by bringing together monolayer-coated water-in-oil droplets, forming a DIB. 
Then, the external bilayer (which separates the compartments from the aqueous 
exterior) is formed by passing the construct through a monolayer at the interface of a 
lipid-stabilised oil/water column. Droplets are loaded with sucrose, which drives them 
to descend through the column, become enveloped by the interfacial monolayer, thus 
encasing it in a bilayer and producing an MCV. This is shown in Fig. 3.1.  
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Fig. 3.1 - Principle behind MCV generation. This involves (i) forming a DIB between two 
droplets and (ii) fully encasing the droplets in a membrane using a process of gravity-mediated 
phase transfer.  
3.1.1 Advantages of Compartmentalisation  
Spatial organisation of content and function is a regularly recurring characteristic in 
biology. This is most commonly achieved via sub-compartmentalisation, for example 
in bacterial microcompartments and eukaryotic organelles. In order for artificial cells 
to more closely mimic biological ones, and for the complexity of real cells to be 
introduced into artificial systems, the introduction of compartmentalisation is key. 
Furthermore, compartmentalisation allows for complex modular droplet-based 
devices to be generated, elaborated on in Chapter Seven. Some of the specific 
advantages associated with vesicle sub-compartmentalisation include: 
(i) Spatial separation of distinct chemical reactions or biochemical processes. 
This is important if the constituent reactants or products of the processes in 
question adversely interfere with one another (i.e. if they are non-orthogonal). 
(ii) Partitioning of content to facilitate specialisation of process and function. The 
components needed for one process may not be needed for another, 
therefore physically separating components may improve how resources are 
utilised. This phenomenon is seen in natural cells in the form of organelles, 
which are membrane-bound subunits that perform specific functions. 
(iii) Compartmentalisation allows reactants to be kept in close proximity to one 
another, thereby increasing their local concentration and promoting the 
desired reaction. 
 
Despite the advantages of compartmentalisation, its associated benefits cannot be 
realised in current vesicle-based systems, as they are largely single compartment 
structures with homogenous aqueous interiors. The MCVs developed and described in 
this chapter addresses this shortcoming.  
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3.1.2 Previous Attempts at Compartmentalisation   
There have been several attempts to form multi-compartment membrane structures in 
the past. These include: multi-compartment polymersomes;[137] polymersomes-in-
polymersomes;[138-139] vesicles-in-vesicles;[140] phase separated vesicles,[141] vesicles 
aggregates[133-134], and multisomes.[78], [142] A description of  these structures together 
with any associated drawbacks is summarised in the Table 3.1 below.  
Table 3.1 – Comparison of Compartmentalisation using Membranes 
Structure 
Name 
Schematic Method Description Drawbacks  
 
 
Droplet 
interface 
bilayers 
Multiple lipid-coated 
w/o droplets are 
brought together. Oil is 
excluded at the interface, 
resulting in a bilayer.  
Exists in bulk-oil.  
 
Applications in 
physiological (aqueous) 
environments are 
therefore prohibited. 
 
 
Vesicles-in-
vesicles 
 
Electroformed vesicles 
are encapsulated in larger 
vesicles using phase 
transfer.  
No control over number 
and content encapsulated 
vesicles.    
 
No connectivity between 
compartments. 
 
 
 
Polymersomes
-in-
polymersomes 
Polymersomes are 
generated and then 
encapsulated in larger 
polymersomes using 
capillary-based 
microfluidics.   
Non-biological 
membranes (polymers). 
Potential for 
incorporation of 
biological machinery 
therefore limited. 
 
No connectivity between 
inner compartments. 
 
 
 
 
 
Multi-
compartment 
polymersomes  
 
W/o/w emulsions are 
generated, with block-
copolymers as the 
stabilising agent. A 
volatile intermediate oil 
phase (chloroform and 
toluene) is then removed 
via evaporation.  
Require the use of  bio-
incompatible solvents 
(chloroform/toluene); 
 
Non-biological 
membranes (polymers).  
Potential for 
incorporation of 
biological machinery thus 
limited 
 
Time scale for generation 
is several hours, due to 
slow solvent removal. 
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Vesicle 
aggregates  
 
 
By designing vesicle 
surface chemistry 
appropriately (e.g. with 
complimentary DNA 
strands, or with lipids of 
opposite charges) 
vesicles aggregate in 
large-scale assemblies.  
Uncontrolled assembly. 
 
Cannot control content/ 
connectivity of 
compartments. 
 
Two bilayers separate 
compartments 
(aggregates, not 
hemifused vesicles), so 
problems regarding 
membrane-protein 
insertion.  
 
 
 
Phase-
separated 
vesicles 
Vesicles are composed 
of solutions that are 
capable of phase 
separating if they contain 
both PEG and dextran. 
Vesicles then ‘bud’ 
resulting in distinct 
compartments.  
No bilayer separating 
compartments. 
 
Restricted to solutions 
that can be phase 
separated. 
 
Limited scope for 
expansion to functional 
use.  
 
 
 
Multisomes 
(see Section 
1.2.3.8 for 
more details) 
A water-in-oil drop is 
suspended on an 
agarose-coated needle. 
Smaller droplets are then 
pipetted into this 
droplet. Droplet 
interface bilayers formed 
at all droplet-droplet 
interfaces.   
Require agarose support; 
not freestanding. 
 
Large intermediate oil 
phase limits use as 
biomimetic structures, 
and could interfere with 
biological process, for 
example, by encouraging 
partitioning into oil, or by 
denaturing enzymes.   
 
3.1.3 Criteria for Use 
In order for vesicles to be useful in a synthetic biology setting and as biodevices, they 
must fulfil several criteria. They need to be composed of  biological materials (lipids), 
to enable them to be functionalised with further biological components, such as 
membrane-associated proteins, receptors, and antibodies. Their method of  formation 
should be biocompatible, and not rely on harmful substances (such as chloroform, 
toluene, or detergents). The generation process should be quick enough (in the order 
of  minutes) so that processes that occur over a short timescale can be incorporated. 
The content of  compartments should be pre-defined, and be different from the 
surrounding solution. Control of  the overall structural arrangement must be achieved. 
Finally, the system must not depend on the presence of  a surrounding oil solution, 
and be fully encased in a bilayer, in order to be truly bio-mimetic. These conditions are 
not fulfilled with compartmentalised structures mentioned above.  
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3.1.4 Vesicle Engineering  
One of principal tenants of in vitro synthetic biology is to use engineering principles 
to construct cell-like constructs. Applying this to our system, where vesicles are 
considered artificial cells, various features need to be introduced with a high degree of 
control. In is necessary to control: compartment number; compartment size; 
compartment content; compartment function. As this method uses water-in-oil 
droplets as a starting point, all these features can be engineered into MCVs.   
To form MCVs we need to reliably control how many droplets pass through the 
interface together as well as their individual contents. This is achieved by pipetting 
droplets one by one, where the content of each droplet is predefined. In addition, by 
expelling them above the same location, one can ensure they would descend together, 
leading to MCVs with a defined number of compartments.  
 
3.2 EXPERIMENTAL - MCVS 
3.2.1 Materials  
All lipids were purchased from Avanti Polar Lipids (Alabaster, USA), except Marina 
Blue DHPE which was purchased from Life Technologies (Carlsbad, USA). The wells 
used to hold the column were Nunc Lab-Tek II chambered coverglass, with a well 
area of 1.7 cm2 (Thermo Scientific, Waltham, USA). Fluo-4 dye was purchased from 
Life Technologies (Carlsbad, USA). All other chemicals and proteins were purchased 
from Sigma Aldrich. All experiments were visualised with a Nikon Eclipse TE2000-E 
inverted microscope, and recorded on a QImaging camera. For fluorescence 
experiments, samples were illuminated with a mercury arc lamp. 
3.2.2 Column Preparation  
An analogous experimental set-up to that used for phase transfer  GUV generation 
was developed. To form the column, 0.4 ml of DI water was first added into the wells, 
followed by 4 mg ml -1 of DOPC dissolved in mineral oil/hexadecane in a 75:25 (v/v) 
mixture (Fig. 3.2). Lipid was pre-dissolved in the oil by sonication for 30 minutes at 
50°. This column was left to stabilise for 90 minutes before vesicles were generated 
during which time a well-packed monolayer self-assembled at the interface. 
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3.2.3 Vesicle Generation 
In order to successfully generate vesicles, droplets needed to be sufficiently heavy to 
penetrate the interface. A 0.5 M sucrose solution in DI water was prepared, which was 
filtered with a 0.2 µm filter prior to use to remove any undissolved contents. To form 
the water-in-oil droplets, 1 mm inner diameter tubing was filled with the lipid/oil 
solution, and sucrose-containing droplets were pipetted in. Droplets we pre-incubated 
in this tubing for 15 minutes before being expelled into the column, to ensure they 
were sufficiently stabilised by a monolayer. After the appropriate number of droplets 
were made, they were expelled onto the column using a syringe (Fig. 3.2). Droplets 
descended into the column, one by one in close succession, over the same location to 
generate the MCVs. As droplets fell in the same location, they descended through the 
interface together. The number of droplets that were expelled determined the vesicle 
compartment number (n droplets yielding n compartments). It important to note that 
immediately prior to droplet pipetting, a dense sucrose solution (0.1 ml, 1.5 M) was 
syringed into the bottom of the column. This provided a cushion above which the 
MCVs rested to prevent contact with the glass slide, which was observed to destabilise 
the vesicles. It also crucially reduced the osmotic imbalance between the vesicle 
interior and exterior, increasing MCV yield and lifetime.  
 
 
Fig. 3.2 – Schematic of experimental setup for MCV generation. 
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3.3 RESULTS AND DISCUSSION - MCVS 
3.3.1 Constructing Vesicles with Defined Compartment Number, Size and 
Content  
As this method converted water-in-oil droplets into vesicles, it was possible to 
precisely define compartment number, size, and content. As droplets were expelled 
one by one above the same location, the number of  compartments was simply 
determined by how many droplets were expelled together — two droplets produced 
two compartments, three droplets produced three compartments and so on (Fig. 3.3).  
 
Fig. 3.3 – Vesicle engineering. (A) Compartment number and content could be controlled 
by how many droplets were expelled together and by their content. In this case, compartments 
contained liposomes with different fluorescent lipids. Blue channel = Marina Blue PE lipid; 
Yellow channel = NBD-PE lipid; Green channel = Rh-PE lipid. Right hand image shows a 
six-compartment vesicle. (B) Compartment size was controlled by expelling droplets of 
different sizes. Image shows compartments of 2 different sizes. (C) Different  compartment 
connectivities could be generated (uncontrolled). Scale bars = 500 µm. 
As the droplets were formed individually beforehand their content could be 
controlled, meaning that each of the eventual vesicle compartments could have 
different pre-defined internal content. To demonstrate this, each compartment of a 
two- three- and four- compartment vesicle was loaded with different fluorescent 
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cargoes, in this case 5 ml ml-1 100 nm DOPC liposomes with different fluorescently 
tagged lipid (0.1 wt. %) within them (Fig. 3.3A). The fluorescent lipids we used were 
Rh-PE, NBD-PE, Marina-Blue PC, and were viewed with standard TRITC, FITC and 
DAPI filter sets respectively, with exposure times of 200 ms. The fluorescent cargoes 
were retained in the compartments throughout the course of the experiment (40 
mins). The lack of leakage suggests an effective, continuous barrier between the 
individual compartments, and between the vesicles and the external aqueous solution.  
Finally, by using droplets of defined volumes, compartments of defined sizes could be 
generated. In this way, either heterogeneous MCVs (with compartments of different 
sizes) or homogenous MCV (with compartments of the same size) could be generated 
(Fig. 3.3B). Importantly, there was a size limit to MCVs that could be reliably 
generated (ca. 200 µm MCV radius). This was due to the fact the downward force 
driving the droplets through the interface (governed by its size and density) had to be 
greater than the opposing tension of the water/oil interface. If droplets were not large 
enough they were observed to simply lie on the on the interface. At lower sucrose 
concentrations, the gravitational force acting on the droplets was insufficient to 
overcome the opposing interfacial tension, and droplets remained resting on the 
water/oil interface. 
It is important to emphasise that the size regimes of phase transfer GUVs described in 
the literature (and in Chapter Eight), and the MCVs described here are different by an 
order of magnitude (50 µm vs. ~ 500 µm radius). The empirical observation that 
vesicles smaller than ~ 200 µm radius could not be generated using this ‘macro-scale’ 
droplet expulsion method suggest the physical mechanisms involved in phase transfer 
were different for the two size regimes. 
The precise connectivity of the compartments were determined by the how droplets 
arranged themselves as they sunk through the interface. As this process was 
uncontrolled, vesicle connectivity could not be defined. Fig. 3.3C shows two observed 
compartment geometries for a 4 compartment vesicles. Notice the possibility of 
compartments adopting a planar 2D arrangement, and a tetrahedral-like 3D 
arrangement.  
3.3.2 Fluorescence Visualisation of Bilayer  
MCVs were generated with 1 mol % fluorescently tagged lipid (headgroup labelled 
NBD-PE) present in the oil phase. Fluorescent imaging with the corresponding FITC 
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filter at 200 ms exposure showed distinct fluorescent boundaries between the 
compartments themselves (the ‘internal’ bilayers), and between the compartments and 
the bulk aqueous solution (the ‘external’ bilayer), shown in Fig. 3.4. This gave an 
indication to the presence of an encasing bilayer, and of an internal bilayer partition. 
These experiments also revealed regions of trapped oil that also fluoresced due to 
presence of dissolved lipid. 
 
Fig. 3.4 – Florescence visualisation of membranes. By doping vesicles with fluorescent 
lipid, the various membranes of 1, 2, and 3 compartment vesicles could clearly be seen under 
fluorescent microscopy. Note the presence of oil pockets, most markedly in the vertex regions 
where multiple membranes meet. These appeared as fluorescent patches due to the presence of 
dissolved lipid.   
3.3.3 Phase Transfer Visualisation in Real Time  
The process of multi-droplet phase transfer was observed in real time. Droplets were 
observed to go through distinct stages upon their transformation from droplet 
collections to MCVs, shown in Fig. 3.5.  
(i) After droplets were expelled into the column, they sunk through the oil 
phase until reaching the water/oil interface, where they settled, being 
supported by the interfacial tension. 
(ii) Because droplets were expelled above the same location they lied adjacent 
to one another which led to the formation of a DIB — a process 
deduced by the characteristic refractive patterns.  
(iii) Over a period of between 5 and 90 seconds, the interface gradually 
started to deform around the monolayer-coated droplets as they sunk 
further into the water phase. Eventually, they were completely submerged 
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in water, and enveloped by the interfacial monolayer. An external bilayer 
thus encased the droplets. 
(iv) During this process, oil was occasionally trapped in the structure. In 
addition, the constituent monolayers continued to come together to from 
the encasing bilayer, leading to the displacement of oil from the interface. 
As the bilayers ‘zipped-up’, oil accumulated as an oil lens at the top of the 
structure (a phenomenon observed by others in polymersomes).[143] 
(v) As more oil accumulated, this lens increased in volume, until it was 
eventually expelled from the structure. Due to its lower density, it rose 
away from the vesicle, into through the external water phase, until it 
reached the oil phase (Fig. 3.5B). 
(vi) This process of oil accumulation and ejection occasionally occurred twice, 
depending on the amount of trapped oil from the phase transfer process.   
(vii) Any residual oil left over after oil ejection continued to accumulate at the 
vertices between the compartments. 
The description above describes two-compartment vesicle generation; similar steps 
were seen for higher order vesicles.  
 
Fig. 3.5 – Visualisation of MCV Generation. (A) The stages involved in two-compartment 
MCV generation. Dotted line indicates the imaging plane. (i) Droplets descended through oil 
phase. (ii) Two droplets rested on the interface, gradually deforming it. (iii) Droplets sunk 
through the interface into the oil phase. (iv) Droplets were fully submerged, with an encasing 
bilayer. Note the presence of a trapped oil lens. (v) Oil lens was ejected from the MCV. (B) 
Sequence of images showing gradual accumulation of oil in a lens as bilayer ‘zipped up’ and oil 
was excluded. This was followed by lens ejection.  
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3.3.4 Oil Tracking 
The process of oil accumulation was elucidated using fluorescent microscopy. The 
incorporation of 10 µM Fluo-4 (a florescent dye), allowed this, as the dye has different 
emission intensities when exposed to an oil environment.[144] The dye was monitored 
under fluorescence microscope with a TRITC filter set at 100 ms exposure. This 
allowed the movement of oil pockets to be tracked over time, and revealed the gradual 
accumulation of oil, and its movement towards the compartment vertices (Fig. 3.6). 
The process of sequential oil-lens formation, ejection, and residual oil accumulation 
took approximately 10 minutes. 
 
Fig. 3.6 – Oil tracking, after MCV generation. (A) Brightfield images of oil accumulation at 
compartment vertices over time. Note the regions of transparency where oil was completely 
excluded, leaving only a bilayer. (B) Fluorescence images used to track movement towards to 
the vertex regions.  
3.3.5 Vesicle Stability  
Vesicle stability was highly variable, with lifetimes ranging from several minutes to 1.5 
hours. There were also occasion when droplets burst upon contact with the interface. 
The yield of successful two-compartment vesicle formation was found to be 43% 
(n=30). It was found that when the starting droplets contained 2 mg ml-1 extruded 
DOPC liposomes inside, the yield of successful phase transfer events rose to 83% 
(n=30). This is because the ‘lipid-in’ approach increased the likelihood that droplets 
were encased with a well-packed monolayer (i.e. they were effectively stabilised).  
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MCVs could be degraded in one of two ways. The first was internal bilayer rupture. In 
this case, compartments merged to give a single-compartment vesicle with the 
combined volume of the two constituent compartments. More commonly however 
the external bilayers ruptured (the ones separating the compartment from the external 
environments), leaving a vesicle with one less compartment. The likely reason for 
rupture was the large osmotic differences between the inner/outer solutions. The 
osmotic pressure, Π, is determined by the Morse equation (Equation 3.1): 
Π ൌ ݅ܯܴܶ																					ሺ3.1ሻ                 
Where M is the molarity, R is the gas constant, T is the temperature, and I is the van’t  
Hoff factor (i = 1 for sucrose).  If the assumption is made that the external aqueous 
solution had no sucrose present, then the calculated osmotic pressure between the 
inner and outer volumes of the membrane was 24 atm (others have found that DIBs 
can withstand pressures of up to 50 atm).[69] 
3.3.6 The Effect of the Sucrose Cushion 
The above calculations of osmotic pressures do not take into account the effect of the 
sucrose cushion at bottom of the column — this was necessary to prevent vesicle 
contact with glass, which led to deformation and eventually its rupture (Fig. 3.7).  
 
Fig. 3.7 – Sucrose Cushion. (A) Without a sucrose cushion vesicles wet the glass substrate. 
(B) Brightflied image of vesicle wetting, where area of contact with substrate can be seen. (C) 
This led to vesicle rupture, after which an oil residue was deposited on the substrate. (D) A 
dense sucrose cushion prevented contact with glass substrate, thus increasing vesicle lifetime.  
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The presence of this cushion also aided vesicle stability by reducing the osmotic 
difference between the membranes. The drawback of this however, was that the 
precise concentration of the external solution could not reliably be known due to 
diffusion and mixing of sucrose with the bulk aqueous volume over time. 
3.4 EXPERIMENTAL - PROTEIN INSERTION  
After generation of MCVs it was necessary to demonstrate their capacity to host 
functional transmembrane proteins. This would demonstrate their potential to be used 
for functional purposes, for example as biologically inspired sensing devices. 
Successful insertion would also give an indication into the biophysical parameters of 
the bilayers by showing that membranes were similar enough to cellular membranes to 
not have adverse effects on membrane protein folding and activity. We show 
successful insertion of alpha-hemolysin (α-HL) into both the ‘internal’ and ‘external’ 
bilayers via a Ca2+ leakage assay.  
The principle of the assay is as follows. On one side of the membrane is Ca2+, and on 
the other a fluorogenic Ca2+ sensitive dye. Only in the presence of α-HL pores can 
Ca2+ cross the bilayer, leading to a fluorescence increase in the dye-containing volume. 
The assay was first performed on a DIB setup for optimisation, and then translated 
into a vesicle format. Before the assay is discussed in more detail, an overview of α-
HL is given.  
3.4.1 Alpha Hemolysin  
α-HL is a 33 kDa protein which binds to unilamellar membranes in its monomeric 
form, and self oligomerizes into heptameric  structures on the membrane (Fig. 3.8).[145] 
This results in a beta-barrel structure, with hydrophobic residues facing the lipids and 
hydrophilic residues facing the lumen of the channel. The resulting pore is ~ 1.4 nm 
diameter (~10 nm channel length), which allow ions and small metabolites to 
permeate through the membrane. The protein has therefore been used to demonstrate 
successful bilayer formation in many model membrane systems.[78, 109, 146]  As the 
protein enables the influx of Ca2+ ions, which are otherwise impermeable to the 
membrane, we were able to determine successful protein insertion using fluo-4, a Ca2+ 
sensitive fluorescent dye. 
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Fig. 3.8 -  Alpha Hemolysin structure. A side-on and top-view projection of the protein, 
deduced from X-ray crystallography. Each colour represents a distinct peptide chain. The beta-
barrel segment of the protein sits in a lipid membrane, resulting in a water filled channel (or 
pore), 1.4 nm diameter, allowing material to translocate through the bilayer. Note the seven-
fold symmetry of the oligomer.  
3.4.2 -  Protein Insertion Assay  
In the following experiments, all aqueous solutions were composed a buffer 
containing 25 mM Tris-HCl, 500 mM KCl,  pH 8.0 in DI water. Where α-HL was 
present, it was dissolved in DI water to a concentration of 0.5 mg ml-1, before being 
diluted with the buffer solution to give a final concentration of 60 ng µl-1. Solutions 
containing Ca2+ also contained ethylenediaminetetraacetic (EDTA) in order to chelate 
any residual ions in order to decrease the background fluorescence. 
To monitor dye leakage, fluorescent images were then taken with a TRITC filter at 
800 ms exposure to monitor fluorescence intensity change in the dye containing 
compartments. 
3.5 RESULTS AND DISCUSSION – PROTEIN INSERTION  
3.5.1 Protein Insertion in DIBs    
The assay was carried out in DIB format to optimise the dye and Ca2+ concentrations. 
DPhPC DIBs were formed in hexadecane using the ‘lipid out’ method, described in 
Section 2.6. One droplet contained 500 mM CaCl2, the other 20 µM fluo-4, 200 µM 
EDTA, and 60 ng µl-1 α-HL. In the control experiment, no protein was present. When 
protein was present, a qualitative fluorescence increase was observed after 40 minutes, 
indicating successful protein insertion and subsequent ion leakage. This was not seen 
when no protein was present. These results are shown in Fig. 3.9. 
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Fig. 3.9 – Ca2+ leakage through DIBs. Experimental schematic and composite images the 
Ca2+ leakage assay. (A) As bilayers are impermeable to Ca2+, no florescence was seen in the 
dye-containing droplet after 20 minutes. (B) The presence of α-HL pores in the bilayer 
allowed Ca2+ to diffuse through the bilayer, leading to a fluorescence increase in the adjacent 
droplet. Scale bar = 500 µm.  
3.5.2 Protein Insertion in MCV Internal Bilayer  
Next, the assay was translated to an MCV format. MCVs have two types of bilayers: 
the internal bilayer (separating compartments from one another), and the external 
bilayer (separating compartments from the external solution). To demonstrate protein 
insertion in the internal bilayer, MCVs were generated as before, where one of the 
compartments was composed of 20 µM fluo-4, 200 µM EDTA, and 60 ng µl-1 α-HL 
and the other of 500 mM CaCl2.. 0.5 M sucrose was also present in both 
compartments in order to drive phase transfer. Over a period of ~40 minutes, the 
fluorescence intensity increased as protein inserted into the bilayers and Ca2+ ions 
flowed through the pores (Fig. 3.10). On the other hand, the control experiment 
where no protein was present showed no fluorescence increase.  
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Fig. 3.10 – Protein insertion in inner-bilayer. (A) Schematic of experimental setup. (B) 
Fluorescence intensity of dye-containing compartment of a representative vesicle over time, in 
the presence and absence of protein. (C) Fluorescence and composite images of a 
representative vesicle at the beginning and end of experiment. 
A lag period of ~20 minutes was present before a fluorescence increase was observed. 
This was likely due to the time necessary for sufficient protein monomers to insert 
and assemble on the membrane, and in addition, to EDTA initially chelating inflowing 
Ca2+ ions before becoming saturated, allowing ions to bind to the dye. Indeed, a 
similar time-dependent diffusion of ions through such pores has been observed and 
commented upon previously.[78] 
3.5.3 Protein insertion in MCV external bilayer  
To demonstrate protein insertion into the external bilayers, a vesicle was constructed 
where both compartments contained 20 µM fluo-4, 200 µM EDTA, and 0.5 M 
sucrose. The bulk external solution contained 100 mM CaCl2. 50 µl α-HL was then 
delivered into the vicinity of the vesicle using a syringe. The fluorescence intensity of 
both compartments increased simultaneously over a period of ~40 minutes (Fig. 
3.11), showing successful insertion into the external membrane. This is an example of 
material uptake from environment through the external membranes. The control cases 
where no protein was present showed no fluorescence increase. 
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Fig. 3.11 – Protein insertion in external-bilayer.  (A) Schematic of experimental setup. (B) 
Fluorescence and composite images of a representative vesicle at the beginning and end of the 
experiment. Fluorescence of both compartments increased simultaneously. (C) Fluorescence 
intensity of the dye-containing compartment of a representative vesicle over time, in the 
presence and absence of protein.  
3.5.4 Where Protein Inserted  
It is important to emphasise that as α-HL inserts into any bilayer it encounters. In the 
first experiment, where the protein was initially dissolved in the aqueous volumes of 
one of the compartments, it inserted into both the ‘external’ and ‘internal’ bilayers 
(Fig. 3.12). This would have led to Ca2+ leakage to the external solution as well as 
leakage to the adjacent compartment. A potential strategy that could be explored to 
ensure proteins only insert in the inner bilayer is to pre-form the DIB in a bulk oil 
solution, and wait for all the proteins to insert in the bilayer. Then, encase the DIB in 
an external bilayer at which point there will be no protein left in solution to insert into 
the external bilayer. Indeed, a similar rationale was used by Bayley et al. in their 
generation of electrical DIB networks.[70] 
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Fig. 3.12 – Protein insertion, with monomers present  in internal MCV volume. (A) α-
HL monomers, initially present in one of the MCV compartments, will insert into both internal 
and external membranes. (B) In order for pores insert in the internal membrane only, one 
could first form a DIB in oil environment, wait for all pores to assemble, and then generate 
MCVs.   
In the second experiment, where the protein originated from the external solution, 
pores formed in the external bilayers only, as they never come in contact with the 
internal bilayers (Fig. 3.13). Importantly, although protein can diffuse on the 2D 
surface of the membrane, they cannot diffuse into the inner bilayer as this would 
require protein flip-flop, dragging the hydrophilic portions of the protein through the 
hydrophobic bilayer core — a highly unfavourable processes.  
 
Fig. 3.13 – Protein insertion by the addition of monomers in the external solution. This 
leads to pore assembly in the external membrane only. Protein diffusion into the internal 
bilayer is highly unfavourable, as this would require protein ‘flip’ through the membrane, 
dragging hydrophilic parts of the protein thought the bilayer core.  
3.5.5 Implications of Successful Insertion 
Successful protein insertion and subsequent ion leakage through the internal bilayer 
confirmed that the constructs were not simply vesicle aggregates with two individual 
bilayers separating the compartments. Instead, it indicated they were vesicles with a 
single internal bilayer partition. The experiments also demonstrated the bilayers were 
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functional with respect to their biological activity, and that the level of residual 
trapped oil was not enough to prevent protein insertion, or to cause the protein to 
misfold in a manner which would cause loss of function. This demonstrates that 
residual oil does not significantly affect membrane properties. Importantly, the results 
show that it would be possible to functionalise the membrane for specific purposes by 
incorporating biological macromolecules. This is crucial as many emerging vesicle 
engineering techniques rely on the insertion of macromolecules (DNA origami, 
antibodies, specific transporters and other integral and peripheral membrane-
associated proteins) to impart a desired morphology or function.  
Successful insertion of protein in the internal bilayer allows material transfer between 
the vesicle compartments, and a paves the way for intra-vesicle communication 
networks and trans-compartment reaction cascades. Successful insertion into the 
external bilayer shows uptake of material from the external aqueous surroundings. 
This is important in the context of the vesicles functioning as bio-reactor/proto-cell. 
It opens up the possibility of ‘feeding’ the vesicles by allowing uptake of material from 
the external environments, thus allowing sustained chemical reactions to take place, 
without the vesicle running out of reagents.[129] It is also important if the vesicles are 
to act as chemical sensors, as we shall show in Chapter Five. 
3.6 CHAPTER CONCLUSIONS  
We have constructed vesicles with distinct internal compartments separated by 
internal bilayer partitions. This was achieved by encasing multiple droplets joined by 
interface bilayers with an external bilayer, using a process of gravity-mediated phase-
transfer. The vesicle architecture was determined by the number of droplets encased 
by the bilayer, and the internal contents and volumes of each compartment could be 
rigorously defined by starting with droplets of different compositions and sizes 
respectively. Both the internal and external bilayers were fully functional, as 
demonstrated by the successful reconstitution of transmembrane proteins.  
Spatial segregation of vesicle internal content has implications that span several 
disciplines. Most notably, in in-vitro synthetic biology, the spatial-dynamic 
organisation seen in real cells can start to be introduced into artificial ones. 
Compartments can be dedicated to specific functions, and distinct regions of the 
vesicle membrane patterned with different membrane-associated proteins. This latter 
feature — seen in real cells, where membranous structures have specific proteins 
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associated with them — can be introduced as the internal and external membranes are 
formed separately.  
The sequential assembly of compartments also allows multipart systems to be built 
out of simpler components in a modular manner: individual compartments 
performing distinct operations (e.g. stimuli sensing and subsequent response), can be 
coupled to form a complex functioning unit. This could facilitate a shift in synthetic 
biology away from mono-functional elements and towards more integrated systems — 
indeed, others have commented that the presence of technologies to achieve this shift 
is key for further development of the field.[118] Finally, because the method uses DIBs 
as templates around which a bilayer is encased, many of the promising capabilities of 
DIB networks — such as energy harvesting, light sensing, and bio-batteries[64] — 
could be transformed into a vesicle format, so they could exist as true cell-like bio-
devices.  
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Chapter 4 – In Vitro 
Transcription and 
Translation in MCVs 
  
The results described in this chapter have been described in part in Yuval Elani et al., 
Manufacturing vesicles with internal bilayer partitions: a novel unit for synthetic 
biology. European Biophysics Journal with Biophysics Letters. 01/2013; 42:S55-
S55.[147] 
4.1 INTRODUCTION 
Lipid vesicles are the most widely employed chassis used to define artificial cells. The 
previous chapter focused on developing methods to engineer vesicles with defined 
compartment number, content and size, where compartments were linked to one 
another via a partitioning bilayer. We also demonstrated material uptake from the 
environment, a property shared with biological cells. This chapter builds on this: we 
show that the universal biological process of transcription and translation can be 
incorporated into the vesicles, thus transforming them into artificial cells. Importantly, 
we use the separation of content to achieve segregation of function. In doing so we 
succeed in introducing a level of spatial organisation of function that has not been 
previously achieved in artificial cells. We show that each compartment can be devoted 
to a specific biological process, namely the in vitro biochemical synthesis of distinct 
proteins in different areas. In this way, eukaryotic organelle function in mimicked in 
MCVs. 
4.1.1 In Vitro Transcription and Translation (IVTT) 
Transcription and translation is a conserved biochemical process shared across all life 
classes. The transcribing of DNA template to mRNA, followed by translation to a 
defined protein sequence is integral to all life, and has thus become known as the 
central dogma of molecular biology (Fig. 4.1). Therefore, for vesicles to be considered 
artificial cells, it is important to demonstrate they the can contain this process. 
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Fig. 4.1 – The central dogma of molecular biology. DNA is first transcribed to RNA by 
RNA polymerase. RNA is translated by a ribosome to yield a protein with a defined amino acid 
sequence.  
It has been shown that the individual biochemical components needed for 
transcription and translation can be extracted from bacterial cells and then purified.[148] 
These components can be added to a DNA sequence, either in plasmid form or as 
linear PCR fragments for cell-free protein expression, thereby reproducing a complex 
physiological process. This process of in vitro transcription and translation (IVTT) 
was originally developed for the synthesis of proteins that are toxic to cells and for the 
facile introduction of modified, unnatural or labelled amino acids. However, recent 
years have seen its use expand to in vitro compartmentalisation in synthetic biology. 
4.1.2 IVTT in Artificial Cells 
IVTT has previously been shown to be contained in lipid vesicles for the synthesis of 
membrane and non-membrane proteins, with several uses in functionalising artificial 
cells.[133, 149-150] Miller et al. used IVTT synthesis of GFP as a reporter for the presence 
of lactose using an inducible promoter in an artificial droplet based protocell.[151]  
Others have used IVTT to create biochemical oscillation circuits,[152] and for time-
resolved monitoring of protein expression.[153] A recent impressive study has shown 
vesicle uptake of the necessary building blocks for IVTT from the external 
environment via a protein pore for continual protein synthesis.[129] Normally, these 
components run out after several hours as protein synthesis progresses. In this case 
however, due to constant supply of the necessary building blocks, IVTT could last for 
several days. Finally, there have been several examples of IVTT in vesicle aggregates, 
held together either by complimentary DNA strands, or by vesicle electrostatic 
attraction.[133-134]  
IVTT has also been achieved in DIBs, most notably by Bayley et al. who synthesised 
α-HL (membrane protein) which inserted into the bilayer, as confirmed by current 
traces.[64] These studies demonstrated successful protein synthesis within a timescale as 
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short as five minutes. These experiments were achieved using a ‘lipid-in’ technique, 
showing that protein synthesis can take place in the presence of a high concentration 
of liposomes. Finally, Friddin et al. performed a systematic study of the effects of 
IVTT in DIBs.[154] They found that the complex mixture of biomolecules (particularly 
the energy-supply fractions) destabilise the DIB in the lipid-out method, but not in the 
lipid-in method.  
We use IVTT to show that biological processes can be segregated in space in artificial 
cells based on MCVs, with one compartment synthesising green fluorescent protein 
(GFP), the other red fluorescent protein (RFP). 
4.1.3 Choice of IVTT Kit 
There are several commercial kits for cell free protein expression. We chose the 
PURExpress systems (New England Biolabs), which is reconstituted from the purified 
components necessary for E. coli protein synthesis. It is a one-step reaction that 
simply requires mixing of two components with the template DNA. This kit was 
chosen as it has the following unique advantages: 
‐ Rapid protein synthesis (typically within 20 minutes). 
‐ Option for an ‘added-volume’ of additional components (in our case sucrose 
and lipid). 
‐ Optimised for synthesis of non-membrane proteins, including fluorescent 
proteins.  
‐ Shown to express a wide range of proteins. 
‐ High protein yield: more than 100 μg ml-1. 
‐ High purity; Can withstand more than five freeze-thaw cycles without loss of 
efficiency.  
‐ Nuclease and protease free; therefore preserves  DNA/RNA template 
integrity, and ensures proteins are free of degradation and modification.  
‐ It is the most commonly used kit for artificial cell protein expression – 
enables comparison with other studies.  
 
4.1.4 Transcription and Translation – Mechanism  
Transcription and translation is the process by which a protein sequence is synthesised 
according to the bases on the DNA template. The detailed mechanism for this can be 
found in most undergraduate-level biochemistry textbooks.[3] Briefly, transcription 
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refers to the conversion of DNA to mRNA. This is done by the enzyme mRNA 
polymerase, and is initiated by transcription factors that bind to a promoter region of 
the DNA strand. mRNA polymerase binds to these transcription factors, thereby 
inducing transcription. Then, enzymes unwind the DNA strands and synthesize a 
complimentary mRNA strand. Transcription stops when the enzyme reaches a 
termination sequence in the DNA. 
Translation refers to the synthesis of protein sequence according the bases present in 
the mRNA. A ribosome first attaches to the mRNA (on the ribosome binding site), 
and then induces the binding of tRNAs with the complimentary anticodon sequence. 
These carry with them specific amino acids, which are added to the end of the 
growing polypeptide chain as the mRNA is ‘read’. Translation can be split into four 
steps: initiation, elongation, translocation, and termination, all facilitated by specialised 
proteins. Aminoacyl tRNA sythetase is also needed to catalyse the ‘loading’ of specific 
amino acids on to the corresponding tRNA. 
The IVTT mix must therefore contain more than 100 individually purified 
components. These include: aminoacyl-tRNA synthetases; initiation factors; 
elongation factors; release factors; ribosome recycling factors;  T7 RNA polymerase; 
nucleoside-di-phosphate kinase; 70S ribosomes; amino acids; rNTPs; tRNA.  
 
4.2    EXPERIMENTAL  
4.2.1    Plasmid Design  
To design the plasmid we followed PURExpress recommendations.[155] A constitutive 
(i.e. not inducible) plasmid was designed, depicted in Fig. 4.2. This consisted of the 
following components on an E. coli pJexpress 441 vector: 
(i) T7 promoter region  
(ii) Ribosome binding site (RBS, Shine-Dalgarno sequence)  
(iii) Start codon (ATG) 
(iv) Gene of interest (either Dasher-GFP of RFP) 
(v) Stop codon (TAG) 
(vi) T7 terminator region. 
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Multiple (~8 nucleotide) asparagine linkers were present between the T7 promoter 
and the RBS, the RBS and the start codon, and the stop codon and the T7 terminator. 
The plasmid was designed by us, and sent to be synthesised by DNA 2.0 (CA, USA) 
who also did the large-scale plasmid preparation. Plasmid maps can be found in the 
Appendix. 
 
Fig. 4.2 – Plasmid design. Schematic of plasmid components for IVTT of fluorescent 
protein. Nucleotide linkers were present between the coding regions (full sequence available in 
appendix). 
4.2.2     Fluorescent Proteins  
Synthetic, non-aequorea fluorescent proteins were used (provided by DNA 2.0, IP-
Free). The two proteins synthesised were Dasher Green Fluorescent Protein (GFP; 
gene ID: 111370; 728 base-pairs) and Red Fluorescent Protein (RFP; gene ID: 111369; 
698 base-pairs).  
The choice of fluorescent proteins was governed by the extent of overlap between 
their excitation and emission spectra, to allow the differential detection of the two 
using appropriate filters with fluorescence microscopy. The smaller the spectral 
overlap, the better discrimination between the proteins. Additional factors included 
their low maturation times and high quantum yields. For a general study of cell free 
protein expression of fluorescent proteins, refer to the recent study by Lentini et al.[156] 
4.2.3    General Precautions  
During all experiments, precautions were taken to avoid contamination with nucleases 
(RNAse and DNAse). Eppendorf and pipette tips were sterile and nuclease free and 
gloves were used to handle reagents at all times. In addition, nuclease inhibitor was 
added to the IVTT mix in case contamination took place in spite of the measures 
taken. 
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4.2.4    Plasmid Preparation  
Plasmid powder was dissolved in 1 ml DI water, and left at 4˚C overnight to fully 
dissolve. The concentration was measured using a spectrophotometer, which 
measured the amount of UV irradiation absorbed by the bases. Readings were taken at 
260 nm, with 1 O.D corresponding to 50 ng µl-1. Plasmid concentration was revealed 
to be 324 µg ml -1 for GFP and 456 µg ml -1 for RFP. These were then diluted to 50 
µg ml -1 by adding appropriate volumes of DI water. Plasmids were then aliquoted to 
10 µl volumes, snap frozen with dry ice, and stored in a – 40 ˚ C freezer until use 
(aliquots made to minimise freeze-thaw cycles).  
4.2.5    IVTT Mix Preparation 
The PURExpress IVTT reagents (New England Biolabs) was provided in two tubes, 
A and B. These tubes were thawed on ice and then moved to room temperature (RT). 
Tube A was made into 3.75 µl aliquots; tube B into 5 µl aliquots. These were then 
snap frozen on dry ice and stored in a - 80˚ C freezer until use. 
Preparation of the IVTT mix, depicted in Fig. 4.3, was all done on ice. For each 
individual experiment, 3.75 µl of solution A was added to 5 µl of solution B. 2.5 µl of 
plasmid (encoding either GFP or RFP), and 0.25 µl (10 units) of RNAsin (Sigma 
Aldrich) were then added. Finally, 3.75 µl of ‘added volume’ was added to the mix. 
This consisted of either DI water, 25 mg ml -1 DPhPC lipid, 3 M sucrose, or lipid + 
sucrose depending on the purposes of the experiment (detailed below). When lipid 
was added, this was present as SUVs, formed by sonication in a bath sonicator for 60 
minutes.  The solution was mixed gently by pipetting up and down three times.  
After dilution, the final lipid and sucrose concentrations of the mix were 7.6 mg ml-1 
and 0.9 M respectively. 
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Fig. 4.3 - Preparation of IVTT mix. This was composed of the designed plasmid, 
PURExpress solutions A and B, and an ‘added-volume, the identity of which varied between 
experiments.  
 
4.3      RESULTS AND DISCUSSION  
4.3.1     IVTT in Droplets at Room Temperature  
Before showing IVTT in a vesicle format, we wanted to validate successful plasmid 
design by monitoring fluorescent protein synthesis of water-in-oil droplets using 
fluorescence microscopy. This was also done to investigate if the surrounding oil 
environment affected synthesis in an adverse manner, and if the signal was intense 
enough to be detected with a fluorescence microscope.  
To do this, the IVTT mix was prepared as before, and 1 µl droplets were pipetted in a 
hexadecane-containing PDMS well. GFP and RFP synthesis was monitored using a 
fluorescence microscope with a standard FITC and TRITC filters respectively, with a 
1 s exposure. Droplets were incubated at room temperature for 2 hours, after which 
time fluorescence images were taken, see Fig. 4.5A. 
Despite the high exposure times, only a weak fluorescence increase was recorded, 
demonstrating failure of GFP synthesis at sufficient levels. Droplets were also 
observed to ‘wet’ the surface of the slide — this indicated that the complex mix of 
biomolecules had an effect on the droplet interfacial properties.  Finally, protein fibrils 
were seen to form on the droplet surface after ~24 hours (Fig. 4.5C). It is likely these 
were proteins from the PURExpress mix aggregating at the interface with the oil.   
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4.3.2 IVTT in Droplets at 37 ° C 
To increase IVTT efficiency, protein synthesis was attempted in droplet form with 
incubation at 37° C, which was the recommended temperature according to published 
protocols.[155] For this, a temperature-controlled well was designed (Fig. 4.4), with the 
assistance of Dr. S. Purushothaman (refer to indicated reference for full experimental 
details).[157] In brief, this well was fabricated out of acrylic, with a resistance 
temperature detector (Pt 100) inserted. Adjacent to the wells, on a glass slide, heating 
pads were placed. The heating pads and temperature sensors were connected to a 
modulator to form a temperature sensing /heating feedback loop. This allowed the 
sample in the well to be heated to a user-defined temperature.  
 
Fig. 4.4 – Setup of the temperature controlled well. This was used to conduct IVTT 
experiments at 37 ˚C for greater efficiency.  
Protein synthesis was monitored as before using fluorescence microscopy (results 
shown in Fig. 4.5). The higher temperature led a marked increase in droplet 
fluorescence intensity for both GFP and RFP. Fluorescence increase (and hence 
protein synthesis) was seen almost immediately (within 5 minutes) and plateaued off 
after 12 hours. It was observed that RFP fluorescence was significantly weaker than 
GFP. Possible reasons for this are lower synthetic yield, lower quantum yields, or 
longer protein maturation times. Without further experimentation, it is unknown 
which of these factors is responsible for this.  
These results show that plasmid design was successful, and that fluorescence levels 
were high enough for monitoring with fluorescence microscopy. Further, the results 
demonstrate that despite protein synthesis succeeding at room temperature, the 
efficiency was significantly enhanced at the 37° C. Finally, the results show that the 
presence of oil did not preclude protein synthesis, despite the potential aggregation of 
biomolecules on the water-oil interface.  
Another observation was that droplet fluorescence levels after a set amount of time 
were highly variable (Fig. 4.5B), which indicates that IVTT levels were variable as well. 
The source of this variability is uncertain — it could be due to non-homogenous 
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distribution of components, due to different volume size (and hence surface area/ 
volume ratios) or by the level of wetting of droplets on the glass substrate. 
 
Fig. 4.5 – IVTT in water-in-oil droplets. (A) Images of droplets after 1 hour incubation at 
different temperatures, 1 s exposure. These show a qualitatively greater IVTT efficiency at 37 
˚C. (B) Images of two GFP droplets of the same IVTT mix, incubated in the same well for 30 
minutes, 1 s exposure. The variable fluorescence levels indicate variability in IVTT efficiency 
between different droplets (precise cause unknown). (C) Image showing fibrils which appeared 
when droplets were incubated in oil for ca. 24 hours. (D) Image showing the ‘wetting’ of 
IVTT droplets on the glass substrate. (E) Time course of GFP fluorescence at 37˚ C. 500 ms 
exposure. (F) Graph showing fluorescence levels of GFP droplet time. Scale bars = 400 µm. 
4.3.3    Fluorescent Protein Characterisation   
To characterise the fluorescent proteins, an excitation and emission scan of GFP and 
RFP was recorded on a fluorimeter (Cary Eclipse), shown in Fig. 4.6A. The spectra of 
the two proteins exhibited only minimal overlap, which is necessary for effective 
discrimination of the two proteins using florescence microscopy. It also revealed 
correct overlap with the FITC (for GFP) and TRITC (for RFP) filter sets.  
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In another experiment, a GFP emission scan was taken every 15 minutes, at 37˚ C, 
shown in Fig. 4.6B (fluorimeter settings: 1000 V, ex = 470 nm, em =, slit = 20 nm).  
The results show an almost immediate expression GFP (as confirmed by the 
microscopy experiments), and the cessation of expression after ca. 3 hours, 
presumably as the chemical building blocks were gradually consumed.  
4.3.4   Effect of Reaction Conditions 
In order to from MCVs, droplets needed to be loaded with large concentrations of 
sucrose and lipid to drive phase transfer and to increase vesicle lifetime stability. As 
such it was important to test if these two added components have any effect on IVTT. 
To do this, four IVTT samples were made up: 
(i) IVTT mix with DI water (control). 
(ii) IVTT mix with 0.9 M Sucrose. 
(iii) IVTT mix with 7.6 mg ml-1 DPhPC liposomes. 
(iv) IVTT with 0.9 M Sucrose and 7.6 mg ml-1 DPhPC liposomes.  
 
Experiments to monitor GFP synthesis at 37 ˚ C under these conditions were carried 
out on a fluorimeter, under the same settings as before. Fluorescence levels after two 
hours under the four conditions is shown in Fig. 4.6C. This revealed an apparent 
enhancement of IVTT efficiency when lipid was added to the mix, but a decrease 
when sucrose was added. When both lipid and sucrose were added, IVTT efficiency 
was lower than in the control scenario where only DI water was added.  
This set of experiments revealed that protein synthesis can occur in the presence of 
high concentrations of both lipid and sucrose. Indeed, the presence of lipid actually 
appeared to enhance protein synthesis.  Therefore IVTT can be successful using the 
reaction conditions we have developed to generate MCVs. 
It must be stressed that these results are not conclusive and caution is needed in their 
interpretation. The results have a relatively high variability indicated by the large 
standard deviations. This likely arises for low sample volumes, the possibility of 
evaporation over time, imprecise temperature maintenance, and due the inherent 
variability of IVTT efficiencies, as previously observed in Section 4.3.2.  
In Vitro Transcription and Translation in MCVs 
  88   
 
 
Fig. 4.6 – IVTT experiments on fluorimeter.  (A) Emission and Excitation profile of GFP 
and RFP proteins. (B) Emission profile of GFP IVTT sample taken at 15 minute intervals. 
(C) Fluorescence levels of GFP IVTT, after 1 hour incubation, with different types of ‘added 
volumes’. Error bars = 1 S.D, n=5.    
4.3.5 Effect of Plasmid Concentration  
An important variable which influences IVTT is known to be the concentration of the 
template DNA.[148]   Too little template reduces the number of translated mRNA. On 
the other and, if too much template is added, then excessive amounts of mRNA are 
produced which overwhelms the translation mechanism. Therefore the right balance 
had to be struck. For GFP, the optimum plasmid concentration was found to be 125 
ng of plasmid per 12.5 µl of reaction.  Higher and lower DNA concentrations (60 ng 
and 325 ng) were both qualitatively found to decrease IVTT efficiency.  
4.3.6 IVTT in Multi-Compartment Vesicles  
After preliminary studies of IVTT in droplets, protein synthesis in MCVs was 
attempted, to demonstrate that segregation of content could lead to segregation of 
function. A system was setup whereby IVTT of two distinct proteins took place in 
MCVs: one compartment was designated with synthesising GFP, the other with RFP.  
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To do this, MCVs were generated using the same method as described in Section 3.2. 
Both compartments contained the IVTT mix, but differed in the plasmids which they 
contained (Fig. 4.7): 
Droplet A: IVTT mix + GFP plasmid + 0.9 M sucrose + 7.6 mg ml-1 DPhPC lipid. 
Droplet B: IVTT mix + RFP plasmid  + 0.9 M sucrose + 7.6 mg ml-1  DPhPC lipid. 
 
Fig. 4.7 – Schematic of IVTT in MCVs. (A) Experimental setup of generation of MCVs 
with different plasmids in each compartment. (B) Schematic showing the contents of the two-
compartment vesicle. 
0.1 µl of droplets A and B were expelled above a water-oil column on a temperature 
controlled well plate described previously, heated to 37˚ C.  The two compartment 
vesicles that were generated were then monitored under brightfield and fluorescence 
microscopy using two channels: FITC for GFP, and TRITC for RFP. Exposure time 
was 1 s for both channels. As before, successful IVTT was confirmed via fluorescence 
microscopy, during the 60 minute lifetime of the MCVs. Fig 4.8 shows brightfield 
image and fluorescence images of a typical MCV, showing successful GFP and RFP 
synthesis in defined vesicle regions. As elaborated on before, RFP fluorescence was 
significantly lower than GFP.  
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Fig. 4.8 – IVTT in MCVs - fluorescence microscopy. (A) Brightfield and fluorescence 
images of a representative MCV, showing different proteins being expressed in defined regions 
over time. (B) Composite images of two compartment vesicles. Green channel = GFP, Red 
Channel = RFP. Scale bars = 200 µm. 
4.3.7 Temporal Stability 
The temporal stability of the vesicles containing the IVTT mix was qualitatively 
observed to be lower that when the mix was absent. As we have seen previously, 
without the added IVTT components vesicles would typically have lifetimes of ca. 60 
minutes. Although there were instances of vesicles containing the IVTT mix surviving 
this long, most vesicles tended to rupture within five minutes of formation. This is 
thought to be because of interactions between the high concentrations of biological 
macromolecules in the droplets (estimated to be 2.6 mg ml –1 of protein by the 
supplier) which could interfere with bilayer integrity. In addition, many of these 
macromolecules may also assemble themselves at the water/oil droplet interface 
before the bilayer is formed, thus interfering with effective monolayer packing and 
leading to less robust bilayers. It is clear that more optimisation is needed to increase 
the stability of such systems, especially when adding high concentration of potentially 
disrupting components.  
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4.4    CHAPTER CONCLUSIONS  
We have shown that IVTT can take place within MCVs. This demonstrates that they 
are robust enough to contain within them the relatively complex biochemical reactions 
necessary for protein synthesis. In addition, we have shown that reactions conditions 
necessary to generate MCVs (namely high concentrations of sucrose and lipid) do not 
significantly impair IVTT efficiency. This indicates that additional biological processes 
can also be contained within MCVs in the future (for instance, PCR), and that they are 
a valid chassis on which artificial cells can be based.  
In more general terms, it was shown that the separation of content achieved in the 
previous chapter can be used for segregation of function. This basic principle, 
employed in biological cells, can start to be incorporated into artificial ones using 
MCVs. Separation of function can lead to more efficient processes under the principle 
of division of labour — an increasingly complex division of labour is associated with 
greater output. It will also allow several functions that are otherwise incompatible with 
one another (non-orthogonal processes) to be contained in a single cell-like unit, by 
separating processes in space.  
These results also demonstrate the greater biomimetic potential that MCVs offer over 
traditional spherical, uni-compartment vesicles. It allows the defined spatial 
organisation of biological cells to be introduced into artificial cells, and will enable 
more complex features to be introduced in the future. In our case, different proteins 
could be synthesised in distinct regions, which could not be achieved without 
segregation of content.    
Finally, segregation of content according to function allows modular cell-like devices 
to be constructed, where each process is contained in district spatial locality. This 
principle of modularity is an important principle in synthetic biology, as allows sub-
components to be designed separately, and later combined to produce more complex 
functioning devices.  
 
 
 
  
Spatially Segregated Cascade Reactions in MCVs  
  92   
 
Chapter 5 – Spatially 
Segregated Cascade 
Reactions in MCVs 
  
The results described in this chapter have been published as: Yuval Elani et al., 
Vesicle-based artificial cells as chemical microreactors with spatially segregated 
reaction pathways, Nature Communications, 5, 2014, doi: 10.1038/ncomms6305.[158]  
5.1 INTRODUCTION  
As seen in the introduction chapter, chemical reactions and biological processes 
performed in lipid vesicles are of great importance to the discipline of bottom-up 
synthetic biology. The ultimate goals of this field can largely be split into two 
categories: (i) the design of artificial cell-like systems using chemical building blocks 
and (ii) the assembly of smart, bio-inspired ‘machines’ employing various types of 
chemistries  for purposes such as drug-delivery and the production of bio-molecules. 
Spatial segregation of content in compartments — and the subsequent interaction 
between these compartments— is key if these goals are to be achieved. 
The previous chapter dealt with segregation of content leading to separation of 
function, by showing IVTT of two different proteins taking place in distinct 
compartments. However, these processes were passively occurring — they were 
taking place independently of one another. In cells however, there is constant 
chemical communication between different regions. Signals are transmitted, often 
across lipid bilayers, to different cellular regions via a signalling cascade.[3] This chapter 
aims to introduce such a signalling cascade into MCVs. A signalling cascade can also 
be thought of as a sequential multi-step chemical reaction sequence. As such, showing 
spatially segregated chemical reactions is also important in the context of vesicles as 
aqueous-based microreactors.  
5.1.1 Motivation  
There are two broad motives to contain segregated cascade reaction sequences inside 
vesicles. The first concerns the increased scope it offers to for chemistry to be 
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performed in vesicle interiors. Up to now, most reactions that have been included 
inside vesicles have been ‘one-pot’ processes: vesicles traditionally only have one 
confined space in which reagents must be added in beforehand. This restriction is an 
inherent feature of vesicles, and limits the scope of processes that can be performed 
within them. Chemical (and biochemical) processes that have been encapsulated in 
vesicles to date include click-chemistry,[159-161] simple organic transformations,[131] 
PCR,[53, 127] and IVTT.[134, 149, 162]   
This stands in contrast the way chemistry is performed in a conventional bench-top 
laboratory setting. In simplified terms, every step of a reaction step takes place within 
a designated test-tube, with an optimised set of reagents and conditions, and then 
added to a new test-tube for subsequent reaction steps to occur. This sort of format 
cannot take place in single-compartment vesicles.  
We propose that by using vesicles with multiple compartments, more elaborate 
spatially segregated multi-step reaction systems can be incorporated. Segregation of 
content will allow each compartment to be optimised for specific purposes — for 
example by the presence of reactants or specific chemical conditions — allowing each 
step to be optimised, and increasing the overall efficiency of the system. The analogy 
of a factory with different units performing distinct roles is applicable here.   
The second motive relates to bottom up synthetic biology. Compartmentalisation of 
content and function is a commonly recurring characteristic in biology: this is most 
evident in bacterial microcompartments and  eukaryotic organelles.[163]  Introducing 
compartmentalisation into artificial cells will allow some universal features to be 
reproduced. One such feature is a signal transduction pathway, which in biological 
terms is sequence of chemical reactions where each stage processes the output of the 
previous stage.  
5.1.2 Cascades in Biology 
In biological systems, signal transduction pathways — also referred to as signalling 
cascades—are used to transmit chemical signals between different spatial localities to 
regulate specific functions. They are extensively studied due to the roles they play in 
human diseases. They typically refer to a series of chemical reactions that are initiated 
by a stimulus (primary messenger) which originates externally from a cell. The signal is 
transmitted through the membrane, often by ligand binding to transmembrane protein 
receptors, resulting in the activation of secondary messengers in the cytoplasmic side 
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of the membrane. It is then spread within the cell via intra-cellular signalling networks, 
which may modulate the signal in various ways, for example, by amplifying it. 
Eventually, the signal is transmitted to effector molecules, which elicit a cellular 
response to the initial stimulus. Cellular responses most commonly involve the 
activation or inhibition of proteins via phosphorylation (or dephosphorylation) events, 
or the expression of effector genes. A schematic of the various stages typically 
involved in a cellular signalling cascade is shown in Fig. 5.1.  
 
Fig. 5.1 – The three stages of a signalling cascade: reception, transduction, and 
response. In the example shown, the exogenous signal (growth factor), is received by a 
transmembrane receptor, and is then transmitted across the cell membrane to different cellular 
regions (for example the nucleus), leading to a response (gene synthesis).   
5.1.3 Examples of Sequential Chemical Reaction in Vesicles  
Surprisingly, given the commercial use of vesicles as drug delivery vehicles, there have 
been relatively few examples of multi-step chemical reactions taking place in vesicles. 
Bollinger et al., formed giant vesicles which were loaded with different populations of 
SUVs, each containing distinct reagents and composed of lipids with varying phase 
transition temperatures.[164-165] The surrounding temperature was slowly increased, 
leading to sequential release of reagents for multi-step synthesis (Fig. 5.2). A 
disadvantage of such systems is that an external input (increasing temperature) is 
needed to initiate each step. Furthermore, there is a lack of defined spatial 
organisation of content, and the absence of connectivity between the inner vesicles is 
detrimental to their potential use and applications. 
There have also been elegant methods to form networked vesicle nanoreactors with 
nanotubes facilitating reagent transfer between regions.[166-167] However, these require 
manual manipulation of individual vesicles using expensive apparatus, and are 
therefore unsuitable for scale-up and for potential uses as functional devices. 
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Fig. 5.2 – Examples of vesicle-based spatially segregated multi-step reactions. (A) 
Bollinger et al. used a vesicle-in-vesicle setup, where inner vesicles become permeable at their 
phase-transition temperature. Their internal content is thus released, inducing a reaction with 
external reagents. (B) Orwar et al. used micromanipulation/injection techniques to create 
vesicle networks linked together by lipid nanotubes, where each network segment contained a 
different reagent. The different parts of the network were then brought together using a 
micromanipulator, resulting in a chemical reaction.  
Finally, there have been demonstrations of sequential reactions in a polymersome-in-
polymersome systems.[138, 168] These however lack the biological relevance of lipids, 
and have a diminished ability for functionalisation with biological components 
(protein pores, receptors, antibodies etc.). Future incorporation of such components is 
integral if some of the more complex features of cells are to be reproduced. In 
addition, block co-polymers also do not possess the rich phase behaviour that lipids 
do, which can be taken advantage for the introduction of responsiveness. 
Furthermore, due to the lack of resemblance to real cells, they are less useful as 
models to with which to examine and gain insights into biological processes. 
Importantly, all the above examples do not possess the myriad advantages that 
droplet-based technologies lend themselves to, such as control over compartment size 
and content, high throughput generation, potential for automation etc. 
For the above reasons, more suitable structures are required with which to confine 
content in defined vesicle regions to allow spatial segregation of multi-step processes, 
and to enable communication between regions.  
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5.2 EXPERIMENTAL 
5.2.1 Reaction Cascade  
We propose to contain an engineered three-step artificial reaction cascade within 
MCVs, with each step mediated by a single enzyme and isolated in a distinct 
compartment. The reaction pathway we use has been employed for the fluorescent 
detection of lactose in biological samples for a number of years.[169-170] 
The cascade reaction scheme, shown in Fig. 5.3, is as follows: 
Step (1): Lactose hydrolysis by lactase to yield D-galactose and D-glucose.  
Step (2): D-glucose oxidation by glucose oxidase (GO) and dissolved oxygen, to yield 
D-gluconolactone and hydrogen peroxide.  
Step (3): Oxidation of non-fluorescent organic molecule Amplex Red by hydrogen 
peroxide in the presence of horseradish peroxidase (HRP), yielding fluorescent 
resorufin.  
 
Fig. 5.3  -  Multi-step reaction sequence. (A) Three-step reaction sequence, where each 
step is mediated by a specific enzyme. Protein structures shown below. (B) Lactase (C) 
Glucose oxidase. (D) Horseradish peroxidase. Structures obtained from the Protein Data 
Bank.  
Transfer of reagents between the compartments is facilitated by α-HL, a trans-
membrane protein pore. In this way, the products of one step can traverse through 
the bilayer into the adjacent compartment to become the reactant for the next step. 
Before proceeding, a brief overview of the components used will be given. 
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5.2.2 Overview of Reaction Components  
The first enzyme in the cascade is lactase (EC 3.2.1.23). It is an essential enzyme in 
cellular biology which hydrolyses the glycosidic bond in lactose to yield D-glucose and 
D-galactose.[171] In E-coli it is encoded by the lacZ gene as part of the inducible lac 
operon — a widely used genetic circuit in molecular and synthetic biology. The 
protein is a homotetramer (464-kDa) whose active site is contained in the third 
domain.  
The second enzyme is GO (EC 1.1.3.4). It is used by cells to break down glucose into 
its constituent metabolites.[172] The enzyme is used commercially for medicinal 
diagnostic applications, as well as in the food industry to detect sugar levels. It is a 
homodimeric protein (80 kDa per subunit), with a deep pocket as an active site to 
which the substrate binds. Each subunit contains one equivalent of flavin adenine 
dinucleotide (FAD) and iron. 
The third enzyme is HRP (EC 1.11.1.7). It is a 44 kDa heme-containing enzyme 
found in horseradish roots and used heavily for biochemistry applications.[173] It is 
commonly used as a reporter system for probe-based assays, such as enzyme-linked 
immunosorbent assays (ELISA) and Western Blotting. In these cases it is usually 
conjugated to antibodies, which can then be detected by HRP oxidation of a non-
fluorescent substrate into a fluorescent product. 
The reporter molecule we use is a fluorogenic dye, Amplex Red, which is oxidised by 
H2O2 in the presence of HRP in a 1:1 stoichiometry, to produce highly fluorescent 
resorufin (excitation/emission maxima = 570/585 nm, see Fig. 5.4).[174] It is an 
attractive reporter due to its ability to operate at physiological pH, its high chemical 
stability, and the long wavelength spectra of the oxidised product, leading to less 
interference from biological samples and glass slides. 
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Fig. 5.4 -  Amplex Red fluorescent reporter. (A) Chemical structures of Amplex Red and 
resorufin. Oxidation by hydrogen peroxide is mediated by HRP. (B) Excitation and emission 
profile of fluorescent resorufin.  
Communication across bilayers is mediated by α-HL (pore diameter 1.4 nm). A full 
description of this protein was given in Section 3.4.1. 
5.2.3 Materials and Methods 
All lipids were purchased from Avanti Polar Lipids. GO, HRP, and Amplex Red were 
purchased from Life Technologies. Lactase, α-HL and all other chemical were 
purchased from Sigma Aldrich. Importantly, molecular biology grade sucrose and 
lactose (BioUltra) were used to reduce to possibility of glucose contamination.   
Reaction solutions were all prepared in 50 mM sodium phosphate buffer, pH 7.4. 
Glucose and lactose were present in the relevant droplets at 0.25 M concentrations. 
All other droplets contained sucrose (0.25 M), to prevent an osmotic imbalance either 
side of the membrane. Depending the experiment, different enzymes and dyes were 
present in each compartment. Lactase was present at concentrations of 15 U ml-1. GO 
was present at concentrations of  2 U ml -1. HRP was present in concentrations of 0.2 
U ml -1.  Amplex Red was present at a concentration of 100 µM. All reagents were 
prepared according to the protocol booklet provided by the supplier. α-HL was 
present in relevant droplets at 60 ng µl-1. 
In DIB experiments, DIBs were formed via the ‘lipid-out’ method, with ~0.1 µl 
droplet in 25 mg ml-1 DPhPC dissolved in mineral oil. Fresh oil, unused wells, and 
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new needles were used to prevent contamination. In the MCV experiments, all 
solutions had an additional 0.5 M sucrose dissolved. This was to provide the large 
density difference needed for droplets to descend through the column. MCVs were 
generated using the phase-transfer of two- or three- droplets across a water-oil 
interface as described in Section 3.2. To increase the stability of the structures, the 
starting droplets were also loaded with 10 mg ml-1  100 nm DPhPC liposomes, formed 
by extruding 11 times through a polycarbonate membrane. 
Production of the reaction product resorufin was monitored with fluorescence 
microscopy, using a TRITC filter, and an exposure of 10 ms. Shutters were closed 
between acquisition events to minimise photobleaching.  
5.3 RESULTS AND DISCUSSION 
5.3.1 Cascade Reactions in DIBs 
The overall aim of this chapter is to segregate each step of the reaction sequence in 
distinct compartments of MCVs, with the product of each step translocating to 
adjacent compartments and initiating subsequent steps. However first we wanted to 
demonstrate compartmentalisation in a DIB format using a series of experiments, 
each one building upon the previous one by the addition of a further step. The 
experimental setup, results, and explanations are summarised in the Table 5.1 below. 
Table 5.1 - Enzyme Cascade Reactions in DIBs. 
Experimental Setup and Results 
Scale bar = 500 µM. 
Explanation 
 
 
 
 
In this experiment steps (2) and (3) of the 
reaction sequence were isolated in individual 
droplets. One droplet contained glucose 
and GO, the second contained HRP and 
Amplex Red. Seconds after the droplets 
were bought into contact a fluorescence 
increase was seen in the dye-containing 
droplet. 
 
Glucose was oxidised by GO, producing 
H2O2, which is permeable to bilayers due to 
its neutral charge and small size (Log P = 
0.43±0.48).[175]  H2O2 thus rapidly diffused 
into the adjacent compartment, oxidised 
Amplex Red in the presence of HRP, 
yielding fluorescent resorufin.  
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This experiment was analogous to the 
previous one, with one added step. Instead 
of glucose present in the GO-containing 
droplet, it was initially present in adjacent 
droplet. The presence of α-HL protein 
pores allowed glucose to translocate 
through the bilayer, leading to reaction 
initiation, which took place as before.  
 
 
This experiment contained steps (1) (2) and 
(3) of the reaction cascade, each step 
isolated in a distinct droplet. Glucose was 
produced in the first droplet via the 
hydrolysis of lactose by lactase. Glucose 
then translocated through α-HL pores, and 
the second and third reaction steps 
proceeded in the corresponding droplets as 
before.  
 
 
In the final experiment, lactose was not 
initially present in the lactase-containing 
droplet. Instead, it diffused through an 
adjacent droplet through α-HL pores to 
initiate the three-step reaction as before.  
 
Note that with the addition of each 
additional step, the time taken for a 
noticeable fluorescence signal was observed 
to qualitatively increase. 
 
In the two-droplet experiment, fluorescence was observed to propagate through the 
droplet in a wave-like manner (Fig. 5.5). This indicated the rate of reaction between 
H2O2 and Amplex Red was generally greater than the rate of diffusion.  
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Fig. 5.5 – Fluorescence propagation across droplets. (A) Schematic of the fluorescence 
‘wave’ seen as H2O2 rapidly crossed the bilayer into the adjacent droplet. (B) Brightfield image 
of DIB. (C) Fluorescence time-course images showing propagation of fluorescence signal. (D) 
Composite brightfield/fluorescence images of DIBs over time. Scale bar = 250 µm. 
5.3.2 Backflow of Reagents and Products  
Amplex Red, and the corresponding fluorescent product, resorufin, are small organic 
molecules, and therefore were expected to be partially permeable to a lipid bilayer 
(predicted partition coefficients of 0.89±1.29 and 1.02±1.09 respectively).[175] Indeed, 
over time, a fluorescence increase was seen in the droplet that did not initially contain 
the dye (Fig. 5.6). This indicated that the dye, in its oxidised or non-oxidised form 
crossed into the adjacent droplet. This backflow of reactant/product led to a certain 
degree of loss of product, but could prove useful in the future as it opens the potential 
of a feedback loop between the product and the reaction that leads to its formation.
 
Fig. 5.6 – Backflow of Amplex Red/resorufin. (A) Schematic of the backflow (red arrows) 
of the reagent/product across the bilayer. (B) Microscopy images showing fluorescence 
increase in the right hand droplet due to transfer of either Amplex Red or resorufin across the 
bilayer (white arrow). Scale bar = 250 µm. 
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5.3.3 Reaction in MCVs 
After the reaction cascade was established in DIBs, we conducted a series of 
experiments to translate it into a vesicle format, and showed the segregation of the 
various steps of the cascade in an MCV. As before, the synthesis of resorufin was 
monitored using fluorescence microscopy.   
5.3.4 Isolation of Step (2) and (3) in Two-Compartment MCVs 
In the first experiment, we encapsulated steps (2) and (3) of the cascade in a two-
compartment vesicle. One compartment contained glucose and GO, the other HRP 
and resorufin. A schematic of this experiment, together with graphs showing 
fluorescence increase over time, and brightfield and fluorescence images of the 
vesicles is shown in Fig. 5.7. 
 
Fig. 5.7 - Segregation of steps (2) and (3) in MCVs. (A) Graph of fluorescence of dye-
containing droplet over time. (B) Fluorescence and composite images at the beginning/end of 
reaction. Scale bar = 250 µm. (C) Schematic of vesicle setup, showing the production of H2O2, 
which then crosses the interface bilayer to yield fluorescent resorufin.  
The product of the first step, H2O2 , was permeable to lipid bilayers due to its small 
size (0.4 nm) and neutral charge.[176] For this reason as soon as the vesicle were 
formed an almost instantaneous fluorescence increase was observed in the second 
compartment: as H2O2  diffused in, the second step was initiated, and Amplex Red 
was oxidised yielding fluorescent resorufin. The reaction between H2O2, Amplex Red, 
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and HRP was rapid and the reaction went to completion within ~10 minutes.[174]  In 
this case, H2O2  can be thought of as a signalling molecule, mediating between the two 
steps (indeed, the role of H2O2 as an intracellular signalling molecule is increasingly 
being recognised).[177]  The control experiment,  where vesicles were identical apart for 
the absence of glucose, showed a constant and low fluorescence level, showing that 
H2O2 was produced specifically by the action of GO on glucose. 
5.3.5 Initiation of Segregated Reaction by an Exogenous Chemical Signal  
In the next experiment, we wanted to show the initiation of the cascade by an 
exogenous factor, namely the presence of glucose in the external solution. To do this 
we generated two-compartment vesicles where one compartment contained GO, and 
the second contained HRP and resorufin. Glucose was absent in the internal vesicle 
volume, but was instead present in the surrounding aqueous solution. We also loaded 
the vesicles with α-HL monomers which spontaneously insert into bilayers and 
aggregate to form heptameric protein pores (1.5 nm diameter), allowing glucose (1 nm 
molecular diameter), to diffuse through the pore lumen.[178] Schematic of the 
experiment and results are shown in Fig. 5.8. 
 
Fig. 5.8  – Initiation of segregated reaction by an exogenous chemical signal. (A) Graph 
of fluorescence of dye-containing droplet over time. (B) Fluorescence and composite images 
at the beginning/end of reaction. Scale bar = 250 µm. (C) Schematic of vesicle setup, showing 
glucose translocation from the external solution into the vesicle interior, through α-HL pores, 
initiating the spatially segregated reaction as before.   
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Glucose translocated from the external solution, through the pores into the vesicle 
interior. This caused initiation of the reaction as before, and a fluorescence increase 
was observed until a maximum intensity was reached after 22 minutes. It is 
noteworthy that the fluorescence increase was significantly slower than that of the 
previous experiment due to the requirement of glucose diffusion through the α-HL 
pores. The lack of fluorescence increase in the control scenario, where α-HL was not 
present, demonstrated that glucose originated from the external solution and was not 
present in the vesicle interior. This example of an external stimulus initiating multi-
step processes in distinct specialised compartments demonstrates the potential use of 
such systems for drug-delivery and bio-sensing applications.  
5.3.6 Isolation of Steps (1), (2), and (3) in Three-Compartment Vesicles 
In the final experiment we generated three-compartment vesicles and isolated steps 
(1), (2) and (3) in distinct compartments. The first compartment contained lactose, 
lactase, and α-HL. The second contained GO. The third contained HRP and Amplex 
Red. A schematic of the setup and results are shown in Fig. 5.9. 
 
Fig. 5.9 – Isolation of 3 steps of the reaction cascade in a 3 compartment MCV. (A) 
Schematic of the MCV setup. Each step of the three-step reaction sequence was housed in a 
distinct compartment. Lactose was first hydrolysed and glucose was produced. This then 
translocated through α-HL pores into the adjacent compartment, and the final two reaction 
steps took place as before. (B) Fluorescence and composite images at the beginning/end of 
reaction. Scale bar = 250 µm. (C) Graph of fluorescence of dye-containing droplet over time. 
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Lactose hydrolysis by lactase took place in the first compartment. The resulting 
hydrolysis product, glucose, passed through α-HL into the adjacent compartment 
containing GO. As before, this initiated the next step in the cascade, with H2O2 
oxidising Amplex Red to fluorescent resorufin in the third compartment. The 
fluorescence time-course profile followed a similar pattern as in the previous 
experiments. One exception was that a lag phase of 6 minutes was present before 
fluorescence increase was observed. This was due to the time taken for the additional 
step that was added to the cascade to take effect, namely lactose hydrolysis by lactase 
to produce glucose. The control experiment, which was identical apart for the absence 
of lactose, showed no fluorescent increase over time, thereby demonstrating that 
glucose indeed originated from lactose hydrolysis.   
5.3.7 Decrease in Fluorescence  
In all three experiments, a steady decrease in fluorescence was seen after peak 
fluorescence was reached. This was due to a combination of three factors: over-
oxidation of product into non-fluorescent resazurin,[174] photobleaching, and leakage 
of fluorescent product through the bilayers due to its partially hydrophobic character. 
The effect of over-oxidation of product was revealed by obtaining a graph of glucose 
concentration vs. fluorescence intensity on a fluorimeter. Samples contained between 
0 and 100 µM glucose, Amplex Red (100 µM), and HRP (0.2 U µl -1). The sample was 
excited at 570 nm and the signal at 585 nm was recorded (Fig. 5.10A, B). This showed 
that above 10 µM glucose the signal intensity started to drop off, due to product over-
oxidation.  
The effect of photobleaching was determined by constant exposure of water-in-oil 
droplet containing 100 µM Amplex Red and 100 µM H2O2 with the fluorescence 
microscopy setup. This revealed an exponential decrease in signal over time (Fig. 
5.10C). When the droplet initially contained HRP and glucose instead of H2O2, 
fluorescence was seen to rise over a period 1000 s as resorufin was produced, and 
then decay exponentially as photobleaching took effect (Fig. 5.10D). Note in this case 
the shutters were constantly left open, in contrast to the DIB and MCV experiments 
where they were shut after every exposure event.  The effect of product loss via 
leakage across the bilayers was validated in the preceding DIB experiments (Section 
5.3.2), where leakage into droplets which did not originally contain the dye was 
observed.  
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Fig. 5.10 – Sources of fluorescence decrease over time. (A) Over-oxidation of resorufin by 
H2O2 into non-fluorescent resazurin. (B) Graph showing fluorescence levels of 
GO/HRP/Amplex Red reaction mix with different glucose concentration, taken on a 
fluorimeter. The gradual decrease after the maximum is reached is due to over oxidation of the 
dye. (C) Graph showing the effect of photobleaching on dye fluorescence. As the dye is 
continually exposed under the fluorescence microscope, intensity decreases.  (D) Graph of 
fluorescence of droplet containing glucose and GO/HRP/Amplex Red reaction mix over 
time. Fluorescence initially increases due to resorufin production, then decreases due to 
photobleaching. Note, in this case fluorescence shutters were left open, so the dye was 
continuously exposed to light.  
5.3.8 Reagent Diffusion in MCVs 
One issue regarding this system was the lack of specificity regarding the direction of 
reagent diffusion. Without electrically driven flow, α-HL will let material diffuse in 
both directions. In addition, once H2O2 was generated, it permeated through all 
bilayers, and not just through to the intended compartment. This resulted in gradual 
loss of reagents and intermediate. However, as the enzymes were too large to move 
across the protein pore, the basic principle of the system was not compromised: each 
step still only took place within a designated compartment. 
5.3.9 Prevention of Sucrose Contamination 
In developing the reaction cascade one practical problem that had to be overcome was 
the exceptionally high sensitivity of the assay. The assay has previously been shown to 
detect 10 picomoles of glucose in 100 µl (50 nM),[174] so significant efforts had to be 
made to prevent contamination, and to ensure that any glucose arose from the 
adjacent droplets only. To do this, gloves were changed after the glucose solution 
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sample was prepared, and after any contact with the glucose-containing sample. In 
addition, ultra-pure grade chemicals were used. It was found that reagent grade 
sucrose had significant quantities of glucose contaminants, which led to fluorescence 
increase in the control experiments.   
5.3.10 Natural Lactose Hydrolysis Rates  
The use of sucrose to create the density difference which drove MCV formation was a 
potential source of problems regarding glucose contamination. As sucrose is a 
disaccharide composed of glucose and lactose, hydrolysis would therefore lead to the 
production of glucose. However, the sucrose hydrolysis rate constant at 25°C is 5 x 
10-11 s-1, which corresponds to a half-life of 440 years.[179] Therefore, the levels of 
glucose originating from hydrolysis was assumed to be negligible. This was confirmed 
in the control experiments shown above, where no increase in fluorescence was seen 
despite the presence of 0.5 M sucrose.  
5.3.11 Implications  
The implications of this work broadly fall into two categories. Firstly, it bridges the 
gap between table-top chemistry and chemistry that can be performed within the 
confines of lipid vesicles. Normally, discrete chemical steps of multi-step reaction 
pathways are segregated in time:  the steps are performed sequentially, one after the 
other. Different reagents can be added or removed in each step, and the reaction 
conditions can also be altered. However, when employing chemistry in confined 
structures such as vesicles this is more problematic: it is difficult to manually influence 
and manipulate these systems, especially if it is intended for them to do their function 
in an inaccessible environment (for instance, in vivo). By segregating the reaction 
steps in space this issue can be circumvented: each step can take place in a distinct 
compartment of a multi-compartment vesicle, each one with the necessary reagents to 
perform that particular step. It also opens up possibilities for more advance systems, 
where different conditions are imposed on individual steps, as is seen in multi-step 
organic syntheses.  
The second implication is most apparent in the context of bottom-up synthetic 
biology. Each compartment can be said to host one step of a signalling cascade, 
transducing a signal from one compartment to the next via a series of intermediaries. 
Signalling networks such as these are ubiquitous in biological systems, yet this work 
represents the first time it has been incorporated in such a manner in synthetic cell-
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like system. It can thus be added to the repertoire of cell-like features contained in 
vesicles which have emerged in recent years. It also offers the same service that 
organelles do in biological cells, where distinct membrane bound regions are 
specialised to perform specialised tasks. In the systems described here, each 
compartment is optimised to perform each reaction by inclusion of the enzyme 
catalyst.   
Such systems could also see use as multi-component bio-devices which detect 
surroundings and deliver an appropriate response — either to be interpreted by the 
end user, or to induce an automated response as an intrinsic part of the system. In 
terms of future directions, the most immediate are those concerning the development 
of microfluidic technologies to reduce the size of the vesicle and for high throughput 
generation. This, together with engineering vesicle response to more-biologically 
relevant stimuli (antibodies or metabolites for instance), are the key areas which need 
to be addressed for the ambitious goals of the proposed systems are to be realised.   
 
5.4  CHAPTER CONCLUSIONS  
We have designed and constructed a series of multi-compartment vesicle systems that 
enable discrete steps of chemical reaction sequences to be segregated in space. These 
factory-like ‘protocell’ units — composed of lipids, metabolic and membrane proteins, 
and small molecule substrates — have different compartments specialising in 
performing distinct tasks. The output of one of these compartments is passed on to 
the next, either by passive diffusion through the bilayer partitions, or through protein 
pore conduits. The vesicles are also shown to be able to process exogenous chemical 
signals. This work demonstrates the ability of this new class enclosed structure, the 
MCV, to increase the scope of the chemistry that can be performed in vesicles and 
opens up avenues for more complex vesicle-based chemical factories to be used in 
physiological environments.  
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Chapter 6 – Microfluidic 
Generation of 
Multisomes 
 
6.1 INTRODUCTION  
In the previous chapters we generated multi-compartment vesicles (MCVs) with 
control over compartment number and content. The major deficiency of the method 
developed was that vesicles were generated one-by-one, via manual pipetting. This 
limited both their minimum size, and the number of vesicles that could be generated 
in a given time. In this chapter, we aim to rectify this by developing microfluidic 
technologies that allow similar membrane-based compartmentalised structures to be 
generated in high throughput and with a fine degree of control. This is essential to 
achieve if the power and potential of such structures are to be scaled-up, for example, 
to yield functional biomimetic devices.  
6.1.1 MCVs and Multisomes  
The novel structures we developed up to now in this thesis, MCVs, are similar to 
other compartmentalised droplet-based assemblies described by others, termed 
multisomes: these are oil-in-water droplets with a water-in-oil DIB network embedded 
within (see Section 1.2.3.8 and Fig. 6.1).[78] The key difference is that multisomes have 
a significant intermediate oil phase between the inner and outer droplets. In functional 
terms, both these structures are the same: bilayers exist between the inner-droplet 
themselves, and between the inner droplets and the external aqueous environments. 
Both these structures have been made by sequential manual pipetting of droplets. 
Because of this they are relatively large (minimum internal volume 0.1 µl), and no 
more than a handful can be generated at any one time. We address this by generating 
multisomes using microfluidic technologies, using a PDMS-based device to produce 
water-oil-water (w/o/w) double-emulsions which act as multisome templates.  
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Fig. 6.1 – Multisomes vs. MCVs. (A) Multisomes have an intermediate oil phase. Interface 
bilayers separate internal droplets from both the surrounding aqueous solution, as well as from 
one another. (B) MCVs have a fully encasing external bilayer, as well as a bilayer separating the 
internal compartments.   
6.1.2 Double Emulsions 
Double emulsions refer to droplets encapsulated within larger droplets. These systems 
consist of three components: inner droplet, outer droplet, and external phase. They 
can either be w/o/w or o/w/o. Double emulsions have traditionally been made by 
sequential bulk emulsification methods, and have potential commercial use in food 
science, cosmetics, and therapeutics.[180] 
Recently, microfluidic methods for double emulsion generation have also been 
developed, using traditional microfluidic chips assembled via soft lithography, as well 
as using capillary-based devices.[104, 181-183] These are advantageous as they allow a 
greater degree of control over double emulsion architecture to be achieved. For 
instance, it is possible to encapsulate a set-number of droplets of defined 
compositions in a larger droplet (Fig. 6.2). They also enable higher-order triple and 
quadruple emulsions to be generated.[104] Furthermore, the size distribution profile of 
both the inner and outer droplet is greatly narrowed.  
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Fig. 6.2 – Multiple emulsions. (A) Schematic showing the difference between single, double 
and triple emulsions. (B) Images of double emulsion with controlled numbers of inner 
encapsulated droplets. (C) Images of triple emulsions with controlled numbers of inner and 
intermediate encapsulated droplets. Images modified from referenced paper.[104] 
In order to prevent droplets of the same phase coalescing, emulsions traditionally 
have been stabilised by some form of surfactant. In this chapter, microfluidic devices 
that produce double emulsions were constructed, and emulsions were instead 
stabilised by lipids. Bilayers thus form at all droplet-droplet interfaces, resulting in 
multisomes. In this way, the advantages associated with microfluidics are conferred 
upon multisomes. In this context, the most important advantages are miniaturisation 
(pl vs. µl volume regimes), and high throughput generation.  
6.2    EXPERIMENTAL 
6.2.1 Soft Lithography  
The device was generated in a clean room using standard soft-lithography techniques, 
the details of which have been extensively reviewed by others, and outlined in Fig. 6.3: 
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Fig. 6.3   – Soft lithography steps. (i) Photoresist spin-coating on a silicon wafer to achieve 
deposition of a defined depth. (ii) Photomask placement on photoresist (iii) Exposure to UV 
light. Only the exposed regions of the photoresist are cross-linked. (iv) Removal of non-cross-
linked photoresist by a developing agent. (v) PDMS poured onto the masks. (vi) PDMS cured 
in an oven, and peeled off to reveal features.  
The first step in the fabrication process was to design a photomask with the 
appropriate regions of transparency which define the outline of the fabricated 
channels and device features. This was designed with the AutoCAD software package, 
and designs were sent to JD Photo-Tools (Photodata Test Services Ltd, Oldham) for 
development. The marked features on the design were intended to be the clear areas 
of the mask, so a darkfield polarity was specified.  
In the next step, a silicon wafer (100 mm diameter, thickness 525 µm, single sided 
polish, IDB Technologies, UK) was cleaned with isopropylalcohol (IPA) and dried 
over a stream of nitrogen. Su-8 2150 photoresist (MicroChem, Westborough, MA, 
USA) was spin coated at the appropriate speeds to deposit a film of defined thickness. 
This was then pre-baked at 65° followed by soft-bake at 95°. The photomask was 
then placed on top of the photoresist and exposed with 350 nm UV light, and then 
removed. A post exposure bake at 60° was then performed to selectively cross-link 
the exposed portions of the film, followed by a bake at 95°. The non-cross-linked 
portion of the film was removed by immersing the wafer in Microposit EC-Solvent 
(Chestech Ltd, Rugby, UK) with agitation until all exposed photoresist was dissolved. 
The wafer was subsequently rinsed with IPA and distilled water, and finally dried 
under a stream of nitrogen.  
The precise spin coater speeds and settings, and timings of baking, UV exposure, and 
development varied according to the depth the intended channels. The recommended 
details for each depth are given in the MicroChem photoresist manual.[184]  
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After the master was made, 30 g uncured PDMS was poured on onto it, following by 
curing at 50° C for a minimum of 3 hours. Cured PDMS was carefully peeled off 
revealing the fabricated features. 
6.2.2 Double Lithography  
The above protocol describes the process for fabrication of channels of a single 
uniform depth. However, for the devices we constructed, two different channel 
depths were needed. To do this, a double lithography strategy was implemented, 
which involved two sequential spin coating and exposure steps. The first layer of 
photoresist was deposited at depth 1, followed by UV exposure. A second round of 
spin coating at depth 2 was then performed, again followed by UV exposure. By 
appropriately designing the photomasks used in the two steps, multiple channel 
depths were fabricated. The regions exposed only in the first step had depth 1. 
Regions exposed in both steps had depths 1 + 2. This procedure is shown in Fig. 6.4.  
 
Fig. 6.4 – Schematic of double lithography procedure to produce multiple channel 
depths. The first layer was constructed by the spin-coating of photoresist, placement of a 
photomask, and UV exposure. Before development, a second round of spin-coat and exposure 
was conducted, with correct alignment of the second photomask to produce the second layer. 
Unexposed photoresist from both steps was then removed using a developing agent.  
An important step in this process was correctly aligning the designs of the two 
photomasks so they would lie directly above one another. This was done by eye, using 
a Nikon stereoscope (model number SMZ745), in a cleanroom. To aid with the 
alignment specialised features were designed on the edges of the photomask, as shown 
in Fig. 6.5.  
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Fig. 6.5 – Photomask features to guide correct alignment. (A) Schematic of the features 
on both photomasks. By placing the masks above one another and ensuring the crosses and 
squares tightly overlapped, correct alignment could be achieved. (B) Brightfield  image of the 
resulting features. Scale bar = 200 µm. 
6.2.3 Device Fabrication   
After PDMS with the appropriate channels was peeled off the master, holes for the 
inlets and outlets were drilled using a sharp 1 mm diameter biopsy punch (Kai 
Medical, Solingen, Germany). The PDMS surface was then rinsed with IPA to remove 
any dirt, and then irreversibly bonded to a second thin sheet of PDMS to seal the 
device. This was done by exposing the PDMS surfaces to plasma for 30 s (Harrick 
Plasma, Ithaca, USA), and gently pressing them together.   
1 mm outer diameter polyethylene tubing (Harvard Apparatus, Kent, UK) was 
connected to all inlets and outlets. As the tubing and the drilled holes were both 1 mm 
in diameter, the PDMS tightly fit around the tubing and there was no need for a 
connector. This tubing was in turn connected to 1 ml plastic syringes (Becton 
Dickinson, NY, USA) via a needle (Microlance 23G, 1.25, Becton Dickinson, NY, 
USA). Finally, syringes were connected to precision pumps to drive flow (Fusion 100, 
Chemyx, Stafford, USA). The outlet was connected to a 2 ml Eppendorf tube via 
polyethylene tubing. Schematics of the above procedures are shown in Fig. 6.6. 
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Fig. 6.6 – Device fabrication. (A) 1 mm diameter holes were drilled into inlets and outlets 
using biopsy punches. (B) 1 mm outer diameter tubing tightly fit in the drilled holes, negating 
the need for connectors. (C) Tubing was connected to syringe by threading it into a needle tip. 
(D) Outlet was connected to an Eppendorf, to collect waste product. 
6.2.4 Device One – Design  
The design outline and the basic mechanism by which it is used to generate double 
emulsion are shown in Fig. 6.7.   
 
 
Fig. 6.7 – Device for generating double emulsions. (A) Device design showing the 
different widths, depths, and surface properties of the various channels. Channel widening and 
deepening reduced confinement of droplets, ensuring they were not heavily squeezed by the 
channels, leading to bilayer instability.  (B) Schematic showing the principles behind operation 
of the device. W/o droplets were generated in the first flow focusing junction, which were 
then encapsulated in the second flow focusing junction to yield double emulsions. (C) 
Photograph of the PDMS device, filled with Methylene Blue dye in DI water to reveal the 
channels. 
The device consisted of two flow-focusing droplet generation modules separated by a 
meandering channel. The principles behind the device operation are as follows. W/o 
droplets are generated in the first junction, which then pass through a meander, giving 
enough time for a well-packed lipid monolayer to self-assemble at the w/o interface. 
These droplets then encounter a second flow-focusing junction, where a set number 
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are encapsulated in larger o/w droplets, resulting in double emulsions. The channels 
then widen to reduce droplet confinement or ‘squeezing’. Droplets are then stored in 
meandering channel for observation.  
6.2.5 Channel Geometries  
One important consideration in designing the device was the channel dimensions of 
the different regions, particularly of the two droplet generation junctions (Fig. 6.8). 
The ratio between the channels widths of the two junctions is referred to as the 
‘dimension ratio’ with a 1:1 ratio indicating identical channel widths. This ratio is 
important as the sizes of the inner and outer droplets were predominantly determined 
by the channel dimensions at the first and second flow focusing junctions respectively.  
Therefore, with a dimension ratio of 1:1 the inner and outer droplets would be 
comparable in size. This is detrimental as (i) it would prevent more than one droplet 
being encapsulated and (ii) the inner droplets would be heavily squeezed. The forces 
resulting from this squeezing have been found to lead to bilayer instability and 
rupture, leading to droplet coalescence. Therefore, as a general principle for 
microfluidic DIB construction, excessive droplet squeezing should be minimised as 
much as possible.  
On the other hand, if the channel sizes of the two droplet-generation junctions were 
radically different, for instance with a dimension ratio of 1:5, then a large number 
(~tens) of smaller droplets would be encapsulated in a much larger droplet. As the 
aim was to encapsulate two or three droplets in controlled manner, this is 
disadvantageous. We found than an optimal dimension ratio was 1:1.5, where channel 
width in the first junction was 100 µm and the second junction 150 µm.  For the same 
reasons, it was necessary to have different channel depths in the different regions of 
the chip.   
 
Fig. 6.8 – Schematic depicting effect of different channel width ratios (x:y). If the two 
channel dimensions are identical (1:1), only one droplet can be encapsulated. If the ratio is too 
large (1:5) then tens of droplets are encapsulated uncontrollably. For two-droplet 
encapsulation, an intermediate ratio is used (1:1.5). 
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6.2.6 Surface Modification  
A crucial factor in successful double emulsion generation is the surface chemistry of 
the device channels, as this dictates the identity of the continuous/discrete phase — 
the continuous (i.e. external) phase being the one which preferentially wets the 
channels (Fig. 6.9A).  In the device we deigned, the continuous phase was oil in the 
first half (where w/o droplet form) but water in the second half (where o/w droplets 
form). Therefore, the surface chemistry of the device had to be appropriately 
patterned to be hydrophobic and hydrophilic in the first and second half of the chip 
respectively (Fig. 6.7). 
As the device was based on PDMS (a hydrophobic material), we had to selectively 
modify the second half of the device to be hydrophilic. This was achieved via 
sequential layer-by-layer deposition of charged polymers immediately after exposure to 
plasma, using method first reported by Bauer et al. (Fig. 6.9).[181]  The positive polymer 
used was polyallylamine hydrochloride (PAH) and the negative was 
polystyrenesulfonate (PSS), both purchased from Sigma Aldrich. As discussed 
previously, exposure of PDMS to plasma leads to negative silanol groups on the 
surface, making it temporarily hydrophilic. When a PAH solution was applied to the 
channels, the positive polymers were deposited on the channel walls. The 
overcompensation of the surface charge led to a positively charged surface. Next, 
when a PSS solution was applied, a negative change on the surface was likewise 
deposited. By repeating these depositions, the temporary hydrophilic modification 
after plasma treatment was rendered permanent.  
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Fig. 6.9 – Layer-by-layer surface modification by polymer deposition. (A) (i) Hydrophilic 
channels lead to water being the continuous phase. (ii) Hydrophobic channels lead to oil being 
continuous phase. (iii) Partially hydrophobic/hydrophilic channels lead to wetting of the 
surface by droplets. (B) Chemical structures of the two polymers that were deposited during 
the surface treatment. (C) PDMS surface was rendered hydrophilic by sequential positive and 
negative polymer deposition immediately after plasma treatment.  
The precise protocol used for the surface modification was as follows: 
(i) PDMS with fabricated channels, and a thin PDMS strip, were exposed to 
plasma for 30 s and then bonded by pressing the two surfaces together. 
(ii) Immediately after this (no longer that ca. 1 minute), a solution of 0.1 wt. % 
PAH in 0.1 M NaCl in DI water was manually applied to the channels via a 
syringe and tubing, for two minutes. 
(iii) Using a stream of air, the solution was removed from the channels.  
(iv) A solution of 0.5 M  NaCl was passed though the channels for one minute to 
remove any residual PAH that had not deposited on the surface. This was 
then removed by a stream of air. 
(v) Steps 2-4 were repeated with 0.1 wt. % PSS instead of PAH. 
(vi) The above process was repeated 3 times, to yield 3 layers of positive/negative 
layers. 
(vii) The channels were cleared through with DI water, and then with a stream of 
air. The devices were then ready for use.  
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It was necessary that only the second half of the device be modified. In order to 
ensure this, it was essential to prevent polymer solution from infiltrating the channels 
from the first half, which were intended to be hydrophobic. This was accomplished by 
applying a constant high pressure air stream (200 µl min -1) through that region of the 
device, and blocking all other inlets with a plug (Fig. 6.10).  
 
Fig. 6.10 - Selective surface modification of PDMS channels. (A) Polymer solutions were 
prevented from reaching intended hydrophobic regions of the device by applying a stream of 
air through specific channels. In this way, only certain regions of the device were surface-
modified. Red channel = hydrophobic. Black channels = hydrophilic. (B) After polymer 
deposition, polymer crystals were occasionally observed on the channel walls.  
It was found that despite the precautions taken, there was a certain degree of 
penetration of polymer solution to the unintended part of the device, which later led 
to aqueous droplets wetting the hydrophobic surface. To counter this, a commercial 
hydrophobic agent, Rain-X (Kraco Enterprises, CA, USA) was applied to the 
hydrophobic part of channel. 
6.3 RESULTS AND DISCUSSION  
6.3.1 Contact Angle Measurements  
In order to quantify the hydrophilic surface modification, the contact angle of water 
on treated and untreated PDMS was measured (Fig. 6.11). The contact angle is 
defined as the angle made by the intersection of the liquid/solid interface and the 
liquid/air interface, and gives an indication into the surface properties of the substrate. 
A low water contact angle (i.e. a high degree of wetting) indicated a hydrophilic 
surface and vice versa. In theoretical terms, it is determined by three interfacial energies 
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that are present in the system: solid-gas (γSG), solid-liquid (γSL) and liquid-gas (γLG). 
The equilibrium contact angle, θc, is related to these by Young’s equation as shown in 
Equation 6.1: 
0 ൌ ߛௌீ െ	ߛௌ௅ െ ߛ௅ீܿ݋ݏߠܿ																		ሺ6.1ሻ 
Successful surface treatment was confirmed by contact angle analysis (static sessile 
drop method) using a drop shape analyser (EasyDrop FM40, Kruss, Germany), and 
the provided software (Drop Shape Analysis DSA 100). A sheet of PDMS was made 
hydrophilic by the same method used for the channel treatment. The average water-air 
contact angle was found to change from 105˚ ± 6.1˚, to 43˚± 6.8˚ upon hydrophilic 
treatment (n =10, errors = one S.D), thus confirming successful surface modification.  
 
Fig. 6.11 - Contact angles of treated and untreated PDMS. (A) Schematic showing the 
three interfacial energies influencing the contact angle. Image on right shows droplet 
boundaries and glass surface being detected and fitted (green) using the image analysis 
software, allowing contact angles to be extracted.  (B) Images of water droplets on untreated 
and treated PDMS. Hydrophilic treatment resulted in reduction of contact angles. (C) Graph 
comparing the contact angles of treated and untreated PDMS. Error bars = one S.D, n=10. 
6.3.2 Double Emulsion Generation  
Lipid-stabilised double emulsions were generated with 25 mg ml-1 DPhPC (Avanti 
Polar Lipids) dissolved in the intermediate mineral oil (Sigma Aldrich), and DI water 
in all aqueous phases. The device was viewed in real-time with a brightfield 
microscope as w/o/w emulsions were generated. This allowed each step in the double 
emulsion construction to be viewed (Fig. 6.12).  
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Fig. 6.12 – Double emulsion generation device. Schematic of device is shown, together 
with brightfield microscopy images at different regions of the chip. Flow rates were 1, 2, and 8 
µl min-1 for the inner-aqueous, oil, and outer-aqueous phases respectively. 
By varying the volumetric flow rate of the inlets, the number of encapsulated droplets 
(henceforth referred to as packing numbers) could be controlled (Fig. 6.13A). At 
AQint/O/AQext flow rates of 1, 1, and 8 µl min-1 one-droplet double emulsions were 
generated (one inner droplet). At AQint/O/AQext flow rates of 1, 2, and 8 µl min-1 
two-droplet double emulsions were generated (two inner droplets). By further 
increasing the flow rate of the middle oil phase compared to the inner aqueous phase, 
higher packing numbers could be achieved.  
With the specified flow rates, emulsions were generated at ca. 5 Hz. It is important to 
stress that using higher flow rates, double emulsions (surfactant stabilised) have 
previously been shown to be generated at up to 5000 Hz.[185] We do not do this at 
higher speeds the trapping of droplets in observation channels became more difficult.  
Inner-droplets adhered to one another where they made contact, and the characteristic 
optical patterns associated with DIB formation were observed (Fig. 6.13). 
Importantly, bilayers also formed between the inner droplets and the external aqueous 
solutions. This was optically evident when inner-droplets were highly confined in the 
horizontal plane and touched the oil droplet surface (Fig. 6.13B). Importantly, even 
when inner droplets were not confined in this manner, it was likely that bilayers were 
always also formed in the vertical plane, as inner-droplets were essentially residing on 
the oil droplet surface due to their higher density compared to the oil phase.  
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Fig. 6.13 – Multiple droplet double emulsion. (A) With different flow rates, different 
numbers of internal droplets were encapsulated. With the device used, only 1 and 2 droplet 
double emulsions could be generated reproducibly. (B) If droplets were highly confined, the 
presence of external bilayers could be deduced by the characteristic optical patters and contrast 
difference in the bilayer regions. (C) When inner droplets were less confined, they presumably 
still made contact with the droplet bottom, as they were denser than surrounding oil phase.  
Importantly, for each packing number, the internal droplet network could adopt 
different geometries (Fig. 6.14). For example, in 6 droplet double emulsions, the inner 
droplet could either lie in the same plane or in a 3D orientation in an octahedron-like 
arrangement. Network geometry was determined by the level of confinement of the 
inner droplets. Large droplets (highly confined), were forced to lie above/below the 
central plane, forming a 3D network. Smaller droplets (low confinement) could reside 
in the same plane without being heavily constrained.  
 
Fig. 6.14  – Double emulsions geometries. Emulsions of the same packing number could 
have different inner-droplet packing geometries. With increasing confinement, inner droplets 
moved away from a planar geometry towards a 3D packing arrangement.  (A) Four droplet 
double emulsions. (B) Five droplet double emulsions. (C) Six droplet double emulsions. Scale 
bar = 50 µm.  
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6.3.3 Emulsion Collection and Properties  
Double emulsions were collected and viewed in observation channels by stopping the 
syringe pump flow and plugging the outlet (Fig. 6.15). One and two-droplet double 
emulsions had 100% and 98%  (n = 300) encapsulation efficiencies respectively– 
under the correct flow rates, nearly all double emulsions had the desired number of 
droplets encapsulated within them. The stability efficiencies were 95% and 87 % 
respectively, with a proportion of internal droplets merging with one another within 
several seconds of encapsulation. One-droplet emulsions were less heavily squeezed, 
and were therefore more stable. Droplets that did not coalesce after the initial seconds 
following generation were stable throughout the observation time (ca. two hours).  
Importantly, with the device used, only one- and two-droplet double emulsions could 
be generated with such high efficiencies. Although higher packing numbers could be 
generated by altering flow rates, it was not possible to ensure that all emulsions had 
the same number of encapsulated droplets — the number of inner droplets 
encapsulated was increasingly variable. By using different device designs, this is 
expected to be resolved.   
 
Fig. 6.15 – Double emulsion collection in channels. (A) One droplet double emulsions. 
(B) Two droplet doublet emulsion. Scale bars = 600 µm. 
6.3.4 Droplet Size Distribution 
Uniform droplet size is considered to be a principle advantage of microfluidic 
technologies. In the context of multisomes, controlled and uniform droplet size is 
important as droplet diameter largely determines the bilayer area, as well as the level of 
confinement.  To measure droplet size distribution, a video of droplet flow through a 
channel was taken. Droplets were loaded with dye (Methylene Blue, 20 mg ml -1) for 
increased contrast, and their contours were determined by the  ‘analyse particles’ 
functionality on the Image J analysis software (Fig. 6.16). This was done for ca. 3000 
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w/o/w droplets in total. Average inner and outer droplet volumes were 1.56 pl (72 
µm radius) and 8.79 pl (128 µm radius) respectively, with corresponding coefficients 
of variations (c.v) of 3.4% and 1.5%. Droplet volumes were therefore highly uniform, 
a common feature associated with droplet-based microfluidic technologies.   
 
Fig. 6.16 - Droplet sizing. (A) Droplets were loaded with dye to increase contrast. (B) 
Droplet borders were determined using the ‘analyse particles’ functionality using image J, 
revealing the areas of individual droplets in the image. (C) Inner and outer droplet size 
distribution for two-droplet double emulsion. 
6.3.5 Channel Wetting  
In developing the above device it was necessary to overcome the challenges associated 
with droplet wetting of the PDMS channels (Fig. 6.17), which occurred due to an 
affinity of droplets to the channel walls. In the case of oil-droplet wetting, the PDMS 
channels were not hydrophilic enough; in the case of water-droplet wetting they were 
not hydrophobic enough. When wetting was minor, droplets would simply stick to the 
surface, and not flow along with the continuous phase. Double emulsions however, 
could still be successfully formed. When wetting was more significant, water/oil sub-
streams would appear, preventing any emulsions form being generated. 
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Fig. 6.17 – Droplet wetting on channel surfaces. Brightfield images of oil phase wetting a 
surface-modified modified hydrophilic PDMS surface. Partial wetting (left) led to droplets 
sticking the channel surfaces. More severe wetting (right), led to the complete collapse of 
droplets on the surface or to the formation of sub-streams. Scale bar = 150 µm.  
Three factors were found to influence the extent of wetting. This first was the 
presence of surfactant vs. lipid: when sodium dodecyl sulfate (SDS) was present in the 
external aqueous phase, wetting was completely eliminated. However the presence of 
surfactant did not lead to the formation of lipid bilayers or multisomes.  A second was 
the concentration of lipid-in-oil. We found that at 25 mg ml -1 showed minimal 
wetting, but at 2 mg ml-1 wetting was severe. In general, the higher the concentration 
of lipid used, the less wetting was observed. A third factor was the type of oil used: 
mineral oil and squalene showed low wetting, in contrast to hexadecane. Finally, 
whether glass or PDMS was used to seal the device was crucial. As expected, a glass 
substrate led to significant water wetting, due to its hydrophilic nature.  
It was found that in order to prevent wetting, the surface treatment protocol 
described in Section 6.2.6 had to be rigidly followed immediately following plasma 
treatment. In addition, repeated use of the device led to the modified PDMS surfaces 
regaining some hydrophobic character, resulting in prohibitive levels of wetting. The 
device was therefore for one-time use only, with fresh devices used for each 
experiment. 
6.3.6 Device 2 – Multisome Generation with Different Droplet Compositions   
The above device was capable of generating double emulsions of defined architectures 
in high throughput. One deficiency however was the lack of control over the 
composition of individual inner droplets — their contents were identical. To rectify 
this we designed a second device with two aqueous inlets — this enabled two-
compartment multisomes to be generated with each inner-droplet having a different 
composition. This is important if the compartments are to interact with each as shall 
be seen later. 
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6.3.7 Generating Droplets of Alternating Composition  
To allow the construction of multisomes with different inner-droplet compositions, a 
modification to the previous device was made, whereby the first droplet generation 
module consisted of two opposing T-junctions, each being connected to a different 
inlet (Fig. 6.18). With this arrangement, if the aqueous flow rates were identical, 
droplets from each inlet were alternately generated. Importantly, for this to be 
achieved sufficient time was needed for the two flow rates to equilibrate and reach an 
identical rate. This was typically achieved after ca. 5 minutes. 
 
Fig. 6.18  – Alternating droplet generation. (A) By having two T-junctions facing each 
other, the generation of droplets of alternating composition was achieved. Arrows point to 
direction of flow. (B) Brightfield time sequence showing alternating production of two types 
of droplets. Black droplet contained Methylene Blue dye. Time between images = 50 ms. (C) 
Alternating droplet collection in high confinement channels (left) where they were present as 
plug-like droplets, and low confinement regions (right) where they were present as spherical 
droplets. Scale bar = 200 µm. 
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6.3.8 Multisome Generation  
Device design and images of the operation of different regions is shown in Fig. 6.19. 
In the first droplet generation region, droplets of alternating compositions were 
generated using the opposing T-junction principle described previously. These 
droplets travelled through a meander to allow for monolayer stabilisation, before 
encountering second a flow-focusing junction, where a set number of them were 
encapsulated to form multisomes with inner droplets of different compositions.  
 
Fig. 6.19 – Microfluidic device for double emulsion production. (A) Schematic of device 
and corresponding brightfield images of different regions. First, alternating droplets of two 
different compositions were generated by two opposing T-junctions. These travelled through a 
meander, allowing time for monolayer stabilisation. Two such droplets were then encapsulated 
downstream in an oil droplet using a flow-focussing channel geometry, generating two-droplet 
double emulsions. (B) Schematic of device channel dimensions and surface properties.  
As before, double emulsions were generated and stored in channels.  By varying flow 
rates, two distinct types of emulsions were generated. At AQint/O/AQext rates of 0.5,1 
and 8 µl min-1 one-droplet double emulsion were formed. As the inner aqueous 
droplets were formed with alternating compositions, two populations of multisomes 
were generated, one with dye and one without (Fig 6.20A). When flow rates were 
changed to AQint/O/AQext rates of 0.5, 2, and 8 µl min-1, inner aqueous droplets were 
generated at a higher frequency which led to two-compartment double emulsions, 
with different inner droplet compositions (Fig. 6.20B).  
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Fig. 6.20 – Double emulsion collection. (A) Two populations of one-droplet double 
emulsions, one with, and one without dye. (B) Two-droplet double emulsions, with inner 
droplets of different compositions. Scale bar = 200 µm. 
6.3.9 Comparison of Microfluidic vs. Manual Pipetting Multisomes 
Microfluidic methods of multisome generation detailed above show several crucial 
advantages over alternative manual pipetting methods. The multisomes we generate 
exist in the pl size regimes, and were thus several orders of magnitudes smaller than 
the µl volumes which have previously been achieved — these were limited by the 
minimum volume one can pipette. By reducing chip dimensions — in principle a fairly 
trivial step — multisomes can potentially be miniaturised further, to lie in fl regimes. 
At this point they would possesses the same volumes as biological cells — eukaryotic 
cells are ca. 3.4 fl, 15 µm diameter —  which would prove useful in a synthetic biology 
context, where multisomes could act as cellular mimics, or as artificial cell-like devices. 
In addition, multisomes were free-flowing in a bulk aqueous environment, and did not 
require the presence of an embedded agarose tip to hold it in place. This confers upon 
them the ability to operate away from a laboratory, e.g. in vivo, or as portable 
biosensing devices.  
Importantly, multisomes were generated in high throughput. In the experiments 
described, hundreds of multisomes were generated in minutes, in contrast to manual 
pipetting methods, where each multisome took minutes to form. In principle, this 
could be increased by several orders of magnitude simply by increasing flow rates. We 
did not go to higher frequencies simply because of issues in storing the multisomes in 
channels.  
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Finally, microfluidic technologies facilitates a fine size distribution of the inner and 
outer droplets (c.v. of 1.5% and 3.4% respectively). This cannot be achieved via 
manual pipetting methods, due to the high errors involved in pipetting such small 
volumes (c.v. of up to 20%) 
6.3.10 Comparison with MCV 
Microfluidic multisomes also possess advantages over MCVs developed in Chapter 
Three. MCV compartment volumes were limited to ~ 0.1 µl. Below this size, droplets 
would not penetrate the interface, as they were not heavy enough to overcome the 
water-oil interfacial tension. In addition, MCV lifetimes were limited to a maximum of 
1 hour, due to the large osmotic differences that were required to drive phase transfer. 
Multisomes on the other hand, were not observed to degrade over several hours. 
Microfluidic multisomes also show advantages over MCVs with respect to generation 
throughput and fine size distribution, as described above. One disadvantage of 
multisomes over MCVs is the presence of an intermediate oil phase. This might pose 
problems with respect to biocompatibility (e.g. if the oil is toxic) and with regards 
encapsulated chemical partitioning into the oil phase (determined by the compound’s 
Log P value).  
6.4 CHAPTER CONCLUSIONS 
This chapter dealt with microfluidic methods to generate multisomes in pl volume 
regimes in high-throughput. The devices constructed were used to generate double 
emulsions, which when stabilised by lipids led to multisomes. We showed that control 
over droplet packing number could be achieved using flow rates, and that multisomes 
exhibited a narrow droplet size distribution. The generation of multisomes with 
different inner-droplet contents was also demonstrated. The advantages that 
microfluidic multisomes show over MCVs and multisome formed via manual 
pipetting pave the way for them to be used as functional devices for uses in vivo. They 
also allow the power of DIB devices (e.g. as bio-batteries, as electrical components 
and as light-harvesting devices) [70, 76, 186] to be scaled up. In the next chapter, potential 
applications for multisomes are explored, in particular for them to be used as modular 
droplet devices for in situ chemical synthesis. 
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Chapter 7 – Multisomes 
as Modular Chemical 
Microreactors  
  
7.1 INTRODUCTION  
In the previous chapter, multisomes were generated in high throughput and with a 
fine degree of control using microfluidic technologies. The resulting scale up in 
generation throughput, and scale down in terms of size paves the way for them to be 
used for functional purposes. In this chapter, their use as modular droplet reactors will 
be explored. In particular, we will aim to demonstrate in situ organic synthesis within 
them, where each inner compartment acts as specific module within the multisomal 
chemical ‘factory’. 
7.1.1 Droplet Microreactors   
Recent decades have seen substantial efforts to transform traditional benchtop 
chemical reactors into microreactors, where reactions are confined within sub-
millimetre dimensions.[80-81, 84] The driving forces behind scaling-down, described in 
more detail in the Introduction chapter, include increased reaction efficiency, small 
sample size, better energy dissipation, portability, low cost and footprint, on-site and 
on-demand synthesis, and fine process control.[81] 
Traditionally these reactions were confined in microfluidic channels. However, from 
this a new movement of droplet-based reactors has sprung: microdroplets, usually 
water-in-oil, are formed in high throughput and with fine size control, where each 
droplet can be considered a single reaction vessel with volumes in pl-nl range.[82, 88, 187-
188] In this way thousands of miniature reactors can be generated on demand and in 
seconds. Droplet reactors have therefore lent themselves to high throughput studies 
such as drug library and enzyme kinetics screening,[189-190] and for analysis of biological 
assays.[191] They have also been used for a range of chemical syntheses, including 
nanoparticles,[91-94]  microgels,[95] mesoporous particles,[96] polymers,[97] as well as for 
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organic functional group transformations.[98-100] Excellent reviews of microdroplet 
applications can be found elsewhere.[82, 188]  
One powerful vision is for droplet reactors to serve functional roles in physiological 
environments as in situ chemical factories responding to set stimuli, producing 
biologically relevant compounds. In this context, they can be viewed as artificial cells, 
relating this discipline to that of bottom-up synthetic biology. Despite this, studies 
involving reactors serving functional roles in physiological environments have been 
sparse.  
7.1.2 Deficiencies of Existing Droplet Reactor Systems  
For the aforementioned vision to progress two issues must be tackled. First, w/o 
droplet reactors need to be capable of operating in aqueous environments as opposed 
to bulk oil surroundings. Second, the complexity gap between chip-based reactors and 
droplet reactors needs to be bridged. Whereas chip-based reactors use fabricated 
structures on the device itself to serve specific purposes — including material 
transfer,[192] mixing,[193] dilution[194] and concentration[195]—this has been lacking in 
droplet reactors: they have mostly been vessels which simply contain reactions within 
them. Methods to self-contain some of these operations in droplet reactors need to be 
developed, for them to take place in environments external from the microfluidic 
device. 
The multisome systems developed here, addresses the above issues. They exist in a 
bulk physiological surroundings (i.e. aqueous environments), and the presence of 
bilayer-linked internal compartments allows more intricate, multi-component reactors 
to be constructed. As we shall see, this will allow some of the processes commonly 
associated with chip-based reactors to be incorporated into droplet-based reactors.  
The primary aims of this chapter is to demonstrate chemical synthesis within a 
multisome. In the upcoming sections we explore the potential for the incorporation of 
click chemistry reactions, as well as pyridinium organic synthesis within multisomes.  
7.1.3 Click Chemistry  
Click chemistry refers the cycloaddition reaction between alkynes and azides. More 
specifically, the azide-alkyne huisgen cycloaddition is a 1,3-dipolar cycloaddition 
between an azide and a terminal or internal alkyne to give a 1,2,3-triazole (Fig. 7.1). 
Traditionally, this reaction is catalysed by Cu(I), however Cu free systems have also 
Multisomes as Modular Chemical Microreactors  
  132   
 
been developed. For more information on this reaction, readers are referred the 
review article by Meldal et al.[196]  
 
Fig. 7.1 – Click chemistry reaction. Alkynes (blue) and azides (red) react in the presence of 
Cu (I) in a 1,3-dipolar cycloaddition to yield 1,2,3 triazoles.  
Recent years has seen a surge in the popularity of this reaction system, particularly for 
use in chemical biology, where it is used as a tool for tagging biological 
macromolecules (including proteins, lipids and DNA)[196-197] with dyes and pull-down 
agents. The primary attraction of this system is that it is bio-orthogonal: azides and 
alkynes do not react with surrounding biological components, only with one another. 
Other advantages include the extremely mild reaction conditions needed, high 
chemical yield, lack of by-product, and the ability for the reaction to occur in aqueous 
solutions. For these reasons, and due to its increasingly wide use, we decided to 
incorporate click chemistry into multisomes to demonstrate their use as droplet-based 
chemical factories.  
The principle of the proposed multisomal click chemistry reactor is as follows. One 
compartment would contain the alkyne and azide, and the second the Cu (I) catalyst. 
In the presence of α-HL pores, Cu (I) would translocate through the internal DIB, 
and initiate the reaction (Fig. 7.2). In principle, this system could be modified so that 
pores would open upon encountering physical or chemical stimuli. This could be 
achieved by taking advantage of lipid phase behaviour, using mechanosensitive 
channels, or by using an inducible genetic circuit for synthesis of protein pores. This 
would make the reactor responsive, with clear applications for drug synthesis in a 
physiological setting. 
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Fig. 7.2– Proposed click chemistry multisomal reactor. One compartment would contain 
click reagents, the other the copper catalyst. Only in the presence of membrane pores would 
copper translocate to initiate synthesis. The induction of pores using lipid phase behaviour or 
the production of transmembrane proteins via an inducible genetic circuit could lead to a 
responsive drug-synthesis system.   
7.2 EXPERIMENTAL – CLICK CHEMISTRY  
7.2.1 Fluorogenic Reagent  
In order to monitor reaction progression in real time within a multisome, a 
fluorescence detection method was explored, namely using a fluorogenic azide: only 
upon cycloaddition with alkyne would fluorescence be induced (Fig. 7.3A). Sivakumar 
et al. have developed a set of azides containing the coumarin chemical moiety that 
have this fluorogenic property, and which are now commercially available.[198] A recent 
review by  Droumaguet et al. outlines the applications of such fluorogenic click 
reactions, including for the conjugation of cellular components, DNA, Viruses, and 
nanoparticles.[197]  
In our experiments 3-azido-7-hydroxycoumarin was used as the fluorogenic azide 
component, and acetylene-PEG4-Amine was used as the alkyne component. The 
PEG chain on the alkyne rendered it more hydrophilic, and was chosen in order to 
limit partitioning into the external oil phase. Fig. 7.3 shows the chemical structures of 
these reagents. 
 
Fig. 7.3 – Fluorogenic click reaction. (A) A fluorescent product is produced from the 
cycloaddition reaction between non-fluorescent azides and alkynes. (B) Fluorogenic azide, 3-
azido-7-hydroxycoumarin. (C) Alkyne reagent, acetylene-PEG4-amine. 
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7.2.2 Copper Catalyst  
The click reaction is traditionally catalysed by Cu (I), which initially undergoes an 
insertion reaction into the alkynes (a discussion of the precise mechanism can be 
found elsewhere).[196] The reaction will not occur when Cu is present in other 
oxidation states, including Cu (II) and Cu (0). The reaction can be performed with 
commercial sources of copper (I), including CuI or CuBr. However, Cu(I) is known to 
be relatively unstable in aqueous solution, due to its rapid disproportionation into 
Cu(II) and Cu(s). For this reason, it is preferable to generate Cu(I) in situ via the 
reduction of Cu (II) (in the form of CuSO4) into Cu(I) using a reducing agent (in our 
case NaAsc).  
7.2.3 Preparation of Solution  
Azide, Alkynes, NaAsc, and CuSO4 were purchased from Jena Bioscience (Jena, 
Germany) and lipids were purchased from Avanti Polar Lipids. All other reagents and 
oils were purchased from Sigma Aldrich. Three solutions were prepared for the 
cycloaddition experiments, all containing phosphate buffered saline (PBS), pH 7.4, 
and 10 mg ml-1 extruded DPhPC liposomes.  
Solution 7A: Azide + lipid. 
Solution 7B: Alkyne + CuSO4 + NaAsc + lipid. 
Solution 7C: Alkyne + lipid (control). 
 
7.3 RESULTS AND DISCUSSION – CLICK CHEMISTRY 
7.3.1 Reactions in Fluorimeter  
Click reactions were first performed in a well-plate on a fluorimeter setup in order to 
(i) confirm successful reaction between the chosen compounds (ii) determine whether 
the presence of lipid prohibits the reactions and (iii) obtain the excitation and 
emission spectra. To do this, 20 µl of solutions 7A and 7B were mixed in a 384-well 
plate and left to react for 2 hours at room temperature. The fluorimeter was then run 
at a 600 V setting. The control sample, which contained no CuSO4, consisted of 
solutions 7A and 7C. The obtained excitation and emission spectra for samples with 
and without copper is shown in Fig. 7.4A. This confirmed the compound was indeed 
fluorogenic, and that the reaction was successful in the presence of the liposomes. 
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Following this, the time course of reaction progression was monitored. Solutions 7A 
and 7B were mixed as before. The sample was excited at 404 nm (5 nm slit, 600 V 
fluorimeter setting), and the emission at 477 nm (5 nm slit) was recorded over two 
hours (Fig. 7.4B). This revealed rapid reaction progression, with peak fluorescence 
observed after 16 minutes. In the control scenario, where no copper was present no 
fluorescence was detected over this time.  
 
Fig. 7.4 – Fluorogenic click reaction fluorimeter results. (A) Excitation and emission 
spectra in the presence and absence of copper catalyst. (B) Time course profile of the click 
reaction at room temperature. Fluorescence reaches a maximum after ca. 16 minutes, followed 
by a steady decrease, presumably due to photobleaching effects. In the absence of copper 
catalyst, no fluorescence increase was observed. These results confirm the fluorogenic nature 
of the azide, and successful reaction in the appropriate reaction conditions (i.e. in the presence 
of lipid). 
7.3.2 Reaction in w/o Droplets 
Next, the reaction was performed in water-in-oil droplets to determine the influence 
of surrounding oil. To do this, 5 µl of solutions 7A and 7B were mixed together, and 1 
µl of this mixture was immediately pipetted into a well of hexadecane oil. Reaction 
progression was monitored with fluorescence microscopy at 100 ms exposure using a 
tailor made filter set (see Section 2.8). Surprisingly, over a period of 20 minutes, no 
fluorescence increase was seen. As a control, a solution of 7A + 7B was left to react 
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externally from the oil in an Eppendorf tube. 0.1 µl droplets of this reaction mixture 
were then pipetted into the oil after 20 minutes (Fig. 7.5). These results reveal that 
incubating the reaction mixture in oil prohibited the reaction from taking place. 
 
Fig. 7.5 – Fluorogenic click chemistry reaction in w/o droplets, after 20 min 
incubation. (A) When reagents were incubated in bulk oil, no fluorescence was observed after 
20 min. (B) If reagents were incubated in an Eppendorf for 20 min, followed by fluorescence 
imaging of w/o droplets, a fluorescence signal was observed. Exposure time = 100 ms. Scale 
bar = 500 µm. This result shows that the click reaction did not occur in the presence of bulk 
oil.  
There were two possible reasons for this failure. The first was that one of the reagents 
rapidly partitioned into the oil phase, and was therefore not present for the 
cycloaddition to occur. The second was that the reagents orientated themselves at the 
oil/water interface in a manner that interfered with the reaction mechanism. A further 
problem was that solid copper particles appeared to come out of solution within the 
droplet, due to the aforementioned disproportionation. These particles are likely to 
interfere with the stability of DIBs and multisomes in any future experiments. These 
results showed that click reaction system that we tested was incompatible in water-oil 
systems including the one we propose using.  
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7.4  PYRIDINIUM SYNTHESIS IN MULTISOMES 
The demonstration of the incompatibility of click chemistry in w/o droplets led to the 
examination of alternative synthetic chemistry systems.  The alternative chosen was 
the reaction between pyrylium functional groups and primary amines, which react in a 
1:1 stoichiometry to yield pyridinium salts (Fig. 7.6).[199-200] This reaction can be used 
to conjugate two halves of an organic molecule together in an analogous manner to 
click chemistry. 
Pyryliums are aromatic, conjugated, six-membered ring systems, analogous to 
benzene, but with one carbon atom replaced by a positively charged oxygen atom. 
Their reaction with primary amines to yield pyridiniums has been well established 
since the 1970s (see Fig. 7.6B for mechanism).[201] In the first step, nucleophilic attack 
of the pyrylium by the amine produces a 2H pyran. The ring then spontaneously 
opens to yield an open-chain intermediate, which has previously been isolated.[199] The 
final step is ring closure to produce pyridinium salts, which has been determined to be 
the rate determining step.[201]   
 
Fig. 7.6 – Pyrylium chemistry. (A) Reaction between pyryliums and primary amines in a 1:1 
stoichiometry to produce pyridinium. (B) Basic mechanism of reaction. 
The products of this reaction (pyridinium salts), are unsaturated heterocyclic 
compounds that are found in a range of medicinal and agricultural products, including 
anaesthetics, antiprotozoals, and antiallergenics, and are well known for their 
germicidal properties.[199, 202] They are also used as surfactants for applications 
including cosmetics and gene delivery.[199] The reaction which leads to their synthesis  
takes place in extremely mild, aqueous conditions. It proceeds at a fast rate at room 
temperature and does not require any catalysts. The only pre-requisites is for a slightly 
alkaline pH of 8-9, and for the amine to be protonated at this pH.  These properties, 
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together with their bioactivity and commercial use therefore make them attractive 
candidates to use as a proof-of-concept for in situ chemical synthesis in multisomes. 
7.5 EXPERIMENTAL – PYRIDINIUM SYNTHESIS 
7.5.1 Fluorogenic Pyrylium - Chromeo P540 
We employed  a commercially available fluorogenic compound (Chromeo  P540, net 
formula: C25H26NO+BF4-)[203] as the pyrylium component, and ethanolamine 
(HOCH2CH2NH2) as the amine reagent. The pyrylium compound belongs to a family 
of compounds known as ‘Chromeo Py Dyes’. These were first described by Craig et 
al.,  and were originally developed as a method for protein labelling which requires no 
washing step, as only the conjugated dyes are fluorescent;[203] this also lowers the 
background fluorescence. In addition, they are attractive due to their small chemical 
size, and because conjugation maintains the protein’s native charge and isoelectric 
points. 
We chose to use the dye Chromeo P540 instead of alternative dye analogues due to 
the overlap of its fluorescent spectra with the TRITC filter. This compound is only 
weakly fluorescent (1 % quantum yield) but becomes significantly more fluorescent 
when converted to the pyridinium product upon reacting with amines (20% quantum 
yield), due a change in the molecule’s conjugation system. In effect, it can therefore be 
considered to be fluorogenic. Reaction progression could therefore be monitored 
using fluorescence microscopy. 
7.5.2 Preparation of Solutions  
Chromeo P540 was purchased from Active Motif, La Hulpe, Belgium. Lipids were 
purchased from Avanti Polar Lipids. All other reagents were purchased from Sigma 
Aldrich. Three solutions were used in the following experiments, all being composed 
of 0.1 M NaHCO3 in DI water, made to pH 8.3 by the dropwise addition of 0.1 M 
NaOH. All aqueous solutions also contained 10 mg ml -1 DPhPC lipid, present as 100 
nm liposomes formed via extrusion, unless otherwise mentioned.  
Solution 7D: 0.23 mM Chromeo P540  + lipid in buffer.  
Solution  7E: 16 mM Ethonalamine + lipid in buffer.  
Solution 7F (control): lipid in buffer. 
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7.6 RESULTS AND DISCUSSION – PYRIDINIUM SYNTHESIS 
7.6.1 Reaction in Bulk  
Pyrylium reactions were first performed in a 384-well plate on a fluorimeter in order 
to confirm successful reaction between the chosen compounds, and to obtain the 
excitation and emission spectra. To do this, 20 µl of solutions 7D and 7E were mixed 
in a well-plate, and the fluorimeter was run at a 600 V setting.  The control sample, 
with no amine present, consisted of 20 µl of solutions 7D and 7F. The excitation and 
emission spectra of samples with and without ethanolamine is shown in Fig. 7.7A. 
This confirmed the compound was indeed fluorogenic (product ex = 533 nm, em = 
627 nm), and that the reaction was successful with the used conditions.  
Following this, the time course of reaction progression was monitored. Solutions 7D 
and 7E were mixed as before. The sample was excited at 533 nm (5 nm slit, 600 V 
fluorimeter setting), and the emission at 627 nm (5 nm slit) was recorded over 90 
minutes (Fig. 7.7B). This revealed rapid reaction progression over 20 minutes, with 
the fluorescence signal subsequently plateauing off.  In the control experiments, where 
no ethanolamine was present, no fluorescence was detected over the 90 minutes.   
 
Fig. 7.7  - Fluorogenic pyrylium/amine reaction. (A) Excitation and emission spectra of a 
pyrylium-containing sample in the presence and absence of amine. This confirms fluorogenic 
nature of the pyrylium, and successful reaction in the chosen reaction conditions. (B) 
Fluorescence time-course profile of reaction, revealing it reaches completion after ca. 20 
minutes.  
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7.6.2       Reaction in w/o Droplets 
Next, the reaction was performed in w/o droplets to determine the influence of 
surrounding oil. To do this, 5 µl of solutions 7D and 7E were mixed together, and 1 µl 
of this mixture immediately pipetted into a well of hexadecane oil. Reaction 
progression was monitored with fluorescence microscopy at 100 ms exposure using a 
TRITC filter set. Brightfield and fluorescence images were taken after 20 minutes (Fig. 
7.9). Significant fluorescence was observed in the ethanolamine-containing droplets, 
but not in droplets where ethanolamine was absent. This result shows that unlike the 
click chemistry experiments, the presence of surrounding oil did not prevent the 
reaction from occurring. In addition, droplet fluorescence was not observed in the 
surrounding solution, which indicated a lack of product partitioning into the oil phase. 
 
Fig. 7.9 – Fluorogenic pyrylium/amine reaction in w/o droplets. Brightfield and 
fluorescent images (100 ms  exposure) after 20 minutes are shown. This demonstrates the 
presence of a surrounding oil solution does not prevent reaction from occurring, unlike in the 
click chemistry experiments. Scale bar = 500 µm.  
7.6.3 Reaction in DIBs 
Next, we investigated the pyrylium reaction system in a DIB format, with each 
reaction component isolated in a distinct water-in-oil droplet (hexadecane oil). One 
droplet contained pyrylium (solution 7D) and the other ethanolamine (solution 7E) 
with a bilayer lying at the interface. Note, that for these experiments DIBs were 
formed via the ‘lipid-in’ method, with liposomes present in all aqueous solutions. 
Fluorescence of the dye-containing droplet was monitored at 2 minute intervals using 
fluorescence microscopy with a TRITC filter and a 100 ms exposure. Fluorescence 
results (Fig. 7.10) show a gradual fluorescence increase in the pyrylium-containing 
droplet. Ethanolamine gradually diffused through the bilayer due to its small size (log 
P = -1.31),[204] leading to the production of the fluorescent pyridinium product. 
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Fig. 7.10  –  Reaction between ethanolamine (Ea) and fluorogenic pyrylium compound 
(Chromeo-450, Ch) to yield fluorescent pyridinium product (Py) in ‘lipid-in’ DIB 
format.  (A) Schematic of the DIB system setup. (B) Composite brightfield/fluorescence 
image showing successful diffusion of ethanolamine through the bilayer for the reaction to 
occur. (C) Fluorescence time course showing gradual fluorescence increase over 10 minutes. 
Scale bar = 500 µm.  
7.6.4 Reaction in Multisomes – Lipid Out  
Next, the reaction system was contained in a multisome format. Two-compartment 
multisomes were generated using the microfluidic device described in Section 6.3.6.  
One inner-droplet contained the pyrylium dye (solution 7D) and the other contained 
ethanolamine (solution 7E). Importantly, unlike the experiments in DIBs and droplets 
described in the previous sections, the inner aqueous compartment did not contain 
any liposomes — later it will become apparent why this was crucial. Instead, 
multisomes were formed via the ‘lipid-out’ method, with the oil phase comprising 25 
mg ml-1 DPhPC lipid in mineral oil. Flow rates for AQin/Oil/AQout were 0.5, 1, and 8 
µl min-1 respectively. Multisomes were collected in the observation channels and were 
observed with fluorescence microscopy using a TRITC filter with 100 ms exposure 
times. 
The results  obtained were  different to those in the preliminary DIB experiments. A 
fluorescence increase was observed in the intermediate oil solution, and not in the 
inner-aqueous droplets where the dye was initially present (Fig. 7.11A). The only 
difference between the multisome and DIB experiments was the absence of liposomes 
in the internal aqueous droplets.  
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Fig. 7.11 – Pyrylium/amine reaction in ‘lipid-out’ multisome format. (A) Brightfield and 
fluorescence images showing the presence of fluorescence in the intermediate oil phase of the 
mulisome, indicating reagent/product partitioning into the oil phase. (B) Brightfiled and 
fluorescence image of w/o droplet containing pyrylium and  amine, but lacking liposomes. 
Fluorescence was observed in the surrounding oil phase, sugesting reactant/product 
partitioning in the absence of liposomes. Exposure = 200 ms. Scale bars = 50 µm. 
This suggests that without liposomes, either the pyridinium product, or indeed the 
ethanolamine/pyrylium reagents, partitioned into the oil phase. To confirm this, the 
two solutions were mixed in a 1:1 ratio in an Eppendorf, and 1 µl droplets of this 
mixture were pipetted into a hexadecane well, which was viewed under identical 
conditions. After 10 minutes, a fluorescence signal was observed in the oil solution 
(Fig. 7.11B), confirming reagent/product partitioning into oil in the absence of 
liposomes.  
7.6.5 Chemical Partitioning into Oil Phase 
The success of the reaction system in a ‘lipid-in’ DIB format, and its failure in a ‘lipid-
out’ multisome format led us to believe that the product was actually embedded 
within the  hydrophobic core of the liposomes,  which were only present in droplets 
in the ‘lipid-in’ case. This was confirmed by visual inspection of two identical 
solutions, both containing 0.23 mM pyridinium product, but only one containing 10 
mg ml-1 100 nm DPhPC liposomes. The two solutions appeared different in colour 
(Fig. 7.12A). In addition, the emission spectrum was shifted by ca. 7 nm upon 
addition of liposomes (Fig. 7.12B).  
Multisomes as Modular Chemical Microreactors  
  143   
 
 
Fig. 7.12 – Comparison of pyridinium properties in the presence and absence of 
liposomes. (A) A colour difference was observed in pyridinium containing solutions 
containing and lacking liposomes. (B) The emission profile of fluorescence product differed 
depending on the presence or absence of liposomes. These results suggest the pyrylium was 
sitting in the hydrophobic membrane core. All solutions were excited at 533 nm, 5 nm slit size. 
Both these results suggest that the dye was residing in a different chemical 
environment (i.e. in solutions of different polarities), leading to the conclusion that it 
was embedded within the bilayer. It may therefore be that the dye was trapped in a 
local thermodynamic minimum, preventing it from partitioning in the oil phase. Note 
that Log P values for the dye have not been determined, so the extent of its 
preference to reside in a hydrophobic environment cannot be established with 
certainty.   
7.6.6    Reaction in Multisomes – Lipid In  
To overcome the issue of product partitioning, multisomes were generated in an 
identical manner to that described in previously, but with the presence of 10 mg ml-1 
extruded DPhPC liposomes in all inner-droplets. Indeed, this strategy let to the 
product being retained in the aqueous phase. Multisomes were monitored in the 
inbuilt device observation channels, and a fluorescence signal of the pyrylium-
containing compartment was recoded over a period of ca. 1000 s (Fig. 7.13). 
Fluorescence gradually increased over a period of 800 s, showing successful reagent 
diffusion across the bilayer and the subsequent reaction, before it plateaued as  the 
reagent was depleted. Fluorescence was not seen to decrease from its maxima, and the 
surroundings exhibited no observable fluorescence increase. This suggests the reaction 
product did not leak into the oil or water external phases over the time course of the 
experiment. 
In control experiments multisomes  were generated in the same manner, but  with no 
ethanolamine present. No fluorescence increase was seen, showing the reaction was 
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not occurring due to external sources of primary amine (originating, for example, 
from the device fabrication process).  
 
Fig. 7.13 - Double emulsion multisomes as chemical microreactors. (A) Schematic of 
droplet reactor. One compartment contains ethanolamine, the other the pyrylium reagent 
(Chromeo P540). As ethanolamine diffuses through the droplet interface bilayer, fluorescent 
pyridinium product is formed. (B) Fluorescence intensity of the pyrylium-containing 
compartment over time. Error bars = one standard deviation, n=5. (C) 
Fluorescence/brightfield composite image of the reactor at start, middle, and endpoints of 
experiment, showing gradual reactant diffusion and reaction progression. Brightness and 
contrasts enhanced equally across all images.  
Previous studies have shown that the rate determining step for the reaction between 
pyrylium and analogous primary amines is the intermediate ring closure to yield the 
pyridinium product (k = 4.04 x 10-3 s-1).[201]  The corresponding approximate reaction 
completion timescales (~ 750 s) are comparable to the ones we observe (~ 810 s).  
These timescales were also similar to those recorded in the bulk experiment 
performed in fluorimeter (Section 7.6.1). The fact that reaction times were not 
significantly slower in the multisome system indicates that the rate of ring closing is 
comparable to, or faster than, diffusion across the membrane.    
7.6.7 Implications  
These results demonstrate a new class of droplet-based microreactors, bearing 
advantages associated with sub-compartmentalisation. Compartmentalisation allows 
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specialised regions to be introduced into the microreactor “factory”. In our case, each 
multisome unit consisted of two inner droplets which acted as modules in the 
chemical reactor. One droplet acted as a chemical reservoir which steadily fed the 
reagent through the droplet interface bilayer into the adjacent droplet, in which the 
chemical transformations took place. 
More elaborate operations can be introduced in the future, including waste droplets 
and processing elements, allowing for grater complexity than traditional uni-
compartment reactors. The system’s modular nature also allows for multiple 
potentially interfering processes (non-orthogonal reactions) to occur in single droplet 
collection by segregating them in space. 
There are also benefits associated with the presence of lipid membranes to delineate 
compartments, and to interface the reactors with the environment. It allows 
functionalization by biological components including transmembrane proteins, 
mechanosensitive channels, and antibodies, as well as ensuring biocompatibility. It 
also enables researchers to take advantage of the varied biophysical behaviour of 
membranes to induce processes within the reactor in response to environmental 
signals. This could be done via the opening of pores in response to a change in 
temperature,[205] UV irradiation,[73] or in the presence of chemical stimuli. The above 
attributes provides an opportunity for the design of dormant systems which become 
active upon encountering particular stimuli, with obvious applications for in vivo drug 
synthesis and delivery.  
The technologies developed here expand the scope and type of chemical syntheses 
that can be contained within droplet reactors. By integrating compartmentalised 
reactors with established chemical procedures that have been demonstrated on-chip 
(such as concentration, evaporation, purification, heating/cooling, crystallisation, 
mixing, phase extraction etc.)[82-83], complex mutli-step synthetic pathways can be 
incorporated into a unified system for multi-step chemical synthesis in a free-floating 
droplet network. It can be seen as an enabling platform to combine the various as-of-
yet single process reactors into integrated multi-part droplet devices.  
Finally, this work is important in the context of recent developments in vesicle based 
artificial cells,[206] which have been capable of synthesising proteins,[162] taking up 
biological building blocks from their environments,[129] replication,[132] and exhibiting 
sub-compartmentalisation.[136] To their detriment, to date such bioreactors have been 
generated using non-microfluidic methods. Although not vesicles, structures formed 
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here are analogous in their function as they possess bilayers connecting the internal 
contents to the external environments. In this light, the different compartments can 
be considered as organelles within the cell-like microreactor.  
7.7 CHAPTER CONCLUSIONS 
In conclusion, by using double emulsions as multisome templates, we generate 
compartmentalised pl-sized droplet reactors. Our attempts at using reactors for click 
chemistry reactions proved unsuccessful due to the presence of an intermediate oil 
phase. However using pyrylium based chemistry proved more successful.  We used 
the multisome reactors for synthesis of a pharmacologically relevant chemical moiety, 
with one compartment acting as a reservoir module feeding reagent into the synthesis 
module. We thus demonstrate its applicability as a platform technology with which to 
perform synthetic chemistry in a physiological setting. The droplet networks 
themselves can be considered to be self-contained devices, with the potential for 
containing processes that have to date only been achieved on-chip. Such structures 
thus have potential use for on-site drug synthesis, or as diagnostic devices.
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Chapter 8 – Phase 
Transfer GUV 
Generation and 
Characterisation  
  
8.1 INTRODUCTION  
In the previous chapters we established a strategy to generate a novel structure, the 
multi-compartment vesicle (MCV), using the phase transfer method. This builds upon 
previous studies (reviewed in the Introduction, section 1.2.3.3), which showed single 
compartment GUV generation using water-in-oil droplets as templates. Despite this 
method being widely used the literature over recent years, most studies have only 
focused on the encapsulated materials and processes.[53, 129, 133-134, 149, 162, 207-208] Attempts 
to actively investigate membrane properties have been sparse, and there have been no 
reported investigation into phase transfer GUV mechanics.  
There is a pressing need to examine the biophysical properties of phase transfer 
GUVs in order to (i) demonstrate that phase transfer GUVs can be used to host 
membrane-proteins for functional use and (ii) demonstrate their potential in studies of 
a membrane-biophysics nature. By determining the mechanical properties of phase 
transfer GUVs, and comparing them to vesicles formed by other methods, both these 
points can be addressed.  
Furthermore, as this method uniquely allows asymmetric vesicles to be generated, it 
paves the way for investigations into the effect of asymmetry on GUV mechanics for 
the first time. Surprisingly, to date, apart from the proof-of-asymmetry experiments,[59, 
62] no further studies concerning GUV asymmetry has been carried out.   
Consequently, this chapter has the following aims: 
i) Develop a robust protocol for phase transfer.  
ii) Optically characterise the transition from droplet to vesicle.  
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iii) Develop vesicle mechanical properties, and to compare these to vesicle 
mechanics formed via electroformation. 
iv) Generate asymmetric vesicles and compare their mechanics to symmetric 
ones.  
 
8.2 EXPERIMENTAL – PHASE TRANSFER  
8.2.1 Materials  
All lipids used in this chapter were purchased from Avanti Polar Lipids. Dyes, oils, 
and all other reagents were purchased from Sigma Aldrich. All experiments were 
visualised with a Nikon Eclipse TE2000-E inverted microscope, and recorded on a 
QImaging camera. For fluorescence experiments, samples were illuminated with a 
mercury arc lamp. 
8.2.2 GUV Generation via Phase Transfer  
A protocol for phase transfer generation of GUVs was developed, using the 
previously reported methods of Malmstadt et al. as a basis.[59]  PDMS wells were first 
assembled by plasma bonding PDMS to a glass slide as described in Section 2.5. As 
will be elaborated upon later, this plasma exposure also made the PDMS hydrophilic, 
which is beneficial for successful phase transfer.  
Immediately after fabrication of the wells, 150 µl of 500 mM glucose in DI water was 
added. This was followed by the addition of 150 µl of 2 mg ml-1 lipid dissolved in 
mineral oil. This column was left to stand for two hours to ensure effective monolayer 
assembly at the water-oil interface. Next, w/o emulsions were made by adding  100 µl 
solution of 2 mg ml-1  lipid in hexadecane to 10 µl of 450 mM sucrose in DI water, and 
then pipetting up and down five times. The emulsion was then added into the oil 
phase of the column. Droplets descended through the interface resulting in GUVs, 
which were monitored under a microscope. The above process is schematically 
depicted in Fig. 8.1. 
In asymmetric GUV generation different lipids were dissolved in the oils forming the 
column and the emulsion. The lipid dissolved in mineral oil (which formed the 
column) formed the external leaflet of the bilayer leaflet; the lipid in the hexadecane 
oil (in which the emulsion was made) formed the inner leaflet of the bilayer.  
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Fig. 8.1 - Phase transfer generation of GUVs. A w/o emulsion was pipetted into a column 
of water and oil, with lipid present in all oil phases. A lipid monolayer self-assembled at all 
water-oil interfaces. The emulsion, which contained sucrose, sunk through the column, 
through the interfacial monolayer, resulting in GUVs.   
 
8.3 RESULTS AND DISCUSSION – PHASE TRANSFER  
8.3.1 Factors Influencing Successful GUV Generation  
In developing the above protocol, several factors were found to be crucial in 
successful GUV generation. The first concerned forming a lipid film prior to 
dissolution in oil. This was achieved by dissolving lipids in chloroform first, which was 
then removed under a stream of nitrogen. If lipid powder was simply dissolved in oil 
without this step, GUV yield was significantly reduced. It is currently unknown why 
exactly this was the case, but it is likely due to how well the lipid dissolved in the oil 
upon sonication.  
Secondly, plasma treatment of the wells immediately prior to construction of the 
column significantly improved GUV yield. This process is known to make PDMS 
hydrophilic due to the induction of polar functional groups on the exposed surfaces, 
predominantly the silanol group (SiOH).[209]  Therefore, the meniscus of the water/oil 
interface was concave and not convex, which aided droplet encapsulation by the 
interfacial monolayer. However, this surface modification was temporary as the 
mobile PDMS polymer chains migrate from the bulk towards the surface, thus 
restoring surface hydrophobicity over time. As such, it was ensured that the time 
between plasma treatment and column preparation was no greater than 10 minutes.  
Thirdly, the density difference between the emulsion and the external aqueous phase 
had to be large enough to provide sufficient force for the emulsions to penetrate the 
interface. The concentrations we used (450 mM sucrose in droplets vs. 500 mM 
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glucose in external aqueous phase) resulted in a density difference of 0.06 g ml-1 which 
was sufficient to drive phase transfer. When a lower density difference of 0.02 g ml -1   
was used (with 100 mM sucrose and 500 mM glucose) GUVs were not successfully 
generated. If needed in future, this could be combated by introducing a centrifugation 
step, as others have done.[59]  
Finally, the identity of the lipid used was found to significantly influence the yield. 
Using POPC lipid yielded several hundred GUVs per well. However when forming 
DOPC GUVs, the yield was reduced to tens of GUVs per well. The source of this low 
yield was ineffective formation of stable emulsions: when using DOPC most droplets 
rapidly coalesced, in contrast to POPC which did not. In future, in order to mitigate 
this, emulsion could be made in a more controlled manner (e.g. with a microfluidic 
device), to give sufficient time for lipid monolayer assembly before contact with other 
droplets. This stabilisation has previously been shown to take tens of seconds.[69]  
8.3.2 Optical Characterisation of Phase Transfer  
The process of phase transfer using POPC lipid was viewed using phase contrast 
microscopy. Droplets at different stages of the process could be observed by focusing 
on different planes of the column (Fig. 8.2). Focusing on the upper oil phase of the 
column revealed the free-flowing emulsions descending down under gravity. At this 
point there was a high contrast between the droplets and their surroundings, as they 
were present in a bulk oil environment. 
Droplets then resided on the water-oil interface of the column. They proceeded to be 
gradually enveloped by the interfacial monolayer, encasing the droplets in a bilayer. 
Following the transition from droplet to vesicle, vesicles were observed to adhere to 
the interface, with only a small proportion of vesicles continuing to descend to the 
bottom of the well to sit on the glass substrate. Importantly, depending on the lipid 
composition, some droplet merging/rupturing occurred on the water/oil interface. 
Droplets either merged with one another to form larger droplets, or they merged with 
the underlying aqueous solution. 
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Fig. 8.2 – Different stages of the phase transfer process. (A) GUV generation. Notice the 
different contrast levels as the w/o droplet was transformed into a w/w vesicle.  (B) Hemi-
fused GUVs were generated when two droplets descend through the interface together. Scale 
bar = 50 µm. 
8.3.3 Multi-Compartment Vesicle Generation  
Due to the high density of droplets made during the emulsion formation stage, many 
droplets deposited on the water-oil column interface in close proximity to one 
another. As such, there were instances when two or more droplets would descend 
through the interface together. This stochastic phenomenon resulted in multi-
compartment vesicles (or hemi-fused vesicles). Fig. 8.3 shows 1, 2, 3 and 4 
compartment vesicles generated in this way. It important to emphasise that the 
formation of such structures were completely random, with no control over the 
vesicle morphology, or indeed inner compartment content. In Chapter Three we 
showed how multi-compartment vesicles can be formed one-by-one with full control 
over vesicle features, including compartment number, size, and content.  
 
Fig. 8.3 – Hemi-fused vesicles. Phase contrast microscopy images of one, two, three and 
four compartment vesicles formed by the encapsulation of several w/o droplets together. 
Unlike the vesicles described in Chapter Three, this process was completely random and 
uncontrolled. Scale bar = 25 µm. 
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8.3.4 Other Membranous Structures  
In addition to simple spherical GUVs, a host of other lipidic structures were formed. 
In order to more clearly detect these, vesicles were doped with 1 mol % Rh-PE 
(fluorescent lipid) and were observed under fluorescent microscopy with a TRITC 
filter. After vesicles were generated, the upper oil phase of the column was removed 
using a syringe to reduce the background fluorescence. The substructures that were 
observed, shown in Fig. 8.4 included: 
(i) Pearling.[210] These were characteristic growths of cylindrical vesicle 
protrusions, which evolved towards a collection of spherical bulbs 
connected by thin tethers, like pearls on a necklace. These pearls were 
dynamic, and underwent elongation and shrinkage with time.    
(ii) Lipid tubular networks. These were networks of lipid tubes and pearls 
that formed a criss-crossing pattern, connecting several vesicles together.  
(iii) Budding. Occasionally, when large (>100 µm) GUVs were formed with 
solid lipid aggregates present, many smaller GUVs were seen to bud off 
the vesicle surface. 
(iv) Tethering. GUVs would regularly be ‘tethered’ to solid aggregates, and 
were deformed accordingly as they were ‘pulled’ toward the tethering 
point.  
(v) Vesicles-in-vesicles. These structures were uncommon, and were only 
observed in a handful of occasions. They were most likely generated 
when vesicles budded inwards, leading to daughter vesicles encapsulated 
inside the parent vesicle.  
 
The formation of these structures are attributed to the excess membrane area 
which resulted from the large osmotic difference between vesicle interior and 
exterior, leading to water departing the vesicles. Vesicle volume thus shrinks, with 
the membrane area remaining constant.   
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Fig. 8.4 – Other lipidic  structures. (A) Vesicle pearling. (B) A network of lipid tubules 
linking various vesicles together. (C) Vesicle budding off a larger ‘mother’ vesicle, with lipid 
aggregates attached to it. (D) A vesicle tethered to a lipid aggregate, leading to vesicle 
deformation. (E) Vesicle-in-vesicle structure. Scale bar = 50 µm. 
8.3.5 Fluorescence Experiments with Membrane Soluble Dye  
One potential pitfall concerning the phase-transfer methodology is the possible 
presence of significant quantities of trapped oil sitting in the hydrophobic region of 
membrane. If this is the case, it is important to know (i) whether oil is present as 
discrete pockets, or evenly distributed throughout the bilayer and (ii) whether 
quantities of trapped oil differ between individual vesicles in a population.  
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To address these two issues, fluorescence images of POPC GUVs with 2 wt. % Nile 
Red (a membrane soluble dye) were recorded, at 100 ms exposures with a TRITC 
filter. Vesicles were generated as before, and analysed as described in Section 2.9, with 
the fluorescence levels of the whole vesicle area analysed. The fluorescence levels of 
only GUVs of a size range of between 40-60 µm diameter were measured. In addition, 
vesicles that were not ‘clean’ (e.g. had observable lipid aggregates or pearling 
structures) were not analysed.  
Fluorescence microscopy revealed no observable fluorescent pockets, suggesting that 
oil lenses were not present (Fig. 8.5A). It was therefore likely that if oil was present it 
was homogenously distributed across the membrane. Comparison between GUVs 
revealed a relatively uniform fluorescence distribution (Fig. 8.5B), with a coefficient of 
variation of 9.8 % (n = 36). This demonstrated that the level of trapped oil (if any) 
was relatively constant within vesicles of similar sizes. In order to obtain absolute 
values for the quantity of trapped oil, alternative methods (e.g. Raman 
spectroscopy)[211] need to be employed, which is beyond the scope of this thesis. 
 
Fig. 8.5 - Trapped oil experiments using a membrane soluble fluorescent dye. (A) 
Brightfield and fluorescence images of a typical GUV. These revealed no visible oil pockets or 
lenses within phase transfer vesicles. Scale bar = 50 µm. (B) Relative fluorescence intensities of 
36 vesicles of 40-60 µm diameter. This reveals a relatively constant level of fluorescence, and 
hence trapped oil (dotted line = average intensity).  
 
8.4 EXPERIMENTAL – BENDING RIGIDITIES  
After optical characterisation of phase transfer GUVs, investigations into their 
mechanical properties were carried out. In particular, GUV bending rigidities were 
studied. This parameter characterises the ability of membranes to bend under low 
stress (refer to Introduction, Section 1.2.2.5 for more details). This property is 
analogous to the bilayer ‘stiffness’ and is related to how much energy is needed to 
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deform it. It is an example of a global membrane property which are thought to 
influence the conformation and behaviour of embedded proteins, as well as 
membrane morphology.[38]  In order to establish whether phase transfer GUVs are 
viable for use in membrane biophysics investigations, it is important to determine the 
bending rigidities of vesicles formed using this method and to compare them to those 
formed via other methods. It should be emphasised that mechanical properties of any 
kind have not been obtained for phase transfer GUVs to date. 
8.4.1 Fluctuation Analysis  
There are several ways to experimentally measure bending rigidities of lipid 
membranes, including micropipette aspiration,[212] by measuring the forces needed for 
tether formation,[213] and via fluctuation analysis.[214] We employ the latter technique as 
it is non-invasive and requires few specialised or expensive equipment. It is based on 
the observation that vesicles undergo thermal fluctuations, where membranes 
undulate in a wave-like manner (see Fig. 8.6).  
One of the prerequisites for fluctuation analysis is for GUVs to be flaccid enough for 
noticeable fluctuations to occur. This is achieved by having a larger concentration of 
sugar in the external solution compared to the inner vesicle volume (450 mM sucrose 
vs. 500 mM glucose respectively), leading to osmosis and a flaccid vesicle capable of 
pronounced fluctuation. From the patterns of these fluctuations, the membrane 
bending rigidity can be extracted.  
 
Fig. 8.6 – Images of phase contrast GUVs. (A) A representative image of a fluctuating 
vesicle. Note the wave like undulations of the membrane surface. (B) Images of a collection of 
~100 vesicles of various sizes. Scale bar = 20 µm.  
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8.4.2 Fluctuation Analysis – Protocol   
The process of fluctuation analysis can be split into four distinct parts: capturing 
fluctuations using video microscopy, extracting the vesicle contours, performing a 
Fourier transform to obtain the constituent modes and their amplitudes, and 
obtaining bending rigidity from this data. These stages, shown in Fig. 8.7, will now be 
described in further detail. 
 
Fig. 8.7 – Fluctuation analysis.   (A) Vesicle contours are found by detecting the bright edge 
at the vesicle boundary. The extracted contour (red) is overlaid on the GUV image.  Scale bar 
= 20 µm. (B) Magnification of a portion of the vesicle. (C) Vesicle contours, converted to 
graph form, showing the wave-like undulations of the membrane. (D) By performing a Fourier 
transform, a power spectrum of the constituent modes is generated. (E) The power spectrum 
is fit to straight line with a gradient of -3 (red). The y-intercept of this line is used to extract the 
bending rigidity.  
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Capturing Fluctuations  
Videos of fluctuating GUVs were recorded using a fast CMOS camera (Luminera 
Infinity-1, exposure of 1 ms, 100 average frames per second). Videos were taken at an 
average ~100 frames per second, for 60 seconds, giving ~6,000 images per vesicle. 
Vesicle outlines were clearly visible as they were viewed under phase-contrast 
microscopy, where the vesicle edges were observed as intensity maxima/minima, 
depending on the phase plates used.  
Contour Extraction  
GUV contours for each frame were extracted using a custom-built Lab-View 
programme (National Instruments, Austin, Texas), designed by Dr S. Purushothaman 
and Dr. N. Brooks. A detailed description of this programme can be found 
elsewhere.[157] Briefly, its underlying operational steps were as follows. First, the 
approximate vesicle centre was defined by the user, together with the internal and 
external regions between which the vesicle boundaries were present. The programme 
then found the membrane outline by detecting a contrast change. The vesicle 
boundary for each frame was then obtained using a radial integration algorithm. The 
precise centre of the vesicle was found by fitting the collected points to a circle, using 
the ‘least square fit’ algorithm. The vesicle diameter was thus attained. The above 
procedure was done for all ca 6,000 frames in the video.  
Contour Analysis  
For small deformations, the distance from the membrane edge to the centre of the 
vesicle was Fourier transformed using an inbuilt LabVIEW function, giving the 
amplitudes of the constituent modes. By doing this to all images collected for a single 
vesicle, average amplitudes for each mode was obtained. Conceptually, each mode 
represents a different type of oscillation that GUVs undergoes, where each 
subsequent mode has two more nodes compared to the previous one. The first mode 
is the simple breathing mode where the vesicles expands and contracts, the second is 
vesicle movement from side to side, the third is a membrane oscillation wave with 4 
nodes and so on (Fig. 8.8).   
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Fig. 8.8 – Vesicle fluctuation modes. The first five modes are shown. The first is the 
breathing mode, the second corresponds to vesicle oscillation from side to side and so on. 
Each subsequent mode has two further nodes associated with it compared to the previous one. 
Obtaining bending rigidities 
To extract vesicle bending rigidities from the data we used the following method, 
explained in more detail by Yoon et al.[215] If the GUV edges are computed in two 
dimensions (x-z plane), setting y = 0, the bending rigidity is given by:[214]  
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Where h is the amplitude of mode qx, L is the vesicle circumference, KB is the 
Boltzmann constant, T is the temperature, σ is the membrane tension, and κ is the 
bending rigidity. For typical values of κ (20-50 kBT) and qx range (105-106 m-1), the 
membrane tension affects the spectrum only if it is greater than ~10-8 N m-1. For 
fluctuations that are bending dominated, σ/(qx2κ)  0, the equation reduces to: 
	ۦ݄ሺݍ௫, ݕ ൌ 0ሻଶۧ ൌ 14ܮ		
݇஻ܶ
ߢݍ௫ଷ 																																						ሺ8.2ሻ 
If we say that L = 2πr, where r is the vesicle radius, and take logarithms of both sides 
of the equation we get:  
log	ۦ݄ሺݍ௫, ݕ ൌ 0ሻଶۧ ൌ െ log 	8ߨݎ 		 ߢݍ௫
ଷ
ܭ஻ܶ																	ሺ8.3ሻ 
The equation is then rearranged to give: 
log	ۦ݄ሺݍ௫, ݕ ൌ 0ሻଶۧ ൌ െ3	log 	ݍ௫ െ log	 8ߨݎߢܭ஻ܶ 						ሺ8.4ሻ 
Therefore, by plotting a graph of  log	ۦ݄ሺݍ௫, ݕ ൌ 0ሻଶۧ   vs. log	q୶, one obtains a 
straight line with a gradient of -3, with a y-intercept (c) of : 
																					C ൌ log	 8ߨݎߢܭ஻ܶ 																																													ሺ8.5ሻ 
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From this, the bending rigidity can be obtained:  
													ߢ ൌ 	10
௖
	8ߨݎ ܭ஻ܶ																																							ሺ8.6ሻ 
The above equation describes the data well above mode 6, due to the assumption we 
previously made where σ is negligible — this is not valid for the first 5 modes which 
are significantly affected by the membrane tension. In addition, as the relaxation times 
for any given mode decreases as a cubic power of the mode number,[215]  high modes 
cannot be detected reliably due to their fast relaxation rate compared to the exposure 
time. In our experiments, exposure times of 1 ms were short enough to capture the 
first ~ 20 modes. All higher modes were discounted. In addition, higher modes have 
smaller amplitudes, so there is also a detection limitation with respect to the spatial 
resolution of the camera. 
8.4.3       Electroformation  
Using the above procedure, bending rigidities were obtained for GUVs formed via 
phase transfer. The rigidities were compared to GUVs formed via the well-established 
‘gold-standard’ method of electroformation. Electroformed vesicles were made by 
depositing 5 µL of lipid in chloroform (1 mg ml-1) between a PDMS spacer on an 
indium tin oxide (ITO) microscope slide. The chloroform was left to evaporate and 
was placed in a lyophiliser for two hours before a second ITO slide was placed above 
the spacer. The slides were clamped together, and the central volume was filled with 
filtered 450 mM sucrose in DI water. Crocodile clips were attached to the two ITO 
slides, and an alternating voltage was applied for one hour (1 V, 10 Hz) leading to 
GUV formation. 10 µl of this solution was then added to 90 µl of 500 mM glucose on 
a glass slide, and vesicles were observed using a phase contrast microscope. The 
various steps involved in electroformation are shown in Fig. 8.9.  
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Fig. 8.9 – Electroformation protocol. (A) lipid-in-chloroform was deposited on an ITO 
slide. (B) Chloroform was then removed by evaporation to give a thin lipid film. (C) A second 
ITO slide was added on top to seal the chamber. (D) Sucrose solution was injected into the 
chamber, filling it completely. (E) Each ITO slide was connected to a function generator. A 
voltage was applied across the slides, leading to GUV formation.  
 
8.5       RESULTS AND DISCUSSION – BENDING RIGIDITIES  
8.5.1 Electroformation vs. Phase Transfer 
Bending rigidities for two types of lipids, DOPC and POPC were measured. These 
lipids differ from one another in the degree of fatty acid saturation and the chain 
length of the R2 fatty-acid tail: in DOPC a double bond and 18 C are present, whereas 
POPC is saturated and has 16 C. The bending rigidities of both these lipids, formed 
either by electroformation or by phase transfer were compared (Fig. 8.10). [Analysis 
performed by Dr. S. Purushothaman]. 
 
Fig. 8.10 – Bending rigidities of DOPC and POPC formed by electroformation and 
phase transfer. For both lipids, values were comparable (within error) regardless of the 
method which was used to form them. Error bars = one standard deviation. The chemical 
structures of the two lipids are shown on the right hand side. Note the different levels of 
saturation and different chain length of the fatty acid regions.  
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Average bending rigidities for ca. 20 individual POPC GUVs made by 
electroformation and by phase transfer were found to be 14.6 ± 2.4  × 10-20 J and 15.2 
± 0.8 × 10-20 J respectively, with errors representing one standard deviation. For 
DOPC, these were found to be 10.7 ± 1.3 × 10-20 J and 11.5 ± 1.3 × 10-20 J 
respectively. The fact that the values obtained by the two methods were comparable 
to one another within error, for both lipids, demonstrates that the quality and integrity 
of GUVs formed by both methods were similar.    
In addition, the values also agreed with those obtained by others (formed via 
electroformation), where DOPC[216] and POPC[217] were found to have rigidities of 
10.8 × 10-20 J and 15.8 × 10-20 J respectively. This agreement with literature gives us 
confidence that the fluctuation analysis technique we use is appropriate, and that it 
produces accurate values for bending rigidities. The differences in values between 
DOPC and POPC has previously been shown to be due to a variation in membrane 
thickness and  the flexibility of the hydrophobic bilayer core,[212] which arise from 
different fatty acid chain lengths and saturation levels. 
Importantly, these results indicate that forming vesicles via the phase transfer method 
does not significantly alter their mechanical properties. They are therefore suitable to 
be used in studies involving embedded proteins, which are affected by bilayer 
mechanics (e.g. MscL). In addition, given the wide use of phase transfer in synthetic 
biology, it offers potential for the incorporation of mechanically-modulated 
components such as mechanosensitive channels and mechanoresponsive membranes 
in functional artificial cells. 
Finally, these results have implications in the context of the debate of how much oil is 
trapped in phase transfer vesicles. The fact that the mechanical properties are the 
same as electroformation (which have no oil present) shows that if there is trapped oil 
it is not in substantial enough quantities to influence their bending rigidities. It must 
be emphasised that the above conclusions must be treated with caution, due to the 
rather low numbers of vesicles studied (~20 for each experiment).   
8.5.2 Asymmetric GUVs  
The phase transfer method for generating GUVs is unique in that it allows the 
introduction of lipid asymmetry. This enables a crucial question to be answered 
experimentally for the first time – does bilayer asymmetry affect GUV mechanics? As 
was elaborated in the Introduction chapter (Section 1.2.1.5), asymmetry is ubiquitous 
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in eukaryotic membranes. Why this is the case however, is still largely unanswered. 
One hypothesis is that asymmetry is used to modulate biological processes by 
influencing membrane mechanics, which in turn has an effect on membrane curvature 
and the conformation of embedded proteins. Up to now, there has been a 
technological bottleneck preventing such theories to be tested on GUVs, due to the 
lack of appropriate methods to make them asymmetric. Here, we conduct a series of 
experiments to investigate the effect of asymmetry on membrane bending rigidities. 
First however, it was necessary to demonstrate if phase transfer GUVs are indeed 
asymmetric.  
8.5.3 Asymmetry Validation   
The asymmetry of vesicles formed via this method have been confirmed by several 
researchers using fluorescent quenching,[59, 62] protein binding experiments,[59] and by 
domain formation studies.[61] We add to these demonstrations by conducting 
fluorescent microscopy experiments on asymmetric hemifused GUVs, which were 
formed as a result of the high densities of vesicles that were generated.  
Asymmetric GUVs were generated in an identical manner to symmetric GUVs, but 
with one crucial difference: the emulsion was incubated with a different lipid to that 
which was present in the water/oil column. The lipid present in the emulsion solution 
comprised the inner leaflet, and the lipid in the oil phase of the column comprised the 
outer leaflet (Fig. 8.1). 
We formed asymmetric GUVs with different fluorescent lipids in their two leaflets. 
The inner leaflet comprised of 1 mol % NBD-PE and POPC. The outer leaflet 
comprised 1 mol % Rh-PE and DOPC. The two fluorophores were imaged using 
FITC and TRITC filters respectively. By introducing different fluorescent lipids in 
each leaflet their distribution could be observed using fluorescence microscopy.  
Fluorescence microscopy revealed that the bilayer separating the two halves of the 
hemifused vesicle pair was composed of the inner-leaflet lipid (Rh-PE), without the 
presence of outer-leaflet lipid (NBD-PE). This is shown in Fig. 8.11. This is the 
expected results if individual GUVs were asymmetric. It must be noted that caution 
needs to be exercised here, due to the low number of hemifused vesicles that were 
observed. 
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Fig. 8.11 – Fluorescence microscopy of hemifused asymmetric GUVs. (A) Schematic of a 
single and hemifused asymmetric GUV. If asymmetric, the segregating bilayer in the hemifused 
GUV will not contain the ‘outer-leaflet’ lipid, shown in red. (B) Asymmetric GUV, with Rh-
PE (yellow channel) and NBD-PE (green channel) in the inner and outer leaflets respectively. 
(C) Hemifused GUVs showed an absence of ‘outer-leaflet’ NBD-PE in the segregating bilayer, 
thus confirming asymmetry. Scale bar = 20 µm. 
8.5.4 Asymmetric GUV Bending Rigidities 
In order to determine the effect of asymmetry on GUV mechanics, three different 
types of GUVs were generated via phase transfer, and their bending rigidity analysed: 
1) DOPC in the inner leaflet and POPC in the outer leaflet.  
2) POPC in the inner leaflet and DOPC in the outer leaflet.  
3) Symmetric 1:1 mixture of DOPC and POPC.  
Results are shown in Fig. 8.12. [Analysis performed by Dr. S. Purushothaman]. 
 
Fig. 8.12 – Bending rigidity of symmetric and asymmetric GUVs. These results indicate 
that asymmetry has the effect of increasing the bending rigidity. Error bars = one standard 
deviation.  
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The bending rigidities obtained, based on an average of 10 vesicles for each 
composition, were as follows: POPC inner, DOPC outer:  32 ± 2 × 10-20 J; DOPC 
inner, POPC outer: 34 ± 7 × 10-20 J; Symmetric 50:50 DOPC/POPC mixture: 15 ± 5 
× 10-20 J. 
The first thing to note is the that the bending rigidities for asymmetric GUVs were 
significantly higher than the symmetric ones. It is tempting to find an explanation to 
this empirical result based on the different desired curvatures of the individual 
monolayers. For example, if the inner leaflet was composed of lipids that preferred the 
curvature associated with the external leaflet, and vice versa, then it would be expected 
that the bilayer would be more rigid, as any further deformation away from its desired 
curvature would be unfavorable. In addition, an asymmetric distribution of lipids will 
lead to an asymmetric lateral pressure profile, and a different stored curvature elastic 
stress, which will also impact on the bending rigidities.   
However, the observation that both types of asymmetric GUVs have higher rigidities 
makes such explanations unlikely. In the example outlined above, it would be 
expected that the ‘inverted’ asymmetric GUV would give lower values than symmetric 
GUVs, with deformations being less energetically unfavorable than in symmetric 
GUVs. In addition, the spontaneous curvatures for both DOPC and POPC are 
almost identical (0.091± 0.008 nm-1, and 0.022 ± 0.010 nm-1 respectively)[218] and both 
are type 0 lipids, meaning their desire for curvature in any case is minimal.  
An alternative explanation is that the introduction of asymmetry leads to the inclusion 
of oil into the bilayer, either as a lens or as a homogenous distribution, perhaps in 
order to relieve local stress imbalances. Rigidity changes resulting from differential 
inclusion of oil would better explain the apparent drastic effects of asymmetry.  
An additional observation is that the rigidities of symmetric 50:50 POCP:DOPC are 
higher than both the pure DOPC and pure POPC GUVs, shown in Section 8.5.1. 
One possible reason for this is that the introduction of a second lipid type may result 
in bilayers with a certain degree of asymmetry, for example due to preferential 
adsorption of one lipid type around w/o droplets. As the previous results indicate, the 
resultant asymmetry appears to result in higher bending rigidity. 
Once again, these results must be treated with care. First of all, the standard deviations 
are significant, at around 6 x 10 -20 × 10-20 J. Such a large variation in the data may be 
attributed to in inherent variability in the amounts of oil trapped in the bilayer. In 
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addition, as the oil is partially soluble in water (0.9 mg ml -1), it is possible that it will 
depart the vesicle over time. As GUVs were measured at different time points after 
formation, they may have different levels of oils present, depending on when their 
fluctuations were recorded.  
The role of flip-flop will also have an impact on the rigidity values, and may 
contribute to the high variability of the data. It is expected that rigidities will change as 
a function of time as the level of asymmetry changes due to lipid flip-flip (flip-flop 
half-life is estimated to be in the order of hours for PC lipids,[18] although others 
dispute this).[214]  This could prove useful in future studies, where bending rigidities 
could be used as a proxy for asymmetry. Changes in bending rigidities could then be 
used a label-free technique to determine flip-flop rates. The indication that asymmetry 
has a stark effect membrane mechanical properties has immediate consequences for 
the study of membrane protein folding,[219-220] the behavior of integral-membrane 
proteins (particularly mechnosensitive pores),[221-222] as well as membrane-associated 
proteins which may be regulated by membrane mechanics.[25] It may have crucial 
implications on the causal mechanisms and biophysics behind processes such as 
membrane trafficking, and endo- and exo-cytosis.  
8.6 CHAPTER CONCLUSIONS  
In conclusion, we develop a protocol for GUV generation via phase transfer, and 
identify crucial factors which influence successful vesicle generation. We use 
fluorescence microscopy to observe vesicle substructures including pearl-like tubular 
networks. By combining classical biophysical techniques to phase transfer 
technologies we measure the mechanical properties of phase transfer GUVs for the 
first time, and show that such vesicles have similar bending rigidities to those formed 
via other methods. This shows the phase transfer method produces GUV of a similar 
quality to electroformation, and as such can be used in biophysical studies and to host 
transmembrane pores.  
Significantly, we obtain the first empirical measurement of a mechanical property of 
asymmetric GUVs, and obtain results which indicate that asymmetry significantly 
affects membrane bending rigidity. This has notable consequences in understanding 
the role of membranes in cells, the majority of which are asymmetric. This 
breakthrough shows that it is possible use asymmetric GUVs to fill the void in our 
knowledge of the precise role that asymmetry plays in cells, and paves the way for 
further studies into the role of asymmetry on membrane mechanics.   
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Chapter 9 – Conclusions 
and Future Directions  
 
The overarching goal of this thesis was to develop multi-compartment vesicles 
(MCVs) and related membrane structures for use as artificial cells and droplet-devices. 
In the preceding chapters we reached several key breakthroughs towards achieving 
this goal.  
9.1 SUMMARY OF FINDINGS   
Chapter Three concerned developing a variation of phase transfer which enabled 
MCVs to be generated with user-defined compartment number, content, and size. 
This novel technological innovation — never previously achieved—has the potential 
to underpin fundamental advances in bio-devices and in creation of artificial cells, 
topics which are explored in subsequent chapters.  
In Chapter Four we transformed the vesicles into artificial cells by encapsulating the 
universal biological processes of transcription and translation. Crucially, we showed 
that compartmentalisation allowed spatial segregation of function. This organising 
principle, seen in eukaryotic organelles, was demonstrated by the biochemical 
synthesis of two distinct proteins in two vesicle regions. Importantly, this result 
demonstrated that MCVs allow the complex spatial organisation of biological cells to 
be introduced into artificial cells for the first time.  
In Chapter Five we introduced a further biological feature into the artificial cells: an 
engineered artificial signalling cascade. A chemical signal, received from the external 
environment, was transmitted through the membrane into the vesicle interior with the 
aid of transmembrane protein pores. The signal was then propagated across the 
various vesicle compartments through an intracellular signalling network, finally 
inducing a response in the form of fluorescent molecule synthesis in a defined 
compartment. This result highlighted what can be achieved with 
compartmentalisation, and demonstrated the potential of MCVs to be used as a new 
class of artificial cells with increasingly complex cell-like features.   
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Chapter Six aimed to counter one of the main deficiencies of the MCV system we 
developed: up to this point they were formed one-by-one through manual pipetting. 
In this light, we designed and constructed microfluidic devices to generate similar 
structures (multisomes) in high-throughput using w/o/w double emulsions as 
templates. Importantly, inner-droplet number, packing geometry, and droplet content 
and size were user-defined.  
In Chapter Seven we demonstrated applications for multisomes as modular droplet 
devices. Initial attempts at demonstrating click-chemistry within them failed due to the 
incompatibility of the reagents in water/oil systems. Pyrylium chemistry on the other 
hand was more successful. We demonstrated the synthesis of a pharmacologically 
relevant moiety (pyridinium), by the reaction between a pyrylium and a primary amine 
in a modular device: one droplet acted as a reagent reservoir, continuously delivering 
reagent to the adjacent ‘synthesis’ droplet. The fact that these devices exist in a 
physiological (i.e. aqueous) environment paves the way for smart in vivo drug 
synthesis in response to relevant stimuli.  
Finally, in Chapter Eight, a protocol for generating GUVs out of w/o droplets was 
developed and characterised, and bending rigidity values for these membranes were 
obtained. These were revealed to be similar to those attained by electroformation, 
confirming the quality and integrity of phase transfer vesicles, and validating their use 
for studies where biophysical membrane properties are important. Bending rigidities 
of asymmetric membranes were then compared to symmetric ones, revealing 
significant differences. This constitutes the first ever study of asymmetric GUV 
mechanics: it is critical milestone paving the way for further studies into the role of 
asymmetry on membrane behaviour.  
9.2 FUTURE WORK AND OUTLOOK 
The experiments detailed in this thesis have opened up multiple avenues for future 
investigations. The nature of these potential studies broadly falls into two categories. 
The first is developing a better understanding of the chemistry and biophysics of the 
structures developed. The second involves designing and constructing structures with 
more intricate features, to perform functional roles – these studies have a significant 
engineering character to them. Potential future research directions will now be 
discussed.  
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9.2.1 Oil Removal from Multisomes  
In this thesis two multi-compartment structures were generated, each with their own 
associated advantages. MCVs (Chapter Three) did not have an intermediate oil phase, 
and were fully encased by a bilayer. The lack of oil increases their bio-compatibility 
and affords them greater biomimetic potential as they better resemble biological cells. 
Multisomes (Chapter Six) on the other hand were constructed on-chip using 
microfluidic technologies, enabling them to be generated in high throughput, with fine 
control over compartment size, and with reduced volumes. This raises the question: 
can one convert multisomes into MCVs, thereby combining the advantages associated 
with each platform?  
The above issue could be tackled in future using one of two strategies. Oil could be 
removed by taking advantage of PDMS’s ability to of absorb organic solvents.[223] This 
process, which occurs due to hydrophobic pores that are present in the polymer 
network, has previously been used to generate black-lipid membranes (Section 
1.3.5.2).[68] By having specialised regions of PDMS ‘sponge-like’ wells on-chip, an 
analogous principle could be adopted to transform multisomes into MCVs (Fig. 9.1).  
Alternatively, a volatile oil which is partially soluble the surrounding aqueous solution 
could be used. This would similarly result in gradual depletion of the intermediate oil 
phase, yielding MCVs.   
 
Fig. 9.1 – Conversion of multisomes to MCVs. PDMS can be used to extract the 
intermediate multisome oil phase. Oil removal will result in an encasing bilayer, yielding MCVs. 
9.2.2 Introduction of Responsiveness  
As stated previously, the overall vision behind this thesis is to develop membrane-
based structures that can be used in physiological environments for functional 
purposes, such as in vivo drug synthesis. In all demonstrations we have outlined, the 
processes contained were passive by nature — crucially, processes were not initiated 
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in response to biologically relevant stimuli. Future work could focus on introducing a 
higher level of responsiveness into the structures developed here. 
Luckily, responsiveness can be introduced  by incorporating the appropriate biological 
machinery, such as mechanosensitive channels which gate in response to bilayer stress, 
or  by incorporation of genetic circuits  which initiate protein synthesis in the presence 
of an inducer or other effector molecule present in the external environment. 
An alternative tactic to introduce responsiveness is to utilise lipid phase behaviour. 
Phase transitions are known to be induced by temperature and pH changes,[78, 224] UV 
irradiation,[73] and by the presence of non-lipidic molecules in the bilayer.[33] As phase 
transitions are often accompanied by changes in bilayer porosity, responsive 
membrane structures can be constructed by appropriately constructing membranes of 
appropriate compositions. Importantly, many of the factors that induce phase 
transition are also associated with disease markers. For example, tumours are known 
to have a higher temperature and lower pH. This is caused by faster cell metabolism 
(increasing temperature), which leads to lactic acid build-up lowering surrounding 
pH.[225] This is supplemented by the poor vasculature surrounding tumours, increasing 
anaerobic respiration.  
By achieving responsiveness, dormant multi-compartment systems could be 
constructed which only become activated upon encountering biologically relevant 
stimuli. This will be a significant breakthrough in the quest for smart drug synthesis 
within a drug delivery vehicle, and will provide a step-change in current drug-delivery 
strategies: it will allow a drug to be synthesised — and not simply delivered — at the 
target site.  
9.2.3 Controlling Compositions of Higher-Order Multisomes  
The devices we use for on-chip multisome generation (Chapter Six) required a 
different inlet for every internal droplet composition. Although for two-compartment 
vesicles this was possible, this becomes more cumbersome for higher-order 
multisomes, not least because of the confined space of a microfluidic device, and the 
need for separate pumps for each inlet. This problem could be addressed by 
networking a double emulsion chip with a droplet generation device capable of 
sampling droplets from tens of different wells (for example, the Dropix system, 
Dolomite Microfluidics).[105]  In this way, multisomes with tens of internal 
compartments, each one with a distinct composition, could be generated (Fig. 9.2). 
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Fig. 9.2  – Forming higher order multisomes with control over inner droplet content. By 
networking a droplet sampling device to a microfluidic chip, multisomes with many inner-
droplets of differing compositions could be formed without the need for separate inlets for 
each droplet composition. 
9.2.4 Asymmetry – The Effects of Different Lipids  
Chapter Eight dealt with vesicles formed via the phase transfer methodology, with a 
specific emphasis on studying bending rigidities of symmetric and asymmetric vesicles. 
We only performed a limited study, concerning only two lipid types, DOPC and 
POPC. This prevented a full understanding of why asymmetry changed the bending 
rigidity. Future experiments may involve measuring the effects of asymmetry with a 
diverse library of lipids, with different headgroups, charge, chain lengths, and 
saturation levels. It would be particularly interesting to investigate how the 
introduction of type II lipids (e.g. DOPE) in the inner and outer leaflets would affect 
bending rigidity, as an asymmetric distribution of these lipids are expected to have a 
larger effect on mechanical properties than the Type 0 lipids we have used.  
By undertaking a comprehensive survey of this type, it is expected that patterns will 
emerge which will help shed light of the precise reasons that asymmetric vesicles have 
different mechanical properties to their symmetric counterparts.  
9.2.5 Quantifying the Levels of Asymmetry  
In Chapter Eight, we demonstrated that vesicles generated by phase transfer are 
asymmetric through fluorescence microscopy experiments of hemifused vesicles, and 
by showing a difference in bending rigidity values. However from these experiments 
— and indeed from all other reports in the literature — the extent of asymmetry is still 
unclear.  For instance, are all the lipids in one leaflet of one type, or is it simply that 
one leaflet has a greater proportion of a certain lipid than the other?  
One way in which the extent of asymmetry can be quantified is via a FRET assay, 
which we have begun to develop. This principle behind this is that FRET efficiencies 
between fluorescent lipids lying in the same leaflet will be different to those lying in 
opposite leaflets due to the different spatial separation between fluorophores — 
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FRET efficiency decreases to the sixth power with distance (Fig. 9.3). By monitoring 
the FRET efficiencies of asymmetric vesicles with the appropriate fluorescent lipids in 
each leaflet, the extent of asymmetry can be quantified. In preliminary investigations, 
we have shown that lipids tagged with two FRET pair fluorophores, Rh and NBD, 
successfully show FRET in symmetric vesicles (Fig. 9.3C).  
 
Fig. 9.3 – GUV asymmetry FRET assay. (A) In symmetric GUVs, FRET-pair lipids will 
reside in the same leaflet, leading to a large FRET efficiency due to low separation distances. 
(B) In asymmetric GUVs, FRET-pair lipids will reside in opposite leaflets, leading to a low 
FRET efficiency. (C) Symmetric vesicles comprising of both NBD and Rh labelled lipids were 
exited at the NBD excitation wavelength. This resulted in an increased emission of Rh 
fluorophore (red arrow), and a decreased emission in the NBD fluorophore (blue arrow) 
confirming FRET. 
9.2.6 Amount of Oil Trapped in Bilayer  
It have been suggested by others that the emulsion method of GUV generation leads 
to trapped oil in the bilayers. The results in Chapters Three and Eight indicate that 
this is minimal, through mechanical measurements and successful protein 
reconstitution.   However, further characterisation of the GUVs is needed to further 
establish this. This could be achieved using Raman spectroscopy, by looking at 
characteristic signals associated with oil in the bilayer. Indeed, such experiments on 
GUVs generated by the ‘jetting’ technique have previously been performed.[211] 
Alternative experiments could involve incorporating an oil-sensitive dye into vesicles, 
and comparing the fluorescence to vesicles formed via oil-free methods 
(electroformation).  
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9.3 CONCLUDING STATEMENTS  
This thesis outlined several technological innovations that underpin the development 
of multi-compartment artificial cells. These breakthroughs facilitated a step-change in 
the type and scope of cell-like features that could be introduced into vesicles systems. 
Proof-of-concept experiments for potential medicinal applications underscored its 
potential as a cornerstone platform for bio-inspired devices. It is expected that 
through future synergies with the disciplines of microfluidics, membrane-science, and 
synthetic biology, the potential of the developed systems as a novel class of smart, 
functional devices can be realised.  
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GFP Plasmid Map 
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